Skip to main content

Browse the archive

https://github.com/ellenakearney/Anopheles_salivary_biomarker_systematic_review
29 September 2023, 12:43:47 UTC
Raw File
Tip revision: eadb7ab1cbf93c730fb463f43e1b13b9ae16ddd3 authored by ellenakearney on 21 February 2022, 04:39:51 UTC
Create LICENSE
Tip revision: eadb7ab
Anopheles salivary biomarkers review.dta 
<stata_dta><header><release>118</release><byteorder>LSF</byteorder><K>k</K><N>Š</N><label></label><timestamp> 8 Sep 2021 19:50</timestamp></header><map>ž>ýBãÌõC
·VÊ=eÊ=MÒ=YÒ=</map><variable_types>úÿ÷ÿúÿùÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿùÿ	÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿúÿúÿùÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿúÿ÷ÿúÿ÷ÿúÿúÿùÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿùÿ	÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿúÿúÿúÿúÿúÿùÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿúÿ÷ÿ÷ÿ÷ÿúÿúÿúÿ÷ÿúÿ÷ÿ÷ÿ÷ÿúÿúÿúÿ÷ÿùÿ	÷ÿ÷ÿ÷ÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿùÿúÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿ÷ÿ÷ÿ÷ÿúÿ
2ùÿúÿ÷ÿ÷ÿ÷ÿ

	

ùÿP÷ÿ÷ÿ÷ÿúÿ
úÿúÿùÿ÷ÿ÷ÿ÷ÿúÿ

úÿùÿ÷ÿ÷ÿ÷ÿ


%ùÿ_÷ÿ÷ÿ÷ÿúÿ
2ùÿùÿúÿúÿ
÷ÿ÷ÿ÷ÿúÿ
ùÿ÷ÿ÷ÿ÷ÿúÿ
2ùÿ÷ÿ÷ÿ÷ÿ

úÿúÿúÿùÿ÷ÿ÷ÿ÷ÿúÿ
ùÿ÷ÿ÷ÿ÷ÿúÿ
ùÿ÷ÿ÷ÿ÷ÿ
."
#_÷ÿ÷ÿ÷ÿ
"ä#‰÷ÿ÷ÿ÷ÿ
÷ÿ÷ÿ÷ÿ
÷ÿ÷ÿ÷ÿ
#ùÿ÷ÿ÷ÿ÷ÿ


úÿùÿ÷ÿ÷ÿ÷ÿúÿ#ùÿ÷ÿ÷ÿ÷ÿ

úÿùÿ÷ÿ÷ÿ÷ÿúÿúÿúÿ÷ÿ÷ÿ÷ÿúÿúÿúÿ÷ÿ÷ÿ÷ÿ
úÿ
ùÿ÷ÿ÷ÿ÷ÿúÿùÿ÷ÿ÷ÿ÷ÿúÿúÿùÿ÷ÿ÷ÿ÷ÿ

úÿùÿ÷ÿ÷ÿ÷ÿ
úÿùÿ÷ÿ÷ÿ÷ÿ
úÿùÿ÷ÿ÷ÿ÷ÿ
úÿùÿúÿ
 Ö&5)*16),,ùÿBËŸúÿøÿ÷ÿúÿúÿ ÷ÿ÷ÿ%ùÿ÷ÿ÷ÿúÿ)øÿ÷ÿ÷ÿ÷ÿ÷ÿúÿ</variable_types><varnames>id1obssubpopulationtimepointtimepoint_ngsg6_igg_nsubpopfsalserogsg6_igg_methodlogygsg6_igg_controlscontrolpopulatgsg6_igg_seroprevalencegsg6_igg_prev_lcigsg6_igg_prev_ucigsg6_igg_med_odgsg6_igg_od_25gsg6_igg_od_75dgsg6_igg_mean_odgsg6_igg_se_odopofsalserogsg6_igg1_nsubpopfsalserogsg6_igg1_methodlogytrolpopulagsg6_igg1_controlscontrolpopulagsg6_igg1_seroprevalencegsg6_igg1_prev_lcigsg6_igg1_prev_ucigsg6_igg1_med_odgsg6_igg1_od_25gsg6_igg1_od_75dgsg6_igg1_mean_odgsg6_igg1_se_odpofsalserogsg6_igg4_nsubpopfsalserogsg6_igg4_methodlogytrolpopulagsg6_igg4_controlscontrolpopulagsg6_igg4_seroprevalencegsg6_igg4_prev_lcigsg6_igg4_prev_ucigsg6_igg4_med_odgsg6_igg4_od_25gsg6_igg4_od_75dgsg6_igg4_mean_odgsg6_igg4_se_odpofsalserogsg6p1_igg_nsubpopsalserogsg6p1_igg_methodogytrolpopulagsg6p1_igg_controlsontrolpopulagsg6p1_igg_seroprevalencegsg6p1_igg_prev_lcigsg6p1_igg_prev_ucigsg6p1_igg_med_odgsg6p1_igg_od_25gsg6p1_igg_od_75gsg6p1_igg_mean_odgsg6p1_igg_se_odofsalserogsg6p1_igm_nsubpopsalserogsg6p1_igm_methodogytrolpopulagsg6p1_igm_controlsontrolpopulagsg6p1_igm_seroprevalencegsg6p1_igm_prev_lcigsg6p1_igm_prev_ucigsg6p1_igm_med_odgsg6p1_igm_od_25gsg6p1_igm_od_75gsg6p1_igm_mean_odgsg6p1_igm_se_odnsubpopofsalserangamsge_igg_nsubpoppopofsalserangambsge_igg_methododologytroangambsge_igg_controlssedcontroangambsge_igg_seroprevalenceceangambsge_igg_prev_lciciangambsge_igg_prev_uciciangambsge_igg_med_ododangambsge_igg_od_2525angambsge_igg_od_7575dangambsge_igg_mean_ododangambsge_igg_se_ododpofsalserangambsge_ige_nsubpopopofsalserangambsge_ige_methododologytroangambsge_ige_controlssedcontroangambsge_ige_seroprevalenceceangambsge_ige_prev_lciciangambsge_ige_prev_uciciangambsge_ige_med_ododangambsge_ige_od_2525angambsge_ige_od_7575dangambsge_ige_mean_ododangambsge_ige_se_ododopofsalseangambsge_igg4_nsubpopopofsalseangambsge_igg4_methododologytrangambsge_igg4_controlssedcontrangambsge_igg4_seroprevalenceceangambsge_igg4_prev_lciciangambsge_igg4_prev_uciciangambsge_igg4_med_ododangambsge_igg4_od_2525angambsge_igg4_od_7575dangambsge_igg4_mean_ododangambsge_igg4_se_ododce5_igg_nsubpopfsalseroce5_igg_methodlogytrolpopulatice5_igg_controlscontrolpopulatice5_igg_seroprevalencece5_igg_prev_lcice5_igg_prev_ucice5_igg_med_odce5_igg_od_25ce5_igg_od_75dce5_igg_mean_odce5_igg_se_odopofsalseroce5_igg1_nsubpopfsalseroce5_igg1_methodlogytrolpopulatce5_igg1_controlscontrolpopulatce5_igg1_seroprevalencece5_igg1_prev_lcice5_igg1_prev_ucice5_igg1_med_odce5_igg1_od_25ce5_igg1_od_75dce5_igg1_mean_odce5_igg1_se_odpofsalseroce5_igg4_nsubpopfsalseroce5_igg4_methodlogytrolpopulatce5_igg4_controlscontrolpopulatce5_igg4_seroprevalencece5_igg4_prev_lcice5_igg4_prev_ucice5_igg4_med_odce5_igg4_od_25ce5_igg4_od_75dce5_igg4_mean_odce5_igg4_se_odpofsalserofsg6_igg_nsubpopfsalserofsg6_igg_methodlogytrolpopulatfsg6_igg_controlscontrolpopulatfsg6_igg_seroprevalencefsg6_igg_prev_lcifsg6_igg_prev_ucifsg6_igg_med_odfsg6_igg_od_25fsg6_igg_od_75dfsg6_igg_mean_odfsg6_igg_se_odopofsalserof5nuc_igg_nsubpopfsalserof5nuc_igg_methodlogytrolpopulaf5nuc_igg_controlscontrolpopulaf5nuc_igg_seroprevalencef5nuc_igg_prev_lcif5nuc_igg_prev_ucif5nuc_igg_med_odf5nuc_igg_od_25f5nuc_igg_od_75df5nuc_igg_mean_odf5nuc_igg_se_odpofsalserog5nuc_igg_nsubpopfsalserog5nuc_igg_methodlogytrolpopulag5nuc_igg_controlscontrolpopulag5nuc_igg_seroprevalenceg5nuc_igg_prev_lcig5nuc_igg_prev_ucig5nuc_igg_med_odg5nuc_igg_od_25g5nuc_igg_od_75dg5nuc_igg_mean_odg5nuc_igg_se_odopofsalserogsg6p2_igg_nsubpopfsalserogsg6p2_igg_methodlogytrolpopulgsg6p2_igg_controlscontrolpopulgsg6p2_igg_seroprevalencegsg6p2_igg_prev_lcigsg6p2_igg_prev_ucigsg6p2_igg_med_odgsg6p2_igg_od_25gsg6p2_igg_od_75dgsg6p2_igg_mean_odgsg6p2_igg_se_odopofsalserotransp1_igg_nsubpopfsalserotransp1_igg_methodlogytrolpoputransp1_igg_controlscontrolpoputransp1_igg_seroprevalencetransp1_igg_prev_lcitransp1_igg_prev_ucitransp1_igg_med_odtransp1_igg_od_25transp1_igg_od_75dtransp1_igg_mean_odtransp1_igg_se_odpofsalserotransp2_igg_nsubpopfsalserotransp2_igg_methodlogytrolpoputransp2_igg_controlscontrolpoputransp2_igg_seroprevalencetransp2_igg_prev_lcitransp2_igg_prev_ucitransp2_igg_med_odtransp2_igg_od_25transp2_igg_od_75dtransp2_igg_mean_odtransp2_igg_se_odpofsalseroperoxp1_igg_nsubpopfsalseroperoxp1_igg_methodlogytrolpopuperoxp1_igg_controlscontrolpopuperoxp1_igg_seroprevalenceperoxp1_igg_prev_lciperoxp1_igg_prev_uciperoxp1_igg_med_odperoxp1_igg_od_25peroxp1_igg_od_75dperoxp1_igg_mean_odperoxp1_igg_se_odpofsalseroperoxp2_igg_nsubpopfsalseroperoxp2_igg_methodlogytrolpopuperoxp2_igg_controlscontrolpopuperoxp2_igg_seroprevalenceperoxp2_igg_prev_lciperoxp2_igg_prev_uciperoxp2_igg_med_odperoxp2_igg_od_25peroxp2_igg_od_75dperoxp2_igg_mean_odperoxp2_igg_se_odpofsalseroperoxp3_igg_nsubpopfsalseroperoxp3_igg_methodlogytrolpopuperoxp3_igg_controlscontrolpopuperoxp3_igg_seroprevalenceperoxp3_igg_prev_lciperoxp3_igg_prev_uciperoxp3_igg_med_odperoxp3_igg_od_25peroxp3_igg_od_75dperoxp3_igg_mean_odperoxp3_igg_se_odcontrolpopulatpfpositive_pcr_estimatepfpositive_pcr_lcipfpositive_pcr_ucipfpositive_pcr_unitpfpositive_pcr_ind_popalpopulatpfpositive_pcr_definitionpfpositive_pcr_casedetectedetecpfpositive_pcr_febrilepfpositive_pcr_timingpfpositive_pcr_cohortdincohortpfpositive_pcr_reportednthestudpfpositive_pcr_sourcepfpositive_pcr_nexposurepfpositive_notespfpositive_micro_estimatepfpositive_micro_lcipfpositive_micro_ucipfpositive_micro_unitpfpositive_micro_ind_popalpopulpfpositive_micro_definitionpfpositive_micro_casedetectedetpfpositive_micro_febrilepfpositive_micro_timingpfpositive_micro_cohortdincohorpfpositive_micro_reportednthestpfpositive_micro_sourcepfpositive_micro_nexposurepfpositive_micro_notespfpositive_asympto_estimatepfpositive_asympto_lcipfpositive_asympto_ucipfpositive_asympto_unitpfpositive_asympto_ind_popalpoppfpositive_asympto_definitionpfpositive_asympto_casedetectedpfpositive_asympto_febrilepfpositive_asympto_timingpfpositive_asympto_cohortdincohpfpositive_asympto_reportednthepfpositive_asympto_sourcepfpositive_asympto_nexposurepfpositive_febrile_estimatepfpositive_febrile_lcipfpositive_febrile_ucipfpositive_febrile_unitpfpositive_febrile_ind_popalpoppfpositive_febrile_definitionpfpositive_febrile_casedetectedpfpositive_febrile_febrilepfpositive_febrile_timingpfpositive_febrile_cohortdincohpfpositive_febrile_reportednthepfpositive_febrile_sourcepfpositive_febrile_nexposureparapos_micro_estimateparapos_micro_lciparapos_micro_uciparapos_micro_unitparapos_micro_ind_popalpopulatiparapos_micro_definitionparapos_micro_casedetectedetectparapos_micro_febrileparapos_micro_timingparapos_micro_cohortdincohortparapos_micro_reportednthestudyparapos_micro_sourceparapos_micro_nexposureparapos_micro_notesparapos_pcr_estimateparapos_pcr_lciparapos_pcr_uciparapos_pcr_unitparapos_pcr_ind_popalpopulationparapos_pcr_definitionparapos_pcr_casedetectedetectioparapos_pcr_febrileparapos_pcr_timingparapos_pcr_cohortdincohortparapos_pcr_reportednthestudyparapos_pcr_sourceparapos_pcr_nexposureparapos_clinincidence_estimateparapos_clinincidence_lciparapos_clinincidence_uciparapos_clinincidence_unitparapos_clinincidence_individualparapos_clinincidence_definitionparapos_clinincidence_casedetectparapos_clinincidence_febrileparapos_clinincidence_timingparapos_clinincidence_cohortdinparapos_clinincidence_reportednparapos_febrile_estimateparapos_febrile_lciparapos_febrile_uciparapos_febrile_unitparapos_febrile_ind_popalpopulaparapos_febrile_definitionxûÐ÷+P 0ÿ
parapos_febrile_casedetectedeteparapos_febrile_febrileparapos_febrile_timingparapos_febrile_cohortdincohortparapos_febrile_reportednthestuparapos_febrile_sourceparapos_febrile_nexposurepvpos_pcr_estimatepvpos_pcr_lcipvpos_pcr_ucipvpos_pcr_unitpvpos_pcr_ind_popalpopulationespvpos_pcr_definitionpvpos_pcr_casedetectedetectionpvpos_pcr_febrilepvpos_pcr_timingpvpos_pcr_cohortdincohortpvpos_pcr_reportednthestudypvpos_pcr_sourcepvpos_pcr_nexposurepvpos_micro_estimatepvpos_micro_lcipvpos_micro_ucipvpos_micro_unitpvpos_micro_ind_popalpopulationpvpos_micro_definitionpvpos_micro_casedetectpvpos_micro_febrileincohortpvpos_micro_timingdnthestudypvpos_micro_cohortdpvpos_micro_reportedpvpos_micro_sourcerepvpos_micro_nexposurepmpos_estimatepmpos_lcipmpos_uciopalpopulationestimapmpos_unitoppmpos_ind_poppmpos_febrileincohortpmpos_timingdnthestudypmpos_cohortdpmpos_reportedpmpos_sourcerepmpos_nexposurepopos_estimatepopos_lcipopos_uciopalpopulationestimapopos_unitoppopos_ind_poppopos_febrileincohortpopos_timingdnthestudypopos_cohortdpopos_reportedpopos_sourcerepopos_nexposurehbr_estimatehbr_lcihbr_uciopalpopulationestimatehbr_unitoponhbr_ind_poponedetectionhbr_definitionhbr_casedetectohorthbr_timingdnthestudyhbr_cohortdhbr_reportedhbr_sourcerehbr_nexposurehbr_notesteeir_estimateeir_lcieir_uciopalpopulationestimateeir_unitoponeir_ind_poponedetectioneir_definitioneir_casedetectohorteir_timingdnthestudyeir_cohortdeir_reportedeir_sourceremergeeir_nexposureeir_notesmatepfeir_estimatepfeir_lcipfeir_uciopalpopulationestimapfeir_unitopctedetectionpfeir_ind_popctpfeir_casedetectohortpfeir_timingdnthestudypfeir_cohortdpfeir_reportedmergepfeir_sourcerepfeir_nexposurepveir_estimatepveir_lcipveir_uciopalpopulationestimapveir_unitopctedetectionpveir_ind_popctpveir_casedetectohortpveir_timingdnthestudypveir_cohortdpveir_reportedmergepveir_sourcereatepveir_nexposureatepfama1_igg_estimatepfama1_igg_lcipfama1_igg_uciopalpopulationepfama1_igg_unitoponpfama1_igg_ind_poponpfama1_igg_definitionohortpfama1_igg_timingdnthestudypfama1_igg_cohortdpfama1_igg_reportedergepfama1_igg_sourcerepfama1_igg_nexposurepfmsp119_igg_estimatepfmsp119_igg_lcipfmsp119_igg_uciopalpopulatiopfmsp119_igg_unitoponpfmsp119_igg_ind_poponpfmsp119_igg_definitionohortpfmsp119_igg_timingdnthestudypfmsp119_igg_cohortdpfmsp119_igg_reportedgepfmsp119_igg_sourcerepfmsp119_igg_nexposurepfmsp2_igg_estimatepfmsp2_igg_lcipfmsp2_igg_uciopalpopulationepfmsp2_igg_unitoponpfmsp2_igg_ind_poponpfmsp2_igg_definitionohortpfmsp2_igg_timingdnthestudypfmsp2_igg_cohortdpfmsp2_igg_reportedergepfmsp2_igg_sourcerepfmsp2_igg_nexposurepfcsp_igg_estimatepfcsp_igg_lcipfcsp_igg_uciopalpopulationespfcsp_igg_unitoponpfcsp_igg_ind_poponpfcsp_igg_definitionohortpfcsp_igg_timingdnthestudypfcsp_igg_cohortdpfcsp_igg_reportedmergepfcsp_igg_sourcerepfcsp_igg_nexposurepfcsp_igg1_estimatepfcsp_igg1_lcipfcsp_igg1_uciopalpopulationepfcsp_igg1_unitoppfcsp_igg1_ind_popincohortpfcsp_igg1_timingdnthestudypfcsp_igg1_cohortdpfcsp_igg1_reportedpfcsp_igg1_sourcereergepfcsp_igg1_nexposurepfcsp_igg3_estimatepfcsp_igg3_lcipfcsp_igg3_uciopalpopulationepfcsp_igg3_unitoppfcsp_igg3_ind_popincohortpfcsp_igg3_timingdnthestudypfcsp_igg3_cohortdpfcsp_igg3_reportedpfcsp_igg3_sourcerepfcsp_igg3_nexposureergepfse_igg_estimatepfse_igg_lcipfse_igg_uciopalpopulationestpfse_igg_unitoponpfse_igg_ind_poponedetectionpfse_igg_definitionpfse_igg_casedetectohortpfse_igg_timingdnthestudypfse_igg_cohortdpfse_igg_reportedpfse_igg_sourcerepfse_igg_nexposurepfse_igg1_estimatepfse_igg1_lcipfse_igg1_uciopalpopulationespfse_igg1_unitoppfse_igg1_ind_popincohortpfse_igg1_timingdnthestudypfse_igg1_cohortdpfse_igg1_reportedpfse_igg1_nexposurepfse_igg3_estimatepfse_igg3_lcipfse_igg3_uciopalpopulationespfse_igg3_unitoponpfse_igg3_ind_poponedetectionpfse_igg3_definitionpfse_igg3_casedetectohortpfse_igg3_timingdnthestudypfse_igg3_cohortdpfse_igg3_reportedpfse_igg3_nexposurepfglurp_igg_estimatepfglurp_igg_lcipfglurp_igg_uciopalpopulationpfglurp_igg_unitoponpfglurp_igg_ind_poponpfglurp_igg_definitionohortpfglurp_igg_timingdnthestudypfglurp_igg_cohortdpfglurp_igg_reportedpfglurp_igg_sourcerepfglurp_igg_nexposurepfmsp3_igg_estimatepfmsp3_igg_lciopalpopulationepfmsp3_igg_ucioponpfmsp3_igg_unitoponpfmsp3_igg_ind_poponohortpfmsp3_igg_definitionhestudypfmsp3_igg_timingdpfmsp3_igg_cohortdpfmsp3_igg_reportedpfmsp3_igg_sourcerepfmsp3_igg_nexposurepvama1_igg_estimatepvama1_igg_lciopalpopulationepvama1_igg_ucioponpvama1_igg_unitoponpvama1_igg_ind_poponohortpvama1_igg_definitionhestudypvama1_igg_timingdpvama1_igg_cohortdpvama1_igg_reportedpvama1_igg_sourcerepvama1_igg_nexposurepvmsp119_igg_estimatepvmsp119_igg_lciopalpopulatiopvmsp119_igg_ucioponpvmsp119_igg_unitoponpvmsp119_igg_ind_poponohortpvmsp119_igg_definitionhestudypvmsp119_igg_timingdpvmsp119_igg_cohortdpvmsp119_igg_reportedpvmsp119_igg_sourcerepvmsp119_igg_nexposure_apprp_igg_nexposurestudyyear_studystudy_typeregioncountryareaendemicitydvsparticipantsage_meanage_sdage_medage_iqrage_rangennumberofsamplesintitialcohortsalivaryseromarkerpreparationofantigenpublishedyearjournaltitleauthorsnotestagsstudy_type2meta_nfirststepauthorscontactedauthorsrespondedauthorsprovideddataprogression_outcomeexclusionfrompaper_reasonmetaanalysismetaanalysis_exclusion_reason1metaanalysis_exclusion_reason2latitudesis_exclusion_reason1longitudeis_exclusion_reason2participants_checkeddvs_checkedyearpfprpfincidencemap_dvs_valuemap_dvsdvs_fulldvs_mapendemicity_mapendem_can4var16endem_can53_merge</varnames><sortlist>
 ÊWsÏ€çsÏÀΗ³ÏÐÐ,m.@ªÍ</sortlist><formats>%8.0g%8.0g%23s%14s%8.0g%8.0g%9sg%21s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%16s%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%31s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%12s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%12s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%16s%8.0g%9s%12s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%16s%8.0g%9s%12s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%16s%8.0g%9s%16s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g_ige_mean_od%8.0g%8.0gangambiaesge_ige_se_od%8.0g%8.0gangambiaesge_igg4_nsubpopofsalse%8.0g%8.0gangambiaesge_igg4%9sgology%8.0gan%8.0gsge_igg4_unexposedcontr%8.0g%8.0gangambiaesge_igg4_seroprevalence%8.0g%8.0gangambiaesge_igg4_prev_lci%8.0g%8.0gangambiaesge_i%8.0g_uci%8.0g%9sgiaesge_igg4_med_od%8.0g%8.0gangambiaesge_igg4_od_25%8.0g%8.0gangambiaesge_igg4_od_75%8.0g%8.0gangambiaesg%8.0gmean_od%8.0g%8.0g%8.0g%8.0g%8.0g%19s%8.0g%9s%9s%10s%9s%9s%9s%306s%8.0g%8.0g%8.0g%8.0g%8.0g%19s%10s%10s%9s%10s%10s%9s%9s%25s%8.0g%80s%8.0g%8.0g%8.0g%19s%8.0g%10s%8.0g%16s%9s%9s%9s%8.0g%8.0g%8.0g%8.0g%8.0g%19s%8.0g%10s%9s%13s%9s%9s%9s%8.0g%8.0g%8.0g%8.0g%8.0g%19s%10s%10s%9s%9s%10s%23s%9s%293s%8.0g%95s%8.0g%8.0g%8.0g%19s%8.0g%9s%11s%10s%9s%9s%9s%306s%8.0g%8.0g%8.0g%8.0g%9s%10s%9s%26s%9s%9s%9s%9s%8.0g%8.0g%8.0g%19s%8.0g%10s%25s%9s%9s%9s%9s%9s%8.0g%8.0g%8.0g%8.0g%19s%8.0g%9s%9s%10s%9s%9s%9s%306s%8.0g%8.0g%8.0g%8.0g%19s%10s%10s%9sg%8.0g%9sg%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%19s%8.0g%10s%9s%9s%9sg%9sg%8.0g%8.0g%8.0g%8.0g%19s%8.0g%10s%9s%9s%9sg%9sg%8.0g%8.0g%8.0g%8.0g%22s%10s%46s%34s%10s%9s%17s%791s%35s%95s%8.0g%8.0g%8.0g%28s%10s%18s%34s%20s%9s%24s%740s%35s%137s%8.0g%8.0g%8.0g%28s%10s%23s%9s%9ss%9ss%275s%16s%8.0g%8.0g%8.0g%28s%10s%9s%9s%9ss%9ss%264s%16s%8.0g%8.0g%8.0g%23s%10s%9s%9s%9s%9s%35s%8.0g%8.0g%8.0g%8.0g%23s%10s%10s%10s%9sg%9sg%8.0g%8.0gKJâ2 €ã
%8.0g%8.0g%8.0g%23s%8.0g%9s%9s%9s%9s%35s%8.0g%8.0g%8.0g%8.0g%23s%10s%9s%10s%9sg%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%23s%8.0g%9s%9sg%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%23s%8.0g%9s%9sg%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%23s%10s%29s%8.0g%9s%9ss%9ssperoxp3_igg_od_25%266s%8.0gpe%8.0ggg_od_75d%8.0g%8.0gperoxp3_igg_mean_od%23s%8.0gperoxp3_igg_se_odcontrolpopu%9s%9sgpfpositive_pcr%9sgte%8.0g%8.0gtive_pcr_lci%8.0g%8.0gpfpositive_pcr_uci%23s%8.0gpfpositive_pcr_unit%23s%8.0gpfpositive_%9sndividualpopulat%9sg%9sgositive_pcr_definition%8.0g%8.0gpfpositive_pcr_exposurecasedetec%8.0g%8.0gpfpositive_pcr_febrile%23s%10spfpositi%9s_timing%10s%9sgpfpositive_pcr_measuredincohort%9sg%8.0gpfpositive_pcr_reportedinthestud%8.0gpfpositive_pcr_sourc%8.0g%8.0gpfpos%8.0gcr_nexposure%23s%10spfpositive_notes%9s%9sgpfpositive_micro_estimate%9sg%9sgpfpositive_micro_%8.0g%8.0gpf%8.0ge_micro_uci%8.0g%8.0gpfpositive_micro_unit%23s%10spfpositive_micro_individualpo%9s%9sgpfpositive_mic%9sgnition%9sg%8.0gtive_micro_exposurecasedet%8.0g%8.0gpfpositive_micro_febrile%8.0g%8.0gpfpositive_micro_timing%23s%10spfpositive_%11smeasuredincohor%9sg%9sgositive_micro_reportedinthest%9sg%8.0g%8.0g%8.0g%21s%10s%32s%21s%21s%214s%38s%53s%23s%41s%42s%49s%16s%54s%41s%44s%127s%44s%19s%8.0g%66s%203s%286s%415s%8.0g%32.0g%9.0g%8.0g%9s%9s%9s%9s%8.0g%9s%30s%32s%8.0g%8.0g%9s0gc_igg_controlscontrolpopula%37s%8.0gg5nuc_igg_seroprevalence%8.0g%8.0gg5nuc_igg_prev_lci%8.0g%41sg5nuc_ig%41.0gci%9.0g%9.0gg5nuc_igg_med_od%12.0gg5nuc_igg_od_25%12s%19.0g%23.0gg5nuc</formats><value_label_names>ðmergemergemergemergemergemergemergemergemergemergemergemergemergemergemergemergemergemergemergešžñè-½Ù%8.0g%8.0g%23s%14s8.0g%8.0g%8.0g%8.0g%9sg%21s%8.0g%8.0g%8.0g%8g%8.0g%8.0g%8.0g%16s%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%31s%8.0g%8.0g%8.0g%8.0g8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%12s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%9sg%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9s%12s%8.0g%8.0g8.0g%8.0g%8.0g%8.0g%8.0g%16s%8.0g%9s%12s%8g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%16s%8.0g%9s%12s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%16s%8.0g%9s%16s%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%8.0g%9sg%8.0g%8.0g%8.0g%8.0g_ige_mean_od%8.0g%8.0gangambiaesge_ige_se_od%8.0g%8.0gangambiaesge_igg4_nsubpopofsalse%8.0g%8.0gangambiaesge_igg4%9sgology%8.0gan%8.0gsge_igg4_unexposedcontr%8.0g%8.0gangambiaesge_igg4_seroprevalence%8.0g%8.0gangambiaesge_igg4_prev_lci%8.0g%8.0gangambiaesge_i%8.0g_uci%8.0g%9sgiaesge_igg4_med_od%8.0g8.0gangambiaesge_igg4_od_25%8.0g%8.0gangambiaesge_igg4_od_75%8.0g%8.0gangambiaesg%8.0gmean_od%8.0g%8.0g%9.0g%9study_type2mergedvs_full_nendEndem_can4Endemicity_5cats_merge</value_label_names><variable_labels>#idë7I8¢@ȪkæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒk#obsë7I8¢@ȪkæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkSub-populationë7I8¢@ȪkæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkub-populationë7I8¢@ȪkæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkub-populationë7I8¢@ȪkæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_n - subpop of sal seroȪkæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_Methodologyf sal seroȪkæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_Unexposed control populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_seroprevalenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_prev_lcilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_prev_ucilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_med_ODilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_OD_25ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_OD_75ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_mean_ODlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG_SE_ODDlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_n - subpop of sal serotionæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_Methodologyf sal serotionæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_Unexposed control populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_seroprevalenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_prev_lcilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_prev_ucilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_med_ODilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_OD_25ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_OD_75ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_mean_ODlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG1_SE_ODDlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_n - subpop of sal seroationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_Methodologyf sal seroationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_Unexposed control populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_seroprevalenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_prev_lcilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_prev_ucilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_med_ODilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_OD_25ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_OD_75ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_mean_ODlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6_IgG4_SE_ODDlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-n - subpop of sal seroionæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-Methodologyf sal seroionæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-Unexposed control populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-seroprevalenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-prev_lcilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-prev_ucilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-med_ODilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-OD_25ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-OD_75ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-mean_ODlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgG-SE_ODDlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-n - subpop of sal seroationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-Methodologyf sal seroationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-Unexposed control populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-seroprevalenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-prev_lcilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-prev_ucilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-med_ODilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-OD_25ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-OD_75ilenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-mean_ODlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P1_IgM-SE_ODDlenceol populationæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_n - subpop of sal seroæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_Methodologyf sal seroæȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_Unexposed control populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_seroprevalenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_prev_lcilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_prev_ucilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_med_ODilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_OD_25ilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_OD_75ilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_mean_ODlenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG_SE_ODDlenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_n - subpop of sal seroationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_Methodologyf sal seroationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_Unexposed control populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_seroprevalenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_prev_lcilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_prev_ucilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_med_ODilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_OD_25ilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_OD_75ilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_mean_ODlenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgE_SE_ODDlenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_n - subpop of sal serotionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_Methodologyf sal serotionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_Unexposed control populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_seroprevalenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_prev_lcilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_prev_ucilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_med_ODilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_OD_25ilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_OD_75ilenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_mean_ODlenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAnGambiaeSGE_IgG4_SE_ODDlenceol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_n - subpop of sal seroeol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_Methodologyf sal seroeol populationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_Unexposed control populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_seroprevalenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_prev_lcilenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_prev_ucilenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_med_ODilenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_OD_25ilenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_OD_75ilenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_mean_ODlenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG_SE_ODDlenceol populationopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_n - subpop of sal serotionopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_Methodologyf sal serotionopulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_Unexposed control populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_seroprevalenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_prev_lcilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_prev_ucilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_med_ODilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_OD_25ilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_OD_75ilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_mean_ODlenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG1_SE_ODDlenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_n - subpop of sal seroationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_Methodologyf sal seroationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_Unexposed control populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_seroprevalenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_prev_lcilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_prev_ucilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_med_ODilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_OD_25ilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_OD_75ilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_mean_ODlenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkcE5_IgG4_SE_ODDlenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_n - subpop of sal seroationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_Methodologyf sal seroationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_Unexposed control populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_seroprevalenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_prev_lcilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_prev_ucilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_med_ODilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_OD_25ilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_OD_75ilenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_mean_ODlenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkfSG6_IgG_SE_ODDlenceol populationpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_n - subpop of sal serotionpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_Methodologyf sal serotionpulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_Unexposed control populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_seroprevalenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_prev_lcilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_prev_ucilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_med_ODilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_OD_25ilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_OD_75ilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_mean_ODlenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkf5nuc_IgG_SE_ODDlenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_n - subpop of sal seroationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_Methodologyf sal seroationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_Unexposed control populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_seroprevalenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_prev_lcilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_prev_ucilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_med_ODilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_OD_25ilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_OD_75ilenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_mean_ODlenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkg5nuc_IgG_SE_ODDlenceol populationulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_n - subpop of sal seroionulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_Methodologyf sal seroionulationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_Unexposed control populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_seroprevalenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_prev_lcilenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_prev_ucilenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_med_ODilenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_OD_25ilenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_OD_75ilenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_mean_ODlenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkgSG6-P2_IgG_SE_ODDlenceol populationationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_n - subpop of sal serotionationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_Methodologyf sal serotionationȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_Unexposed control populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_seroprevalenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_prev_lcilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_prev_ucilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_med_ODilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_OD_25ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_OD_75ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_mean_ODlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P1_IgG_SE_ODDlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_n - subpop of sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_Methodologyf sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_Unexposed control populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_seroprevalenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_prev_lcilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_prev_ucilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_med_ODilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_OD_25ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_OD_75ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_mean_ODlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTRANS-P2_IgG_SE_ODDlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_n - subpop of sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_Methodologyf sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_Unexposed control populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_seroprevalenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_prev_lcilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_prev_ucilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_med_ODilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_OD_25ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_OD_75ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_mean_ODlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P1_IgG_SE_ODDlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_n - subpop of sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_Methodologyf sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_Unexposed control populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_seroprevalenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_prev_lcilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_prev_ucilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_med_ODilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_OD_25ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_OD_75ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_mean_ODlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P2_IgG_SE_ODDlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_n - subpop of sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_Methodologyf sal seroationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_Unexposed control populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_seroprevalenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_prev_lcilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_prev_ucilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_med_ODilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_OD_25ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_OD_75ilenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_mean_ODlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPEROX-P3_IgG_SE_ODDlenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_estimatenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_lcimatenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_ucimatenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_unitatenceol populationtionȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_Individual/Population EstimateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_definitionPopulation EstimateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_Exposure (case detection)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_Febrile (case detection)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_Timing (case detection)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_Measured in cohortction)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_Reported in the studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_Sourced in the studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_PCR_n - exposurehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_notes- exposurehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_estimateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_lcimateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_ucimateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_unitateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_Individual/Population EstimateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_definitionPopulation EstimateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_Exposure (case detection)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_Febrile (case detection)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_Timing (case detection)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_Measured in cohortction)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_Reported in the studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_Sourced in the studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Micro_n - exposurehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_notesn - exposurehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_estimateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_lcimateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_ucimateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_unitateehe studyon)mateȪkë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_Individual/Population Estimatekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_definitionPopulation Estimatekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_Exposure (case detection)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_Febrile (case detection)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_Timing (case detection)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_Measured in cohortction)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_Reported in the studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_Sourced in the studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Asympto_n - exposurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_estimateurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_lcimateurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_ucimateurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_unitateurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_Individual/Population Estimatekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_definitionPopulation Estimatekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_Exposure (case detection)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_Febrile (case detection)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_Timing (case detection)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_Measured in cohortction)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_Reported in the studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_Sourced in the studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfPositive_Febrile_n - exposurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_estimateexposurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_lcimateexposurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_ucimateexposurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_unitateexposurehe studyon)matekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_Individual/Population Estimatematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_definitionPopulation Estimatematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_Exposure (case detection)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_Febrile (case detection)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_Timing (case detection)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_Measured in cohortction)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_Reported in the studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_Sourced in the studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_n - exposurehe studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Micro_notesposurehe studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_estimateosurehe studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_lcimateosurehe studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_ucimateosurehe studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_unitateosurehe studyon)matematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_Individual/Population Estimateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_definitionPopulation Estimateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_Exposure (case detection)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_Febrile (case detection)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_Timing (case detection)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_Measured in cohortction)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_Reported in the studyon)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_Sourced in the studyon)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_PCR_n - exposurehe studyon)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_estimatedyon)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_lcimatedyon)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_ucimatedyon)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_unitatedyon)mateematekë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_Individual/Population Estimateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_definitionPopulation Estimateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_Exposure (case detection)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_Febrile (case detection)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_Timing (case detection)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_Measured in cohortction)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_ClinIncidence_Reported in the studyon)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_estimateorted in the studyon)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_lcimateorted in the studyon)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_ucimateorted in the studyon)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_unitateorted in the studyon)mateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_Individual/Population Estimatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_definitionPopulation Estimatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_Exposure (case detection)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_Febrile (case detection)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_Timing (case detection)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_Measured in cohortction)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_Reported in the studyon)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_Sourced in the studyon)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParaPos_Febrile_n - exposurehe studyon)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_estimate exposurehe studyon)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_lcimate exposurehe studyon)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_ucimate exposurehe studyon)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_unitate exposurehe studyon)matemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_Individual/Population Estimatematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_definitionPopulation Estimatematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_Exposure (case detection)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_Febrile (case detection)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_Timing (case detection)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_Measured in cohortction)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_Reported in the studyon)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_Sourced in the studyon)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_PCR_n - exposurehe studyon)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_estimateehe studyon)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_lcimateehe studyon)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_ucimateehe studyon)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_unitateehe studyon)matematemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_Individual/Population Estimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_definitionPopulation Estimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_Exposure (case detection)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_Febrile (case detection)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_Timing (case detection)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_Measured in cohortction)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_Reported in the studyon)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_Sourced in the studyon)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvPos_Micro_n - exposurehe studyon)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_estimate exposurehe studyon)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_lcimate exposurehe studyon)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_ucimate exposurehe studyon)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_unitate exposurehe studyon)mateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_Individual/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_Febrileal/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_Timingal/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_Measured in cohorton Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_Reported in the studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_Sourced in the studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPmPos_n - exposurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_estimateurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_lcimateurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_ucimateurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_unitateurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_Individual/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_Febrileal/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_Timingal/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_Measured in cohorton Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_Reported in the studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_Sourced in the studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPoPos_n - exposurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_estimateosurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_lcimateosurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_ucimateosurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_unitateosurehe studyEstimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_Individual/Population Estimateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_definitionPopulation Estimateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_Exposure (case detection)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_Timinge (case detection)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_Measured in cohortction)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_Reported in the studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_Sourced in the studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_n - exposurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkHBR_notesposurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_estimateurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_lcimateurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_ucimateurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_unitateurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_Individual/Population Estimateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_definitionPopulation Estimateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_Exposure (case detection)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_Timinge (case detection)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_Measured in cohortction)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_Reported in the studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_Sourced in the studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_n - exposurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEIR_notesposurehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_estimateehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_lcimateehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_ucimateehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_unitateehe studyon)mateemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_Individual/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_Exposure (case detection)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_Timinge (case detection)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_Measured in cohortction)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_Reported in the studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_Sourced in the studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfEIR_n - exposurehe studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_estimateurehe studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_lcimateurehe studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_ucimateurehe studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_unitateurehe studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_Individual/Population Estimatemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_Exposure (case detection)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_Timinge (case detection)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_Measured in cohortction)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_Reported in the studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_Sourced in the studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvEIR_n - exposurehe studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_estimatee studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_lcimatee studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_ucimatee studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_unitatee studyon)matemateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_Individual/Population Estimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_definitionPopulation Estimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_TimingionPopulation Estimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_Measured in cohorton Estimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_Reported in the studyEstimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_Sourced in the studyEstimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfAMA1_IgG_n - exposurehe studyEstimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_estimateehe studyEstimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_lcimateehe studyEstimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_ucimateehe studyEstimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_unitateehe studyEstimateatemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_Individual/Population Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_definitionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_TimingionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_Measured in cohorton Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_Reported in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_Sourced in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP119_IgG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_estimateosurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_lcimateosurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_ucimateosurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_unitateosurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_Individual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_definitionPopulation Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_TimingionPopulation Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_Measured in cohorton Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_Reported in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_Sourced in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP2_IgG_n - exposurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_estimatesurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_lcimatesurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_ucimatesurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_unitatesurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_Individual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_definitionPopulation Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_TimingionPopulation Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_Measured in cohorton Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_Reported in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_Sourced in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG_n - exposurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_estimaterehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_lcimaterehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_ucimaterehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_unitaterehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_Individual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_Timingual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_Measured in cohorton Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_Reported in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_Sourced in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG1_n - exposurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_estimateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_lcimateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_ucimateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_unitateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_Individual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_Timingual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_Measured in cohorton Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_Reported in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_Sourced in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfCSP_IgG3_n - exposurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_estimateosurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_lcimateosurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_ucimateosurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_unitateosurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_Individual/Population Estimateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_definitionPopulation Estimateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_Exposure (case detection)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_Timinge (case detection)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_Measured in cohortction)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_Reported in the studyon)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_Sourced in the studyon)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG_n - exposurehe studyon)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_estimaterehe studyon)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_lcimaterehe studyon)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_ucimaterehe studyon)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_unitaterehe studyon)mateeetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_Individual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_Timingual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_Measured in cohorton Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_Reported in the studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG1_n - exposurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_estimateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_lcimateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_ucimateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_unitateurehe studyEstimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_Individual/Population Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_definitionPopulation Estimateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_Exposure (case detection)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_Timinge (case detection)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_Measured in cohortction)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_Reported in the studyon)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfSE_IgG3_n - exposurehe studyon)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_estimateehe studyon)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_lcimateehe studyon)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_ucimateehe studyon)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_unitateehe studyon)mateetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_Individual/Population Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_definitionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_TimingionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_Measured in cohorton Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_Reported in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_Sourced in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfGLURP_IgG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_estimatesurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_lcimatesurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_ucimatesurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_unitatesurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_Individual/Population Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_definitionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_TimingionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_Measured in cohorton Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_Reported in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_Sourced in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPfMSP3_IgG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_estimateurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_lcimateurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_ucimateurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_unitateurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_Individual/Population Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_definitionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_TimingionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_Measured in cohorton Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_Reported in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_Sourced in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvAMA1_IgG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_estimateehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_lcimateehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_ucimateehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_unitateehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_Individual/Population Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_definitionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_TimingionPopulation Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_Measured in cohorton Estimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_Reported in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_Sourced in the studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPvMSP119_IgG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkvMSP119_IgG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkStudy19_IgG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkYear_StudyG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkStudy_TypeG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkRegionypeG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkCountrypeG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkArearypeG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEndemicityG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkDVSmicityG_n - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParticipantsn - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAge_meanntsn - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAge_sdnntsn - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAge_medntsn - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAge_IQRntsn - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAge_rangetsn - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkNe_rangetsn - exposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒknumber of samplesxposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkIntitial cohortsxposurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkSalivary Seromarkerosurehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPreparation of antigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPublished Yearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkJournald Yearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTitleld Yearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAuthorsd Yearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkNotessd Yearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkTagssd Yearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkStudy_Typeearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒktudy_Typeearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkFirst stepearantigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAuthors contactedigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAuthors Respondedigenrehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkAuthors provided data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkOUTCOMEprovided data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkREASONprovided data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkMETA-ANALYSISed data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkETA-ANALYSISed data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkETA-ANALYSISed data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkETA-ANALYSISed data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkETA-ANALYSISed data rehe studyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkParticipant type for observationyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkDVS code according to studytionyEstimatetemateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkYear of observation (or first year of study)emateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkPf parasite rates in 2-10 year olds (prop))emateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkClinical incidence of Pf infections(prop))emateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkDVS code according to MAP estimates(prop))emateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkDVS according to MAP estimatesates(prop))emateë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkDVS taken from study descriptions and MAP estimatesë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkObservations using MAP DVS estimates MAP estimatesë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEndemicity according to MAP PfPR 2-10 year oldstesë7ý3¢@ȪkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEndemicity 4 cats according to MAP, or as stated in study (if MAP not available)ªkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkndemicity 4 cats according to MAP, or as stated in study (if MAP not available)ªkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkEndemicity 5 categories according to MAP, or as stated in study (if MAP not avaiªkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒkndemicity 5 categories according to MAP, or as stated in study (if MAP not avaiªkXæë7'û˜@ȪkÉ$@ȪkkXæØO„•%@æØ8{CȪký3¢@
ȪkÉ$@ȪkXæp6{Ck‰ñ$@
XÒk</variable_labels><characteristics><ch>pvpos_micro_casedetectt resid="main" id="atom(Window)" sheet="TaskDialog" ltostring¨</ch>h?mT6{C4¢@ȪkFÊ$@Cconverted to string</ch><ch>
_dta_micro_casedetectt resid="main" id="atom(Window)" sheet="TaskDialog" l_lang_c1¨</ch>h?mT6{C4¢@Ȫk
FÊ$@Cdefault</ch><ch>
_dta_micro_casedetectt resid="main" id="atom(Window)" sheet="TaskDialog" l_lang_list</ch>h?mT6{C4¢@Ȫk
FÊ$@Cdefault</ch></characteristics><data>×£@Diama Pharoensis.ELISA45 Marseille¦7½>ܘk>oQ??95%CI: 0.39-0.60eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeee.ELISA45 Marseille@2>2؃=3 ‘>q=Š>95%CI: 0.19-0.34.ELISA45 Marseille&¯!>RÙ+=ÿ3Œ>eee{®>95%CI: 0.22-0.46.ELISA45 Marseille²>¯%>UQÓ>eee?95%CI: 0.40-0.61åeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå€?bites/person/nightpopulation86.9% An. PharoensisHLCconcurrentYesyesFaye O, Gaye O, Konate L, Molez JF, Feller-Dansokho E, Herve JP: Prediction and prevention of malaria epidemics in the valley of the Senegal River. Sante 1998, 8:347–352. ; Faye O, Fontenille D, Gaye O, Sy N, Molez JF, Konate L, Hebrard G, Herve JP, Trouillet J, Diallo S, et al: [Malaria and rice growing in the Senegal River delta (Senegal)]. Ann Soc Belg Med Trop 1995, 75:179–189. ; Faye O, Fontenille D, Gaye O, Sy N, Molez JF, Konate L, Hebrard G, Herve JP, Trouillet J, Diallo S, et al: Malaria and rice growing in the Senegal River delta (Senegal). Ann Soc Belg Med Trop 1995, 75:179–189. ; Sow S, de Vlas SJ, Engels D, Gryseels B: Water-related disease patterns before and after the construction of the Diama dam in northern Senegal. Ann Trop Med Parasitol 2002, 96:575–586.€?infectious bites/person/yearpopulationHLC + pyrethrum spray catchesconcurrentYesreported independentallyFontenille D, Lochouarn L, Diagne N, Sokhna C, Lemasson J-J, Diatta M, Konate L, Faye F, Rogier C, Trape J-F: High Annual and Seasonal Variations in Malaria Transmission by Anophelines and Vector Species Composition in Dielmo, a Holoendemic Area in Senegal. 1997, 56(3):247-253.åeåeåeåeeeeeeeåeåeeåeåeåeåeåAli 20121994-1995Cross-sectionalAfricaSenegalNdiop; Dielmo; DiamaAn. Gambiae; An. Funestus; An. PharoensisAll agesNdiop: 25.87; Dielmo: 28.38; Diama: 17.96Ndiop: 18.34; Dielmo: 21.26; Diama: 11.58134134gSG6; fSG6; g-5'nuc; f-5'nucrecombinant proteinÜMalaria journalAssessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites.Ali ZM.; Bakli M.; Fontaine A.; Bakkali N.; Vu Hai V.; Audebert S.; Boublik Y.; Pagès F.; Remoué F.; Rogier C.; Fraisier C.; Almeras L.e@@INCLUDEDeY¬A­:ƒÁAll agesAn. PharoensisÊ#An. ArabiensisHypoendemic@®G@DielmoFunestus.ELISA45 MarseilleDy
?ÜÊ>ò5?ff&?95%CI: 0.53-0.76eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeee&ELISA45 Marseille<”×=|×û;€µO>\Â>95%CI: 0.29-0.48&ELISA45 MarseilleÂõ>sÛ®>ÖT?eeeÍÌL?95%CI: 0.65-0.96&ELISA45 Marseilleæ5”>.Ã>4
Þ>eee\?95%CI: 0.39-0.63åeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeåÍÌôAbites/person/nightpopulation66.4% An. FunestusHLCconcurrentYesyesFontenille D, Lochouarn L, Diagne N, Sokhna C, Lemasson J-J, Diatta M, Konate L, Faye F, Rogier C, Trape J-F: High Annual and Seasonal Variations in Malaria Transmission by Anophelines and Vector Species Composition in Dielmo, a Holoendemic Area in Senegal. 1997, 56(3):247-253.Cinfectious bites/person/yearpopulationHLC + pyrethrum spray catchesconcurrentYesreported independentallyFontenille D, Lochouarn L, Diagne N, Sokhna C, Lemasson J-J, Diatta M, Konate L, Faye F, Rogier C, Trape J-F: High Annual and Seasonal Variations in Malaria Transmission by Anophelines and Vector Species Composition in Dielmo, a Holoendemic Area in Senegal. 1997, 56(3):247-253.åeåeåeåeeeeeeeåeåeeåeåeåeåeåAli 20121994-1995Cross-sectionalAfricaSenegalNdiop; Dielmo; DiamaAn. Gambiae; An. Funestus; An. PharoensisAll agesNdiop: 25.87; Dielmo: 28.38; Diama: 17.96Ndiop: 18.34; Dielmo: 21.26; Diama: 11.58134134gSG6; fSG6; g-5'nuc; f-5'nucrecombinant proteinÜMalaria journalAssessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites.Ali ZM.; Bakli M.; Fontaine A.; Bakkali N.; Vu Hai V.; Audebert S.; Boublik Y.; Pagès F.; Remoué F.; Rogier C.; Fraisier C.; Almeras L.e@@INCLUDEDeY³¦[A.PƒÁAll agesAn. FunestusÊAn. Arabiensis; An. Funestus; An. GambiaeMesoendemic@@…ë@Ndiop Gambiae2ELISA45 Marseille¸?TVÃ>G’(?áz?95%CI: 0.49-0.66eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeee2ELISA45 Marseille®Ga>ïf×=òm«>33³>95%CI: 0.26-0.442ELISA45 Marseille¢¼†>Ý4ü=
lÎ>eee®G!?95%CI: 0.50-0.762ELISA45 MarseilleÍÌÌ>+F‡>¸)	?eeeff&?95%CI: 0.52-0.77åeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeåš™y@bites/person/nightpopulation94.6% An. GambiaeHLCconcurrentYesyesFontenille D, Lochouarn L, Diatta M, Sokhna C, Dia I, Diagne N, Lemasson JJ, Ba K, Tall A, Rogier C, Trape JF: Four years’ entomological study of the transmission of seasonal malaria in Senegal and the bionomics of Anopheles gambiae and A. arabiensis. Trans R Soc Trop Med Hyg 1997, 91:647–652. ; Sokhna CS, Diagne N, Lochouarn L, Rogier C, Trape JF, Spiegel A, Fontenille D: Comparative evaluation of the plasmodial infection of Anopheles using ELISA and dissection. Consequences for the estimation of the transmission of malaria in 1995 in Ndiop, Senegal. Parasite 1998, 5:273–279.Binfectious bites/person/yearpopulationHLC + pyrethrum spray catchesconcurrentYesreported independentallyFontenille D, Lochouarn L, Diatta M, Sokhna C, Dia I, Diagne N, Lemasson J-J, Ba K, Tall A, Rogier C et al: Four years' entomological study of the transmission of seasonal malaria in Senegal and the bionomics of Anopheles gambiae and A. arabiensis. Transactions of The Royal Society of Tropical Medicine and Hygiene 1997, 91(6):647-652.åeåeåeåeeeeeeeåeåeeåeåeåeåeåAli 20121994-1995Cross-sectionalAfricaSenegalNdiop; Dielmo; DiamaAn. Gambiae; An. Funestus; An. PharoensisAll agesNdiop: 25.87; Dielmo: 28.38; Diama: 17.96Ndiop: 18.34; Dielmo: 21.26; Diama: 11.58134134gSG6; fSG6; g-5'nuc; f-5'nucrecombinant proteinÜMalaria journalAssessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites.Ali ZM.; Bakli M.; Fontaine A.; Bakkali N.; Vu Hai V.; Audebert S.; Boublik Y.; Pagès F.; Remoué F.; Rogier C.; Fraisier C.; Almeras L.e@@INCLUDEDeYÎÚZAÅ¿‚ÁAll agesAn. GambiaeÊAn. Arabiensis; An. Funestus; An. GambiaeHyperendemic€@×£@@Diamasitiveåeeeeeeeeeeee&Multiplex21 French adults
×£=
×£<=
W>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeee&Multiplex21 French adultsìQ¸=eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå 2010eeeåeåeå@infectious bites/person/yearpopulationHLC + pyrethrum spray catchesConcurrentNoReported in background35. Diallo TO, Remoue F, Schacht AM, Charrier N, Dompnier JP, Pillet S, Garraud O, N’Diaye AA, Capron A, Capron M, Riveau G: Schistosomiasis coinfection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol 2004, 26:365-369. 36. Faye O, Gaye O, Konate L, Molez JF, Feller-Dansokho E, Herve JP: [Prediction and prevention of malaria epidemics in the valley of the Senegal River]. Sante 1998, 8:347-352. 37. Dia I, Konate L, Samb B, Sarr JB, Diop A, Rogerie F, Faye M, Riveau G, Remoue F, Diallo M, Fontenille D: Bionomics of malaria vectors and relationship with malaria transmission and epidemiology in three physiographic zones in the Senegal River Basin. Acta Trop 2008, 105:145-153.some generous rounding to be log10 changes in EIRåeåe帅>¸>ö(Ü>proportion seropositivepopulationPfCSPconcurrentyesyeseåeeeeeeeåeåeeåÃõ(?Háú>ÍÌL?proportion seropositivepopulationPfGLURPconcurrentyesyeseåeåeåeåAmbrosino 20101994-1995Cross-sectionalAfricaSenegalNdiop; Dielmo; DiamaAn. Gambiae; An. Funestus; An. Pharoensisadults123123253 people in 3 villages in Senegal, and 124 transiently exposed soldiers in Ivory CoastgSG6-P1; gSG6-P2peptideÚMalaria journalA multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.Ambrosino E.; Dumoulin C.; Orlandi-Pradines E.; Remoue F.; Toure-Baldé A.; Tall A.; Sarr JB.; Poinsignon A.; Sokhna C.; Puget K.; Trape JF.; Pascual A.; Druilhe P.; Fusai T.; Rogier C.e@@INCLUDEDeY¬A­:ƒÁAdultsAn. PharoensisÊ#An. ArabiensisHypoendemic@®GA@Dielmoitiveåeeeeeeeeeeee-Multiplex21 French adults®Gá=ÍÌÌ>Âu>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeee-Multiplex21 French adults
×£=eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå 2010eeeåeåeåHCinfectious bites/person/yearpopulationHLC + pyrethrum spray catchesConcurrentNoReported in backgroundFontenille D, Lochouarn L, Diagne N, Sokhna C, Lemasson J-J, Diatta M, Konate L, Faye F, Rogier C, Trape J-F: High Annual and Seasonal Variations in Malaria Transmission by Anophelines and Vector Species Composition in Dielmo, a Holoendemic Area in Senegal. 1997, 56(3):247-253.some generous rounding to be log10 changes in EIRåeåeåÂu?š™Y?¤p}?proportion seropositivepopulationPfCSPconcurrentyesyeseåeeeeeeeåeåeeå€?…k?€?proportion seropositivepopulationPfGLURPconcurrentyesyeseåeåeåeåAmbrosino 20101994-1995Cross-sectionalAfricaSenegalNdiop; Dielmo; DiamaAn. Gambiae; An. Funestus; An. Pharoensisadults123123253 people in 3 villages in Senegal, and 124 transiently exposed soldiers in Ivory CoastgSG6-P1; gSG6-P2peptideÚMalaria journalA multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.Ambrosino E.; Dumoulin C.; Orlandi-Pradines E.; Remoue F.; Toure-Baldé A.; Tall A.; Sarr JB.; Poinsignon A.; Sokhna C.; Puget K.; Trape JF.; Pascual A.; Druilhe P.; Fusai T.; Rogier C.e@@INCLUDEDeY³¦[A.PƒÁAdultsAn. FunestusÊAn. Arabiensis; An. Funestus; An. GambiaeMesoendemic@@…ëA@Ndiopsitiveåeeeeeeeeeeee(Multiplex21 French adultsÍÌL=
×#<{.>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeee(Multiplex21 French adultsìQ¸=eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå 2010eeeåeåeå Ainfectious bites/person/yearpopulationHLC + pyrethrum spray catchesConcurrentNoReported in backgroundFontenille D, Lochouarn L, Diatta M, Sokhna C, Dia I, Diagne N, Lemasson J-J, Ba K, Tall A, Rogier C et al: Four years' entomological study of the transmission of seasonal malaria in Senegal and the bionomics of Anopheles gambiae and A. arabiensis. Transactions of The Royal Society of Tropical Medicine and Hygiene 1997, 91(6):647-652.some generous rounding to be log10 changes in EIRåeåeåÍÌL?
×#?Ãõh?proportion seropositivepopulationPfCSPconcurrentyesyeseåeeeeeeeåeåeeåHáz?R¸^?€?proportion seropositivepopulationPfGLURPconcurrentyesyeseåeåeåeåAmbrosino 20101994-1995Cross-sectionalAfricaSenegalNdiop; Dielmo; DiamaAn. Gambiae; An. Funestus; An. Pharoensisadults123123253 people in 3 villages in Senegal, and 124 transiently exposed soldiers in Ivory CoastgSG6-P1; gSG6-P2peptideÚMalaria journalA multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.Ambrosino E.; Dumoulin C.; Orlandi-Pradines E.; Remoue F.; Toure-Baldé A.; Tall A.; Sarr JB.; Poinsignon A.; Sokhna C.; Puget K.; Trape JF.; Pascual A.; Druilhe P.; Fusai T.; Rogier C.e@@INCLUDEDeY³¦[A.PƒÁAdultsAn. GambiaeÊAn. Arabiensis; An. Funestus; An. GambiaeHyperendemic€@33ƒ@eåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåeAndrade 20092007Cross-sectionalSouth AmericaBrazilBuritisunstableAn. Darlingiall ages204204An. Darlingi SGEWhole salivaÙMalaria journalAnti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon.Andrade BB.; Rocha BC.; Reis-Filho A.; Camargo LM.; Tadei WP.; Moreira LA.; Barral A.; Barral-Netto M.EK: Reports median OD for uninfected, asymptomatic and symptomatic malaria patients. Doesn't report seroprevalence, and OD cut off calculated in malaria neg cohorte@@YNNINCLUDEDeNAb levels only; Stratified by infection statusåeåÿÿ€?€?ìQÀ@Kisiiperson/yearåeeeeeeeeeeeeÞELISA30 USA)\>ÓMb>²¯>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe
×#=㥛<㥛=proportion positivepopulationMicroscopyACDConcurrentYesyesÞeeeåeeååeååeeeåeåeeeåeåeåÍÌÌ>infectious bites/person/yearpopulationpyrethrum spray catchesConcurrentNoReported in backgroundNdenga B, Githeko AK, Omukunda E, Munyekenye G, Atieli H, Wamae P, Mbogo C, Minakawa N, Zhou G, Yan G: Population dynamics of malaria vectors in western Kenya highlands. J Med Entomol 2006, 43:200–206.222åeåeåeåeeeeeeeåeåeeåeåeåeåeåBadu 20122009/2011Repeated cross sectionalAfricaKenyaKombewa in Kisumu County; Iguhu in the Kakamega County; Marani village in the Kisii CountyHyperendemic; mesoendemic; hypoendemicAn. Gambiaechildren to youn adults1366gSG6-P1peptideÜMalaria journalVariation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.Badu K.; Siangla J.; Larbi J.; Lawson BW.; Afrane Y.; Ong'echa J.; Remoue F.; Zhou G.; Githeko AK.; Yan G.e @YYNINCLUDEDeY'ù¿Ã5BAll agesAn. GambiaeÙ?=¼…=An. Arabiensis; An. Funestus; An. Gambiae€?€?Hypoendemic@×£À@Kakamegason/yearåeeeeeeeeeeeeËELISA31 USA{®>À>…ëÑ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe^ºI>áz>¦›„>proportion positivepopulationMicroscopyACDConcurrentYesyesËeeeåeeååeååeeeåeåeeeåeåeåÍ̄Ainfectious bites/person/yearpopulationpyrethrum spray catchesConcurrentNoReported in backgroundNdenga B, Githeko AK, Omukunda E, Munyekenye G, Atieli H, Wamae P, Mbogo C, Minakawa N, Zhou G, Yan G: Population dynamics of malaria vectors in western Kenya highlands. J Med Entomol 2006, 43:200–206.203åeåeåeåeeeeeeeåeåeeåeåeåeåeåBadu 20122009/2011Repeated cross sectionalAfricaKenyaKombewa in Kisumu County; Iguhu in the Kakamega County; Marani village in the Kisii CountyHyperendemic; mesoendemic; hypoendemicAn. Gambiaechildren to youn adults1366gSG6-P1peptideÜMalaria journalVariation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.Badu K.; Siangla J.; Larbi J.; Lawson BW.; Afrane Y.; Ong'echa J.; Remoue F.; Zhou G.; Githeko AK.; Yan G.e @YYNINCLUDEDeY:->BAll agesAn. GambiaeÙ‡¢>b8>An. Arabiensis; An. Funestus; An. Gambiae@@Mesoendemic@@ÃõÀ@Kombewarson/yearåeeeeeeeeeeeeÊELISA32 USAq=
?²ï>ö(?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeZä>\Â>Ë¡?proportion positivepopulationMicroscopyACDConcurrentYesyesÊeeeåeeååeååeeeåeåeeeåeåeåÍÌøAinfectious bites/person/yearpopulationpyrethrum spray catchesConcurrentNoReported in backgroundNdenga B, Githeko AK, Omukunda E, Munyekenye G, Atieli H, Wamae P, Mbogo C, Minakawa N, Zhou G, Yan G: Population dynamics of malaria vectors in western Kenya highlands. J Med Entomol 2006, 43:200–206.202åeåeåeåeeeeeeeåeåeeåeåeåeåeåBadu 20122009/2011Repeated cross sectionalAfricaKenyaKombewa in Kisumu County; Iguhu in the Kakamega County; Marani village in the Kisii CountyHyperendemic; mesoendemic; hypoendemicAn. Gambiaechildren to youn adults1366gSG6-P1peptideÜMalaria journalVariation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.Badu K.; Siangla J.; Larbi J.; Lawson BW.; Afrane Y.; Ong'echa J.; Remoue F.; Zhou G.; Githeko AK.; Yan G.e @YYNINCLUDEDeYs‚Ö½g
BAll agesAn. GambiaeÙ¢Ú> ^×>An. Arabiensis; An. Funestus; An. Gambiae@@Hyperendemic@@®GÁ@Up hillåeeeeeeeeeeeeèELISA36 USAìQ¸>ÍÌL>ÍÌÌ=š™?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBadu 20122009/2011Repeated cross sectionalAfricaKenyaKombewa in Kisumu County; Iguhu in the Kakamega County; Marani village in the Kisii CountyHyperendemic; mesoendemic; hypoendemicAn. Gambiaechildren to youn adults1366gSG6-P1peptideÜMalaria journalVariation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.Badu K.; Siangla J.; Larbi J.; Lawson BW.; Afrane Y.; Ong'echa J.; Remoue F.; Zhou G.; Githeko AK.; Yan G.e @YYNINCLUDEDeYAll agesAn. GambiaeÙeš™Á@ValleyåeeeeeeeeeeeewELISA37 USA?ìQ8>ÍÌÌ>ÍÌL?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBadu 20122009/2011Repeated cross sectionalAfricaKenyaKombewa in Kisumu County; Iguhu in the Kakamega County; Marani village in the Kisii CountyHyperendemic; mesoendemic; hypoendemicAn. Gambiaechildren to youn adults1366gSG6-P1peptideÜMalaria journalVariation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.Badu K.; Siangla J.; Larbi J.; Lawson BW.; Afrane Y.; Ong'echa J.; Remoue F.; Zhou G.; Githeko AK.; Yan G.e @YYNINCLUDEDeYAll agesAn. GambiaeÙeìQà@AsutuareFebåeeeeeeeeeeee'ELISA25 Europeans‡?zÇ	?1'?JÂ>7‰>X9ô>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå&Â<RI<9ÖE=proportion positivepopulationMicroscopyACD+PCDoconcurrentYesyes'eååeeeåeåeeeåeåeååfˆ?ý‡?ó"?proportion seropositivepopulationPfMSP1(19)concurrentYesyese'eåeåeeeeeeeåeåeeåeåeåeåeåBadu 20152009Repeated cross sectionalAfricaGhanaAsutuarelow-children.5-29 years295885gSG6-P1peptideßParasites & vectorsSerological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity.Badu K.; Gyan B.; Appawu M.; Mensah D.; Dodoo D.; Yan G.; Drakeley C.; Zhou G.; Owusu-Dabo E.; Koram KA.e@@YYNINCLUDEDeYLÓÂ@ ©G>ChildrenÙw¾ß=†r">An. Arabiensis; An. Funestus; An. Gambiae€?@@Low@@×£à@AsutuareMayåeeeeeeeeeeee'ELISA25 EuropeansÓM?KYæ>\ ? ¯>D‹l>åÐâ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÒÞ<[±?<õÛW=proportion positivepopulationMicroscopyACD+PCDoconcurrentYesyes'eååeeeåeåeeeåeåeååË¡?ÄBí>ŠŽ?proportion seropositivepopulationPfMSP1(19)concurrentYesyese'eåeåeeeeeeeåeåeeåeåeåeåeåBadu 20152009Repeated cross sectionalAfricaGhanaAsutuarelow-children.5-29 years295885gSG6-P1peptideßParasites & vectorsSerological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity.Badu K.; Gyan B.; Appawu M.; Mensah D.; Dodoo D.; Yan G.; Drakeley C.; Zhou G.; Owusu-Dabo E.; Koram KA.e@@YYNINCLUDEDeYLÓÂ@ ©G>ChildrenÙw¾ß=†r">An. Arabiensis; An. Funestus; An. Gambiae€?@@Low@@Ãõà@AsutuareAugåeeeeeeeeeeee'ELISA25 EuropeansË¡?ÄBí>ŠŽ?²¯>D‹l>åÐâ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå&Â<RI<9ÖE=proportion positivepopulationMicroscopyACD+PCDoconcurrentYesyes'eååeeeåeåeeeåeåeååÉåß>A‚Â>¶óý>proportion seropositivepopulationPfMSP1(19)concurrentYesyese'eåeåeeeeeeeåeåeeåeåeåeåeåBadu 20152009Repeated cross sectionalAfricaGhanaAsutuarelow-children.5-29 years295885gSG6-P1peptideßParasites & vectorsSerological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity.Badu K.; Gyan B.; Appawu M.; Mensah D.; Dodoo D.; Yan G.; Drakeley C.; Zhou G.; Owusu-Dabo E.; Koram KA.e@@YYNINCLUDEDeYLÓÂ@ ©G>ChildrenÙw¾ß=†r">An. Arabiensis; An. Funestus; An. Gambiae€?@@Low@@ö(ACapango+Canjala2008åeeeeeeeeeeeeåeeåeeeåELISAázT?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåìÀÙ>
È>3Éë>proportion positivepopulationMicroscopyeååeeeåeå2012eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBrosseau 20122008-2009Cross-sectionalAfricaAngolaCapango; Canjala; Chissequele; Barragem; Libata; CandieroSeasonalAn. Funestuschildren2-9 years158411079 blood smears were taken, with blood spots taken from 22 children from each village every two monthsAn. Gambiae WSEWhole salivaÜPloS oneHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.Brosseau L.; Drame PM.; Besnard P.; Toto JC.; Foumane V.; Le Mire J.; Mouchet F.; Remoue F.; Allan R.; Fortes F.; Carnevale P.; Manguin S.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkeré%FÁYmAChildrenAn. FunestusØjjY>îë> An. Funestus; An. Gambiae@@@@ìQACapango+Canjala2009åeeeeeeeeeeeeåeeåeeeåELISA\?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÂ5>¯>ïéU>proportion positivepopulationMicroscopy“eååeeeåeå2012eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBrosseau 20122008-2009Cross-sectionalAfricaAngolaCapango; Canjala; Chissequele; Barragem; Libata; CandieroSeasonalAn. Funestuschildren2-9 years158411079 blood smears were taken, with blood spots taken from 22 children from each village every two monthsAn. Gambiae WSEWhole salivaÜPloS oneHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.Brosseau L.; Drame PM.; Besnard P.; Toto JC.; Foumane V.; Le Mire J.; Mouchet F.; Remoue F.; Allan R.; Fortes F.; Carnevale P.; Manguin S.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarker^ò?Ái²_AChildrenAn. FunestusÙ¹™=ŽÌ> An. Funestus; An. Gambiae€?€?@ázABarragem+Chissequele2008åeeeeeeeeeeeeåeeåeeeåELISAö(?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå' ©>õõ˜>oâº>proportion positivepopulationMicroscopy#eååeeeåeå2012eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBrosseau 20122008-2009Cross-sectionalAfricaAngolaCapango; Canjala; Chissequele; Barragem; Libata; CandieroSeasonalAn. Funestuschildren2-9 years158411079 blood smears were taken, with blood spots taken from 22 children from each village every two monthsAn. Gambiae WSEWhole salivaÜPloS oneHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.Brosseau L.; Drame PM.; Besnard P.; Toto JC.; Foumane V.; Le Mire J.; Mouchet F.; Remoue F.; Allan R.; Fortes F.; Carnevale P.; Manguin S.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkerChildrenAn. FunestusØe×£ABarragem+Chissequele2009åeeeeeeeeeeeeåeeåeeeåELISAq=
?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåù1&>¡¤>¨C>proportion positivepopulationMicroscopyÝeååeeeåeå2012eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBrosseau 20122008-2009Cross-sectionalAfricaAngolaCapango; Canjala; Chissequele; Barragem; Libata; CandieroSeasonalAn. Funestuschildren2-9 years158411079 blood smears were taken, with blood spots taken from 22 children from each village every two monthsAn. Gambiae WSEWhole salivaÜPloS oneHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.Brosseau L.; Drame PM.; Besnard P.; Toto JC.; Foumane V.; Le Mire J.; Mouchet F.; Remoue F.; Allan R.; Fortes F.; Carnevale P.; Manguin S.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkerChildrenAn. FunestusÙeÍÌALibata+Candiero2008åeeeeeeeeeeeeåeeåeeeåELISA@?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåDiÏ>‰~À>ČÞ>proportion positivepopulationMicroscopyReååeeeåeå2012eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBrosseau 20122008-2009Cross-sectionalAfricaAngolaCapango; Canjala; Chissequele; Barragem; Libata; CandieroSeasonalAn. Funestuschildren2-9 years158411079 blood smears were taken, with blood spots taken from 22 children from each village every two monthsAn. Gambiae WSEWhole salivaÜPloS oneHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.Brosseau L.; Drame PM.; Besnard P.; Toto JC.; Foumane V.; Le Mire J.; Mouchet F.; Remoue F.; Allan R.; Fortes F.; Carnevale P.; Manguin S.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkerChildrenAn. FunestusØeÃõALibata+Candiero2009åeeeeeeeeeeeeåeeåeeeåELISAÍÌL>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeån4@>›r%>Ö)]>proportion positivepopulationMicroscopy:eååeeeåeå2012eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåBrosseau 20122008-2009Cross-sectionalAfricaAngolaCapango; Canjala; Chissequele; Barragem; Libata; CandieroSeasonalAn. Funestuschildren2-9 years158411079 blood smears were taken, with blood spots taken from 22 children from each village every two monthsAn. Gambiae WSEWhole salivaÜPloS oneHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.Brosseau L.; Drame PM.; Besnard P.; Toto JC.; Foumane V.; Le Mire J.; Mouchet F.; Remoue F.; Allan R.; Fortes F.; Carnevale P.; Manguin S.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkerChildrenAn. FunestusÙe	ö(ALobitoTrapsMar-05åeeeeeeeeeeeeiELISA14 French5C?)=+?ðV?Ãõ¨>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#=proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeåHá@bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@	ìQALobitoTrapsMay-05åeeeeeeeeeeeeiELISA14 French£\J?‚<3?G!]?=
×>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÓ¼ã=proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeåš™i@bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@	ázALobitoTrapsJul-05åeeeeeeeeeeeeiELISA14 French5C?)=+?ðV?Ãõ¨>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå_)K=proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeå¤p½>bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@	×£ALobitoTrapsAug-05åeeeeeeeeeeeeiELISA14 Frenchû1?J	?H?š™™>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×£<proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeåìQ¸>bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@	ÍÌALobitoTrapsSep-05åeeeeeeeeeeeeiELISA14 French_|E?£Y?{®>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×£<proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeå¤p½>bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@	ÃõALobitoTrapsOct-05åeeeeeeeeeeeeiELISA14 FrenchK9?ãà ?}N?ìQ¸>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÂu=proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåe帅?bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@	¸ALobitoTrapsDec-05åeeeeeeeeeeeeiELISA14 French\Ê%?_?’=?áz”>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#=proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeå{Ž?bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@	®GALobitoTrapsJan-06åeeeeeeeeeeeeiELISA14 French2Z#?YÞ	?\É:?q=Š>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×£<proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeå
×£?bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@	¤pALobitoTrapsApr-06	åeeeeeeeeeeeeiELISA14 French$C=u€<½oÜ=
×#<eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÂõ<proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeåHá*@bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@	š™ALobitoTrapsJul-06
åeeeeeeeeeeeeiELISA14 French‹/>ÚËÖ='Áƒ>Âu=eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#=proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeå…ëQ?bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@	ÂALobitoTrapsAug-06åeeeeeeeeeeeeiELISA14 FrenchҊ¯== >Âõ<eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÍÌL=proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeå@?bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@	…ëALobitoTrapsOct-06åeeeeeeeeeeeeiELISA14 Frenchê >ì¢h>ÿÓ>¸>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#<proportion positivepopulationMicroscopysurveyoconcurrentYesrted in Other paperNoDrame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, Foumane V, Dos-Santos MA, Sembène M, Fortes F et al: Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PloS one 2010, 5(12):e15596.meååeeeåeå0eeeåeåeå…ë>bites/person/nightpopulationCDC Light TrapsconcurrentYesYes6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. Gambiaeeveryone0–6 (n = 49), 7–14 (n = 34) and .14 years (n = 25)1051470230 participants of a trial of ITNsgSG6-P1peptideÚPloS oneHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Cornelie S.; Le Mire J.; Toto JC.; Foumane V.; Dos-Santos MA.; Sembène M.; Fortes F.; Simondon F.; Carnevale P.; Remoue F.e@AYYYINCLUDEDeYxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@
ö( ALobitoTrapsMar-05åeeeeeeeeeeeeåeeåeeemELISA
×£=eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#=proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeåHá@An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@
ìQ ALobitoTrapsMay-05åeeeeeeeeeeeeåeeåeeemELISA=
×>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÓ¼ã=proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeåš™i@An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeee³¦[A.PƒÁåeeeeeeeeeeee(Multiplex21 French adultsÍÌL=
×#<{.>eeåeeeååeeåeeeeåeeeeeeåeeåeeeeåeeeeeeeåeåeeåeeeeeå(Multilex21 Frech adultsìQ¸=eåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@
áz ALobitoTrapsJul-05åeeeeeeeeeeeeåeeåeeemELISAÂu>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå_)K=proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeå¤p½>An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@
×£ ALobitoTrapsAug-05åeeeeeeeeeeeeåeeåeeemELISA…k>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×£<proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeåìQ¸>An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@
ÍÌ ALobitoTrapsSep-05åeeeeeeeeeeeeåeeåeeemELISAÍÌL>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×£<proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeå¤p½>An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@
Ãõ ALobitoTrapsOct-05åeeeeeeeeeeeeåeeåeeemELISAÍÌÌ>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÂu=proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåe帅?An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@
¸!ALobitoTrapsDec-05åeeeeeeeeeeeeåeeåeeemELISAq=Š>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#=proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeå{Ž?An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@
®G!ALobitoTrapsJan-06åeeeeeeeeeeeeåeeåeeemELISA33³>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×£<proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeå
×£?An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeå®GA@Dielmoitive¦[A.PƒÁeåeeeeeeeeeeeeee-Multiplex1 French adultse®G=ÍÌÌ>Â>åeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@
¤p!ALobitoTrapsApr-06	åeeeeeeeeeeeeåeeåeeemELISA
×#<eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÂõ<proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeåHá*@An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdseeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeMltiplex21 French adultsìQ¸ååeeeeeeåeeeeeåeeeeåeeeeeeåeeeeeeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@
š™!ALobitoTrapsJul-06
åeeeeeeeeeeeeåeeåeeemELISA¸>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#=proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeå…ëQ?An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåo+Canjala2008eåeeåeeeeeeeeeeåeåeeåELISAeåeeåeeeeeeåeeeeeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.eeeeeeee.ELISA45 Marseille@2>2؃=3 ‘>q=Š>95%CI: 0.19-0.34.ELISA45 Marseille¯!>RÙ+=ÿ3Œ>eee{®>95%CI: 0.22-0.46.ELISA45 Marseille²>¯%>UQÓ>eee?95%CI: 0.40-0.61åeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeee@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@
Â!ALobitoTrapsAug-06åeeeeeeeeeeeeåeeåeeemELISAÂõ<eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÍÌL=proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeå@?An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeååeeeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. Gambiaearsan-06nighteÖû"!=ÿ›=!An. Gambiae€?€?e@
…ë!ALobitoTrapsOct-06åeeeeeeeeeeeeåeeåeeemELISA…k>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå
×#<proportion positivepopulationMicroscopySurveyconcurrentYesmeååeeeåeå0eeeåeåeå…ë>An. Gambiae/trap/nightpopulationCDC Light Traps6 reference householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20102005-2006LongitudinalAfricaAngolaLobitoAn. GambiaeChildren0-10: 76; >10:331091279230 participants of a trial of ITNsAn. Gambiae WSEWhole salivaÚThe American journal of tropical medicine and hygieneHuman antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Drame PM.; Poinsignon A.; Besnard P.; Le Mire J.; Dos-Santos MA.; Sow CS.; Cornelie S.; Foumane V.; Toto JC.; Sembene M.; Boulanger D.; Simondon F.; Fortes F.; Carnevale P.; Remoue F.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAChildrenAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@ö(0ANgarafåeeeeeeeeeeee8ELISA?ìQ¸>
×#?²o>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌL?bites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.e€AINCLUDEDeY£ÜjAó¡‹ÁAll agesAn. GambiaeØ£¼<
Ü:=An. Arabiensis; An. Funestus; An. Gambiae€?€?@ìQ0ABiscuiterieåeeeeeeeeeeee<ELISA?¤p½>®G!?V>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåš™™>bites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.åeåeeåeåeåeåeåee€AINCLUDEDeYð]kA®—‹ÁAll agesAn. GambiaenestusØoض<©06=An. Arabiensis; An. Funestus; An. Gambiae€?€?Fontenille @áz0AHann MontagneåeeeeeeeeeeeeLELISAvO^?¸E?×£p?33³>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌ¥Bbites/person/nightpopulationHLCconcurrentYeseeåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeåeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee×åMayLÓÂ@ ©>åeåeeeeeeeeeåe'ELISA25 EuropeasÓM?Yæ>\ ?¯eåeeeeeeeeåeeeeåeeeeeeåeeeååeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.åÉåß>A‚Â>¶óý>proportion seropositivepopulationPfMSP1(19)concurrentYesyese'eåeåe€AINCLUDEDeYeeeeªªkAf‹ÁAll agesAn. GambiaearpopulationØoض<©06=An. Arabiensis; An. Funestus; An. Gambiae€?€? background@×£0AHann 3åeeeeeeeeeeee@ELISA]þ#?\?\B?\‚>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍ̈Abites/person/nightpopulationHLCconcurrentYesåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeåeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.ÍÌALibata+Candiero2008åe€AINCLUDEDeYeeeemukA†s‹ÁAll agesAn. GambiaeØoض<©06=An. Arabiensis; An. Funestus; An. Gambiae€?€?@ÍÌ0ADieupeul 4åeeeeeeeeeeee:ELISA2æ?Âõ>¤p=?Ý$†>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÀ?bites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.eeeeåeeåeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeee€AINCLUDEDeYåeЖkA*¤‹ÁAll agesAn. GambiaeeeeØoض<©06=An. Arabiensis; An. Funestus; An. Gambiae€?€?@Ãõ0ACité ASECNA 1åeeeeeeeeeeeeFELISA².>?R¸?=
W?žï§>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåš™ÑAbites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeeeåeåeeåeåeå×£ALobitoTreåg-05xòEÁïÐXAåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.e€AINCLUDEDeYrson/years‚Ö½g
B傶kA¥î‹ÁAll agesAn. Gambiae؁&Â<­@=An. Arabiensis; An. Funestus; An. Gambiae€?€?@¸1AYoff Dagoudaneåeeeeeeeeeeee>ELISAñc?=
×>{.?Ý$†>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌÌ>bites/person/nightpopulationHLCconcurrentYes®GA@Dielmoitive³¦[A.PƒÁåeeeeeeeeeeee-rench adultsGá=ÍÌÌ>Â>åeåeåeåeeeeeee{®>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeååeeåeeeeeeååeåeeeeåeeeeeeeåeeåeeeeeeåeeeeeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.some generous rounding to be log10 changes in EIRe€AINCLUDEDeYlAiڋÁAll agesAn. GambiaeØ÷<³q=An. Arabiensis; An. Funestus; An. Gambiae€?€?32 USA@®G1ACite SOPRIMåeeeeeeeeeeee:ELISA0»'?¸?®G?•>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeå8Bbites/person/nightpopulationHLCconcurrentYes…ëA@Ndiopsitive³¦[A.PƒÁåeeeeeeeeeeee(Multiplex21 French adultsÍÌL=
×#<{.>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeee(Multiplex21 Frech adultsìQ¸=eåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.eeååe€AINCLUDEDeYeglAta‹ÁAll agesAn. GambiaeØÂLÛ<õÛW=An. Arabiensis; An. Funestus; An. Gambiae€?€?ACD@¤p1AGolf Sudåeeeeeeeeeeee@ELISAP?333?fff?ÁÊ¡>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌòBbites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.åeeeåeåeåe€AINCLUDEDeYWClAîG‹ÁAll agesAn. GambiaeØÔ·<Y7=An. Arabiensis; An. Funestus; An. Gambiae€?€?@š™1ACheikh Wadeåeeeeeeeeeeee<ELISA333?…ë?)\O?¨Æ‹>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌì@bites/person/nightpopulationHLCconcurrentYes	ö(ALobitoTrapsMar-05xòEÁïÐXAåeeeeeeeeeeeiELIåC?)=+?ð?Ãõ¨>eeåeeåeeåeeeåeeeeeeeååeeåeåeåeeåeeeeeåeeeeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.åeåe帅>e€AINCLUDEDeYositivepopulationPfCSPconcurrntyesyeseållAw‹ÁAll agesAn. GambiaeØÔ·<Y7=An. Arabiensis; An. Funestus; An. Gambiae€?€?@Â1AArouna Sallåeeeeeeeeeeee>ELISAÛùÞ>R¸ž>…ë?7‰A>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeå33Ó@bites/person/nightpopulationHLCconcurrentYeseeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.åeåeeeåeåe€AINCLUDEDeYåÍÌôAbites/person/nightpoyNlA
þŠÁAll agesAn. GambiaeØÖsÒ<¸éO=An. Arabiensis; An. Funestus; An. Gambiae€?€?@…ë1AThierno KaneåeeeeeeeeeeeeFELISAÄB?Háú>Há:?+‡>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌì@bites/person/nightpopulationHLCconcurrentYesš™Á@ValleyåeeeeeeeeeeeewELISA37 USA?ìQ8>ÍÌÌ>ÍÌL?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeååeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.eeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeee€AINCLUDEDeY%tlAîŠÁAll agesAn. GambiaeØÖsÒ<¸éO=An. Arabiensis; An. Funestus; An. Gambiae€?€?@{2AMaka Colobaneåeeeeeeeeeeee<ELISA&SU?Â5?…k?B`¥>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåBbites/person/nightpopulationHLCconcurrentYeseeeeeeee'ELISA25 Europeans‡?zÇ	?1'?JÂ>7‰>X9ô>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.e€AINCLUDEDeY Ainfect­lA"+‹ÁAll agesAn. GambiaeØÔ·<Y7=An. Arabiensis; An. Funestus; An. Gambiae€?€?@q=2ACité Pépinièreåeeeeeeeeeeee>ELISAãÇ?…ë>ìQ8?7‰>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌdAbites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.eeåeåeåeåeåe€AINCLUDEDeY-'lAd‹ÁAll agesAn. GambiaeØÔ·<Y7=An. Arabiensis; An. Funestus; An. Gambiae€?€?@ff2ADarou Khoudossåeeeeeeeeeeee:ELISA˜ÝS?Â5?Ãõh?33³>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåš™Bbites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeee
ìQ ALobitoTrapsMay-05xòEÁïÐXAåeeeeeeeeeeeeååeåeemeLISAe=×>åeeeeeeeåeeeeeeåeåeeåeeeeåeåeeeeeeåeåeeeeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.åee€AINCLUDEDeYZElAx,‹ÁAll agesAn. GambiaeeeeeeåØÔ·<Y7=An. Arabiensis; An. Funestus; An. Gambiae€?€?@\2ADarou Salam 2åeeeeeeeeeeeeFELISAû
?=
×>Ãõ(?¬Z>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÍÌdAbites/person/nightpopulationHLCconcurrentYesåeåeåeåeeeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåDrame 20122008Cross-sectionalAfricaSenegalNgaraf; Biscuiterie; Hann Montagne; Hann 3; Dieupeul 4; Cité ASECNA 1; Yoff Dagoudane; Cite SOPRIM; Golf Sud; Cheikh Wade; Arouna Sall; Thierno Kane; Maka Colobane; Cité Pépinière; Darou Khoudoss; Darou Salam 2SeasonalAn. Gambiae/ An. Arabiensischildren and adults5; 353-8; 28-422-10; >181010 (505 children and 505 adult women)10104,658 individuals (2,231 children and 2,427 adults, women in majority) from 50 sites of Dakar region were included in the studygSG6-P1peptideÜMalaria journalIgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Drame PM.; Machault V.; Diallo A.; Cornélie S.; Poinsignon A.; Lalou R.; Sembène M.; Dos Santos S.; Rogier C.; Pagès F.; Le Hesran JY.; Remoué F.e€AINCLUDEDeYzlAÑãŠÁAll agesAn. GambiaeØÖsÒ<¸éO=An. Arabiensis; An. Funestus; An. Gambiae€?€?@
ö(PAAlledM3åeeeeeeeeeeee…ELISAü™p?Šb?ÛBy?“Ä>)\>ff?ee…ELISAe´ºÓ>0b¨>±‹?h‘m>sh>´È¶>eeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåÀ?š™™?ffæ?bites/person/nightpopulationpredictedHLCNoReported in paperCottrell G, Kouwaye B, Pierrat C, le Port A, Bouraïma A, et al. (2012) Modeling the Influence of Local Environmental Factors on Malaria Transmission in Benin and Its Implications for Cohort Study. PLOS ONE 7(1): e28812. https://doi.org/10.1371/journal.pone.0028812ázABarragem+Chissequele2008åeeeeeeeeeeeeåeeeeåELISö(?eeeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeå	¤pALobitoTrapsApr-06	xòEÁïÐXAåeeeeeeeeeeeeiELISA14 French$C=u€<½oÜ=
×#<eeåeeeeeeeeeåeeeeeåeeåeeeeeeåeeeeåeeåeeeeååeeeeeåeeeeeeeeeeeeåeeeeeeåeeeeeeeååeåeeåeåeåeåeåDrame 20152007-2008LongitudinalAfricaBeninAvame Centre; Gbedjougo; Houngo; Anavie; Dohinoko; Gbetaga; Tori Cada Centre; Zebe; ZoungoudoSeasonalAn. Gambiae + An. FunestusChildren (=<1year)0-1year133532gSG6-P1peptideßMalaria journalSpecific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.Drame PM.; Poinsignon A.; Dechavanne C.; Cottrell G.; Farce M.; Ladekpo R.; Massougbodji A.; Cornélie S.; Courtin D.; Migot-Nabias F.; Garcia A.; Remoué F.å2012eeeåeåeåe€@YYNINCLUDEDeYÝÐ@´	@ChildrenAn. Gambiae; An. Funestusא	?e@@@@€@
ìQPAAlledM6åeeeeeeeeeeee…ELISA¾9z?³|o?ŽÍ~?ff?þÔ¸>ÕxI?ee…ELISAe`ö?–âÔ>?p?•>1,>¼tÓ>eeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåff@33³?ÍÌ,@bites/person/nightpopulationpredictedHLCNoReported in paperCottrell G, Kouwaye B, Pierrat C, le Port A, Bouraïma A, et al. (2012) Modeling the Influence of Local Environmental Factors on Malaria Transmission in Benin and Its Implications for Cohort Study. PLOS ONE 7(1): e28812. https://doi.org/10.1371/journal.pone.0028812eeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20152007-2008LongitudinalAfricaBeninAvame Centre; Gbedjougo; Houngo; Anavie; Dohinoko; Gbetaga; Tori Cada Centre; Zebe; ZoungoudoSeasonalAn. Gambiae + An. FunestusChildren (=<1year)0-1year133532gSG6-P1peptideßMalaria journalSpecific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.Drame PM.; Poinsignon A.; Dechavanne C.; Cottrell G.; Farce M.; Ladekpo R.; Massougbodji A.; Cornélie S.; Courtin D.; Migot-Nabias F.; Garcia A.; Remoué F.Ýee€@YYNINCLUDEDeYÝÐ@´	@ChildrenAn. Gambiae; An. Funestusא	?e@@@@€@
ázPAAlledM9åeeeeeeeeeeee…ELISA&|?D]r?Pˆ?Ý$&?ö(Ü>¤p]?ee…ELISAee\?~Tó>ÛO&?Õx©>ªñR>-ò>eeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåfff@ÍÌ,@Í̌@bites/person/nightpopulationpredictedHLCNoReported in paperCottrell G, Kouwaye B, Pierrat C, le Port A, Bouraïma A, et al. (2012) Modeling the Influence of Local Environmental Factors on Malaria Transmission in Benin and Its Implications for Cohort Study. PLOS ONE 7(1): e28812. https://doi.org/10.1371/journal.pone.0028812åeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20152007-2008LongitudinalAfricaBeninAvame Centre; Gbedjougo; Houngo; Anavie; Dohinoko; Gbetaga; Tori Cada Centre; Zebe; ZoungoudoSeasonalAn. Gambiae + An. FunestusChildren (=<1year)0-1year133532gSG6-P1peptideßMalaria journalSpecific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.Drame PM.; Poinsignon A.; Dechavanne C.; Cottrell G.; Farce M.; Ladekpo R.; Massougbodji A.; Cornélie S.; Courtin D.; Migot-Nabias F.; Garcia A.; Remoué F.6 reference householdse€@YYNINCLUDEDeYÝÐ@´	@ChildrenAn. Gambiae; An. Funestusא	?e@@@@€@
×£PAAlledM12åeeeeeeeeeeee…ELISA&|?D]r?Pˆ?ÙÎ7?´Èö>ázt?ee…ELISAeiu'?n?<?´È¶>´Èv>î|ÿ>eeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeå @€@š™¹@bites/person/nightpopulationpredictedHLCNoReported in paperCottrell G, Kouwaye B, Pierrat C, le Port A, Bouraïma A, et al. (2012) Modeling the Influence of Local Environmental Factors on Malaria Transmission in Benin and Its Implications for Cohort Study. PLOS ONE 7(1): e28812. https://doi.org/10.1371/journal.pone.0028812åeåeåeåeeeeeeeåeåeeåeåeåeåeåDrame 20152007-2008LongitudinalAfricaBeninAvame Centre; Gbedjougo; Houngo; Anavie; Dohinoko; Gbetaga; Tori Cada Centre; Zebe; ZoungoudoSeasonalAn. Gambiae + An. FunestusChildren (=<1year)0-1year133532gSG6-P1peptideßMalaria journalSpecific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.Drame PM.; Poinsignon A.; Dechavanne C.; Cottrell G.; Farce M.; Ladekpo R.; Massougbodji A.; Cornélie S.; Courtin D.; Migot-Nabias F.; Garcia A.; Remoué F.e€@YYNINCLUDEDeYÝÐ@´	@ChildrenAn. Gambiae; An. Funestusא	?e@@@@€@ö(`AAmbaey2003çELISA®Ç>˧>ž^é>Ãõ(?)\>€?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeÈ^ï=£¯ =6v)>proportion positivepopulationMicroscopysurveyYesYesuredçeeeåeeåoC><N>È}>proportion positivepopulationMicroscopysurveyYesYesuredçgives febrile prevalence estimate, but not specific to malariaeååeeeåeåCÿ„=™»=[¶Ö=proportion positivepopulationMicroscopysurveyeYesYesuredeeçeåeåfˆ³>ô”>¶øÔ>proportion seropositivepopulationPfAMA1YesMeasured珍?)ß>Qƒ?proportion seropositivepopulationPfMSP1(19)YesMeasuredeçeåeåeeeeeeÏfe?¨oY?ªn?proportion seropositivepopulationPf Shizont ExtracteYesMeasuredçeåeeåeåeåäI>©Í=ìiG>proportion seropositivepopulationPvAMA1YesMeasuredyeseç/4‡>
lU>Û¦>proportion seropositivepopulationPvMSP-1(19)YesMeasuredyeseçIdris 20172003; 2007Repeated cross sectionalPacificVanuatuAmbae; Futunamesoendemic; malaria freeAn. Farauti (s.s.)all ages16; 12; 147-27; 6-26; 8-25231; 282; 392231; 282; 392gSG6recombinant proteináParasites & vectorsSerological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu.Idris ZM.; Chan CW.; Mohammed M.; Kalkoa M.; Taleo G.; Junker K.; Arcà B.; Drakeley C.; Kaneko A.	ÍÌALobitoTrapsSep-05xòEÁïÐXAåee@@INCLUDEDeYeeeeeiELIA14 FrenchÖöuÁÙÑ'CAll agesAn. FarautiÓ:’>k}>An. Farauti s.l.@@@@ìQ`AAmbaey2007ELISA§è;úík:©Ð<ÍÌÌ=ÍÌL=ìQ8>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe>‘<'f½;F|'=proportion positivepopulationMicroscopysurveyYesYesuredeeeåeeå“©=EØp<ý‡t=proportion positivepopulationMicroscopysurveyYesYesuredgives febrile prevalence estimate, but not specific to malariaeååeeeåeå;Sh<™G~;Ú =proportion positivepopulationMicroscopysurveyeYesYesuredeeeåeå	ázALobitoTrapsJul-05xòEÁïÐXAåeeeeeeeeeeeeiELISA14 French5C?)=+?ðV?Ãõ¨>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeá>>èÙ=ƒ£D>proportion seropositivepopulationPfAMA1YesMeasuredaàY>w*>›É‡>proportion seropositivepopulationPfMSP1(19)YesMeasuredeeåeåeeeeee•ñ'?î?a6?proportion seropositivepopulationPf Schizont extracteYesMeasuredeeåeeeeeeeåeeeeeeåeeåeeeeeåeåeeeeeåeeeMlteåadultsìQ¸=eeeeeeågíö=‚ÿ­=ÚU(>proportion seropositivepopulationPvAMA1YesMeasuredyesegíö=‚ÿ­=ÚU(>proportion seropositivepopulationPvMSP-1(19)YesMeasuredyeseIdris 20172003; 2007Repeated cross sectionalPacificVanuatuAmbae; Futunamesoendemic; malaria freeAn. Farauti (s.s.)all ages16; 12; 147-27; 6-26; 8-25231; 282; 392231; 282; 392gSG6recombinant proteináParasites & vectorsSerological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu.Idris ZM.; Chan CW.; Mohammed M.; Kalkoa M.; Taleo G.; Junker K.; Arcà B.; Drakeley C.; Kaneko A.eåeåeåeåeåe@@INCLUDEDeYÖöuÁÙÑ'CAll agesAn. Farauti׊°á<Є=An. Farauti s.l.€?€?@áz`AFutuna2011ˆELISA®Gá=ÍÌL=\B>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeproportion positivepopulationMicroscopysurveyYesYesuredˆeeeåeeåproportion positivepopulationMicroscopysurveyYesYesuredˆgives febrile prevalence estimate, but not specific to malariaeååeeeåeåproportion positivepopulationMicroscopysurveyeYesYesuredeeˆeåeåeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeee
×£ ALobitoTrapseAg-eeïÐXAåeåeåe
Â!ALobitoeapåxòEÁïÐXAåeåeeeeeeåeeeåeåeeåeemELIAeåIdris 20172003; 2007Repeated cross sectionalPacificVanuatuAmbae; Futunamesoendemic; malaria freeAn. Farauti (s.s.)all ages16; 12; 147-27; 6-26; 8-25231; 282; 392231; 282; 392gSG6recombinant proteináParasites & vectorsSerological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu.Idris ZM.; Chan CW.; Mohammed M.; Kalkoa M.; Taleo G.; Junker K.; Arcà B.; Drakeley C.; Kaneko A.åeåeåeåeeee@@INCLUDEDeYÝEœÁ™7*CAll agesAn. Farauti>eeåeÛeeå€?€?eeee€?ö(pA3yoåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexo‹=8Ú<½>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå015eeeåeåeåeeåeeemELISAÍÌL>eeåeeeeeeeåeeeeeeåeeåeeeeeåeåeeeeåeeeeeeeeeåeeeååeeeeeeåeeeeeåeeåeeeeeeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeåeeeeeeåeeeeåeeeeeåeeeeeeåeåeåeåeååeåÿÿee[X[AXãÕBAll agesAn. DirusåÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ìQpA7yoåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexi¨=g=a©;>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå015eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeååeåÿÿee[X[AXãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ázpA12yoåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexœùï=ržb=»Vp>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå015eeeåeåeå	®GALobitoTrapsan-06xåeåeåeåeeeeeeeåeåeeåeåeåeåeååeåÿÿee[X[AXãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@×£pA17yoåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexä
>™ú=¿È„>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå015eeeåeåeå	¤pALobitoTrapsApr-06	xòEÁïÐXAåeeeeeeeeeeeeiELISA14 French$C=u€<½oÜ=
×#<eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeeeeeåeeeeeåeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeååeåÿÿee[X[AXãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ÍÌpA24yoåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexN/L>ÙpÉ=+Dµ>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå015eeeåeåeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeååeåÿÿee[X[AXãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ÃõpA34yoåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexŒ¡2>U>=â·¿>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå015eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeååeåÿÿee[X[AXãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@¸qA60yoåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplex~j^>Õeo=G]?eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå015eeeåeåeååeå
e!ALobtoTrpsOct-06xòEÁïÐXAååeeåeeeeeeeeeeeeeåeeemELISAeåeåeeåeåeåeåeååeåÿÿee[X[AXãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeedMultiplex
×£=@ÃÛ<¢^>C€BC€³CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeådMultiplex)\=–Ä£<,Çõ= vC)C¡CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÍÌL=Ž¤î;„â½=proportion positiveePCRYes and noYesYesyesSupp 1åedeååeeeeeåeåeeeåeååå)\=–Ä£<,Çõ=proportion positiveePCRYes and noYesYesyesSupp 1ååeedåeeeeåå
×#=¨ªÐ:`” =proportion positiveePCRYes and noYesYesyesSupp 1ådeeeåeeå
×#<­ñ<proportion positiveeYes and noYesYesyesSupp 1dproportion positiveeYes and noYesYesyesSupp 1d~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÍÌL=}¤î;…â½=n seropositivePfMSP1(1)yesyeseseåÆ«?Œedn seropositiveePfMSP2yeyesyeååHáú>˶È>â…?eåedeeeeeeeeeeeeeeååeeååeeeeåå…ë><¹>Ä?eåPˆ>­edroportion seropositiveopulationfMSP3eseseseåö(Ü>izª>Âë?edÂu=2h\<‰5Ú=edKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ~B?¦ö>n seropositiveeâBYYYINCLUDEDeYeså!ÎJ?}匐=Ÿ˜=yX[ATãÕBAll agesAn. Dirus…k>eeåeeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?eeå@€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee!Multiplexÿ=ø<•×µ=`„C #CpÎCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå!Multiplexÿ=ø<•×µ=€bC€"C@ÍCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÿ=ø<•×µ=proportion positiveePCRYes and noYesYesyesSupp 1åe!eååeeeeeåeåeeeåeåååÿ=ø<•×µ=proportion positiveePCRYes and noYesYesyesSupp 1ååee!åeeeeååproportion positiveePCRYes and noYesYesyesSupp 1å!eeeåeeåproportion positiveeYes and noYesYesyesSupp 1!proportion positiveeYes and noYesYesyesSupp 1!~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å>x=Òl>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe!n seropositiveePfMSP2yeyesyeåå.:>ǵM=Ów >eåe!eeeeeeeeeeeeeeååeeååeeeeååÊ&›>½>oë>eåPˆ>­e!roportion seropositiveopulationfMSP3eseseseåÊ&›>½>oë>e!>x=Òl>e!Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åMultiplex"I>RÞÍ>ÀÅC€(CùCeeåeeeeeeåeeeeeeåeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@%€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeFMultiplexÍÌL>¹°Ù=Ÿ`–>ÀŠC`C˜DeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåFMultiplex±øŠ>D+>VOÀ>ÀlC€ûB`Deeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee’ê<©qŠ=proportion positiveePCRYes and noYesYesyesSupp 1åeFeååeeeeeåeåeeeåeååå(I’=ÖÌ5<[ì>proportion positiveePCRYes and noYesYesyesSupp 1ååeeFåeeeeååíŠ/=Nñ¸=proportion positiveePCRYes and noYesYesyesSupp 1åFeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Fproportion positiveeYes and noYesYesyesSupp 1F~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åŸê=…Ó"=ÀYA>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeFn seropositiveePfMSP2yeyesyeåå_ñ>eµ>dŸ?eåeFeeeeeeeeeeeeeeååeeååeeeeååä+¾>_7„>g ø>eåPˆ>­eFroportion seropositiveopulationfMSP3eseseseånÛ¶>EÅz>:Tð>eFê >Â8“=½7x>eFKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeY¸€ARatanakiri Provice010åyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.e€?€?@1€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeVMultiplex
ú>}Æj=uBK>€RC€ðB@èCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåVMultiplexlÊ>ˆš=ËPh>€BCËB@ëCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeVeååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååeeVåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åVeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Vproportion positiveeYes and noYesYesyesSupp 1V~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å
ú>ŠÆj=uBK>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeVn seropositiveePfMSP2yeyesyeååù‚¾>®4Š>FÑò>eåeVeeeeeeeeeeeeeeååeeååeeeeå僾 >Ò]>÷Ò>eåPˆ>­eVroportion seropositiveopulationfMSP3eseseseå<âŽ>!±<>çk¿>eVú>ŠÆj=uBK>eVKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); }å፦>læe>Œ(Ú>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeSn seropositiveePfMSP2yeyesyeååí!?»ø>}72?eâBYYYINCLUDEDeYeeeeeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@=
€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeGMultiplexÞ.u>Š‰>j­>ÀÁC@eC@DeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåGMultiplex‰VX>g6î=ïȜ>°C€C€øCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee­Âæ<®‚ˆ=proportion positiveePCRYes and noYesYesyesSupp 1åeGeååeeeeeåeåeeeåeååå-=+^¶=proportion positiveePCRYes and noYesYesyesSupp 1ååeeGåeeeeåå-=+^¶=proportion positiveePCRYes and noYesYesyesSupp 1åGeeeåeeå­Âf<©ö)=proportion positiveeYes and noYesYesyesSupp 1Gproportion positiveeYes and noYesYesyesSupp 1G~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åˆÍ>¢8J=áQ>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeGn seropositiveePfMSP2yeyesyeååH´>ÍËv>T*í>eåeGeeeeeeeeeeeeeeååeeååeeeeååóÛ¥>æ?\>ñ—Ý>eåPˆ>­eGroportion seropositiveopulationfMSP3eseseseåÜ¥ž>À%O>ظÕ>eGÜ¥>ì=ªÕt>eGKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åeåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYeåyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@J€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeSMultiplex\=-Cœ=€jC@C@šCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåSMultiplexÐeÅ<•Ôi=ÀYCCÀCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÐeE<k}=proportion positiveePCRYes and noYesYesyesSupp 1åeSeååeeeeeåeåeeeåeåååÐeE=—¬
;lÁ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeSåeeeeåå\=-Cœ=proportion positiveePCRYes and noYesYesyesSupp 1åSeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Sproportion positiveeYes and noYesYesyesSupp 1S~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å\=1Cœ=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeSn seropositiveePfMSP2yeyesyeå幬>CIq>|Íà>eåeSeeeeeeeeeeeeeeååeeååeeeeåå„7š>]O>€ÀÌ>eåPˆ>­eSroportion seropositiveopulationfMSP3eseseseå̊>¢O#>Çm±>eSV=1Cœ=eSKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åeGeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeåeåeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@V€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee@Multiplex€<Æt<= ŸCrCÀÕCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå@Multiplex€=‡aQ;ôtù=À™C€MCàËCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee=tM—=proportion positiveePCRYes and noYesYesyesSupp 1åe@eååeeeeeåeåeeeåeååå€=‡aQ;ôtù=proportion positiveePCRYes and noYesYesyesSupp 1ååee@åeeeeåå@=ºÊ=proportion positiveePCRYes and noYesYesyesSupp 1å@eeeåeeåproportion positiveeYes and noYesYesyesSupp 1@proportion positiveeYes and noYesYesyesSupp 1@~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åà=ÐÊ=LM>>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe@n seropositiveePfMSP2yeyesyeååÈ>ŒÌŠ>º™?eåe@eeeeeeeeeeeeeeååeeååeeeeåå€>£]>.Q¶>eåPˆ>­e@roportion seropositiveopulationfMSP3eseseseå€>£]>.Q¶>e@à=ÐÊ=LM>>e@Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@b€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeAMultiplexÍÌL>(rÒ=C0˜>­C ‰C@ìCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåAMultiplex¾|>!Ó>1¦³>0²C€…C@ëCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeȍÜ=hm=nr;>proportion positiveePCRYes and noYesYesyesSupp 1åeAeååeeeeeåeåeeeåeåååÃNl>l>Řª>proportion positiveePCRYes and noYesYesyesSupp 1ååeeAåeeeeåå܉>zp‡=t[w>proportion positiveePCRYes and noYesYesyesSupp 1åAeeeåeeå°|<]’9=proportion positiveeYes and noYesYesyesSupp 1Aproportion positiveeYes and noYesYesyesSupp 1A~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÃNl>l>Ęª>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeAn seropositiveePfMSP2yeyesyeåå؉?g…þ>ÿÐ;?eåeAeeeeeeeeeeeeeeååeeååeeeeååø?εÅ>Y!?eåPˆ>­eAroportion seropositiveopulationfMSP3eseseseå ø?εÅ>Y!?eA_è…>ti>œ¼>eAKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeeååeeeeååùa‘>¶5>>©Ã>eåPˆ>­eQroportion seroposeâBYYYINCLUDEDeYesese塽„>1Á'>©šµ>yX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@o€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeQMultiplex´=ë =uC;C©CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåQMultiplexžEÊ<Ào=@pC€5CàœCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeQeååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååeeQåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åQeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Qproportion positiveeYes and noYesYesyesSupp 1Q~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?ŒeQn seropositiveePfMSP2yeyesyeåå‡EÊ>Ó>ùc?eåeQeeeeeeeeeeeeeeååeeååeeeeååÖü0>èU¹=]§‚>eåPˆ>­eQroportion seropositiveopulationfMSP3eseseseå×ü0>èU¹=]§‚>eQeQKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeåå<”W=…>ý;FÀÇ=propEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); å_eeâBYYYINCLUDEDeYyZþ<proportion positiveeYes ad noYesYesyesSupp 1_yX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@{€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeaMultiplex8Ë>Ç[˜=Œh[>À‘C€+C€ÞCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåaMultiplex½Y>,W©=Ýh>à—C@-C@ãCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeQ"S=Ò2÷;$¯Ã=proportion positiveePCRYes and noYesYesyesSupp 1åeaeååeeeeeåeåeeeåeååå²<	>K ‡=?©N>proportion positiveePCRYes and noYesYesyesSupp 1ååeeaåeeeeåå1˓=S©<ªAý=proportion positiveePCRYes and noYesYesyesSupp 1åaeeeåeeåWè(<} ù<proportion positiveeYes and noYesYesyesSupp 1aproportion positiveeYes and noYesYesyesSupp 1a~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å8Ë>Ã[˜=h[>n seropositivePfMSP1(1)yesyeseseåÆ«?Œean seropositiveePfMSP2yeyesyeåå8Ë?#Aõ>Ýõ,?eåeaeeeeeeeeeeeeeeååeeååeeeeåå™?MQÚ>~	 ?eåPˆ>­earoportion seropositiveopulationfMSP3eseseseåÐQ?$²Ï>ŽÊ?eaG>>ª˜Ý=Ÿ†>eaKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseåÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@‡€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeBMultiplex>x=j<G;7ò=€ˆC€cCà¿CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåBMultiplex>x=j<G;7ò=à‡C_C¸Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeBeååeeeeeåeåeeeåeååå.:=ßÄ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeBåeeeeåå.:=ßÄ=proportion positiveePCRYes and noYesYesyesSupp 1åBeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Bproportion positiveeYes and noYesYesyesSupp 1B~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÿ=ø<M’=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeBn seropositiveePfMSP2yeyesyeåå>ø>'‚º>üü?eåeBeeeeeeeeeeeeeeååeeååeeeeåå=øà>§©£>j#?eåPˆ>­eBroportion seropositiveopulationfMSP3eseseseå]tÑ>»¸”>?eBŒ.:=ßÄ=eBKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åeYeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeeåeåeeeåeåeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@“€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeQMultiplexÝü°=¾ªÎ<'> KC C°™CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåQMultiplex)´—=C—‹<:A>à>CöBp–Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee„EJ=J;IÅÅ=proportion positiveePCRYes and noYesYesyesSupp 1åeQeååeeeeeåeåeeeåeåååÝü°=¾ªÎ<'>proportion positiveePCRYes and noYesYesyesSupp 1ååeeQåeeeeåå´=ë =proportion positiveePCRYes and noYesYesyesSupp 1åQeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Qproportion positiveeYes and noYesYesyesSupp 1Q~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å„EJ=¦;KÅÅ=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeQn seropositiveePfMSP2yeyesyeååÖü°>´êw>Tæ>eåeQeeeeeeeeeeeeeeååeeååeeeeååO·>1ځ>ÕÃì>eåPˆ>­eQroportion seropositiveopulationfMSP3eseseseå×ü°>´êw>Tæ>eQˆEJ=¦;KÅÅ=eQKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.ååeefåeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYeeeåyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ €ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee,Multiplex@~C€=CCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå,Multiplex@yC @C ˜Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe,eååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååee,åeeeeååproportion positiveePCRYes and noYesYesyesSupp 1å,eeeåeeåproportion positiveeYes and noYesYesyesSupp 1,proportion positiveeYes and noYesYesyesSupp 1,~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œe,n seropositiveePfMSP2yeyesyeåå.:>]öŠ=õp—>eåe,eeeeeeeeeeeeeeååeeååeeeeååºè">õP=ʈ>eåPˆ>­e,roportion seropositiveopulationfMSP3eseseseåºè">õP=ʈ>e,e,Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@¬€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeJMultiplexºgÝ<Fƒ=`ŠCÀkCÀ¦CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåJMultiplexºgÝ<Fƒ=@‰CdC€¨Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeºg]<·#=proportion positiveePCRYes and noYesYesyesSupp 1åeJeååeeeeeåeåeeeåeåååºgÝ<Fƒ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeJåeeeeååºgÝ<Fƒ=proportion positiveePCRYes and noYesYesyesSupp 1åJeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Jproportion positiveeYes and noYesYesyesSupp 1J~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÌ
&=‰¯=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeJn seropositiveePfMSP2yeyesyeååù¬>K˜k>&ä>eåeJeeeeeeeeeeeeeeååeeååeeeeååL‘>¸h9>ÜãÅ>eåPˆ>­eJroportion seropositiveopulationfMSP3eseseseåÝ`Š>n$->ƒ/¾>eJÉg]=4û%;ï7Ø=eJKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYååeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@¸€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeemMultiplexÕ©>
Êw>¦NÖ>€JCžB “CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåmMultiplexØ´Ÿ>"Zf>Ÿ<Ì>FCB`CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÎO–<L[2=proportion positiveePCRYes and noYesYesyesSupp 1åemeååeeeeeåeåeeeåeåååᅃ=d•<ªÆá=proportion positiveePCRYes and noYesYesyesSupp 1ååeemåeeeeååÜã;=&Ø;ea®=proportion positiveePCRYes and noYesYesyesSupp 1åmeeeåeeåproportion positiveeYes and noYesYesyesSupp 1mproportion positiveeYes and noYesYesyesSupp 1m~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÌX>‡¢	>‡A“>n seropositivePfMSP1(1)yesyeseseåÆ«?Œemn seropositiveePfMSP2yeyesyeååË­Î>ö„Ÿ>¢Öý>eåemeeeeeeeeeeeeeeååeeååeeeeååG*æ>ÀY¶>fý
?eåPˆ>­emroportion seropositiveopulationfMSP3eseseseåIÅÜ>+­>È/?emÈwa>>Ï>)˜>emKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.ååeeSåeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); YesyesSupp 1eâBYYYINCLUDEDeYåyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Å €ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeSMultiplex„Þ>›{§>¶T
?ÀCÝB}CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåSMultiplex'¼Ñ>‘›>¢ó?CãBOCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeSeååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååeeSåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åSeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Sproportion positiveeYes and noYesYesyesSupp 1S~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å›:¿>ò‰>#ƒô>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeSn seropositiveePfMSP2yeyesyeååiêü>'ØÅ>Uþ?eåeSeeeeeeeeeeeeeeååeeååeeeeåå፦>læe>Œ(Ú>eåPˆ>­eSroportion seropositiveopulationfMSP3eseseseå³b >~—Z>§yÓ>eSš:¿>ò‰>#ƒô>eSKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeåeeeeeeeåeeeeeeeeeeeeeeeåeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeeeeeeåeeeeeeåeeeeeeåeeeeeeÍÌÌ=úf’>proportion positiveePCRYes and noYesYesyesSupp 1eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Ñ"€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeYMultiplex‘•,>^ã¹=z9|>À5CÀ·B@•CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåYMultiplexq˜C>bîß=ۜ‹>€C€˜BÀvCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeYeååeeeeeåeåeeeåeååå38<ð·=proportion positiveePCRYes and noYesYesyesSupp 1ååeeYåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åYeeeåeeå38<ð·=proportion positiveeYes and noYesYesyesSupp 1Yproportion positiveeYes and noYesYesyesSupp 1Y~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å8>zÊÌ=eä„>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeYn seropositiveePfMSP2yeyesyeååT›Ú> ý¥>ƒœ?eåeYeeeeeeeeeeeeeeååeeååeeeeå唕¬>ޙt>7ÞÞ>eåPˆ>­eYroportion seropositiveopulationfMSP3eseseseå#¡>ë]_>PyÒ>eYs˜C>`îß=ۜ‹>eYKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.ååEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseeeeeeeeåÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.e€?€?eee@Ý$€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeJMultiplexÕg]=¨û%;ê7Ø=°C3C@·CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåJMultiplexºgÝ<Fƒ=0ˆCÀ#C¶Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeJeååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååeeJåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åJeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Jproportion positiveeYes and noYesYesyesSupp 1J~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åºgÝ<Iƒ=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeJn seropositiveePfMSP2yeyesyeååÂù>#ƾ>°±?eåeJeeeeeeeeeeeeeeååeeååeeeeåå¿y>âú>Q—®>eåPˆ>­eJroportion seropositiveopulationfMSP3eseseseåÉg]>©·ú=ß¹ž>eJÉgÝ<Iƒ=eJKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseåÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@é&€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee+Multiplexó‚>=»*à=€YC€C¥Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå+Multiplexó‚>=»*à=€XC€C`¤Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeó‚¾<ã‹=proportion positiveePCRYes and noYesYesyesSupp 1åe+eååeeeeeåeåeeeåeååå6âŽ=1j>proportion positiveePCRYes and noYesYesyesSupp 1ååee+åeeeeååó‚>=»*à=proportion positiveePCRYes and noYesYesyesSupp 1å+eeeåeeåproportion positiveeYes and noYesYesyesSupp 1+proportion positiveeYes and noYesYesyesSupp 1+~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åó‚>=º*à=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe+n seropositiveePfMSP2yeyesyeåå(kÊ>1>êž
?eåe+eeeeeeeeeeeeeeååeeååeeeeåå¶#n>
¬Ù=¶¸·>eåPˆ>­e+roportion seropositiveopulationfMSP3eseseseåú‚>>Üώ=Ϛ>e+ú‚>=º*à=e+Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYååyX[ATãÕBAll agesAn. DiruseÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ö(€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee,Multiplexæ¢>k4=¸xs>€YCÀCÀ½Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå,Multiplex`tQ>êÏ®=bÀ¥>€sCõB€ÀCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee梋=}>proportion positiveePCRYes and noYesYesyesSupp 1åe,eååeeeeeåeåeeeåeååå.º=VoÃ;4>proportion positiveePCRYes and noYesYesyesSupp 1ååee,åeeeeåå.:=V$Û=proportion positiveePCRYes and noYesYesyesSupp 1å,eeeåeeåproportion positiveeYes and noYesYesyesSupp 1,proportion positiveeYes and noYesYesyesSupp 1,~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åºè">õP=ʈ>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe,n seropositiveePfMSP2yeyesyeåå0ºè>¸e>S?eåe,eeeeeeeeeeeeeeååeeååeeeeååºè¢>†ã8>±_é>eåPˆ>­e,roportion seropositiveopulationfMSP3eseseseåÑE—>e$>ðKÜ>e,ºè">õP=ʈ>e,Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeåeeåproportion positiveeYes and noYesYesyesSupp 1"proportion positiveeYes and noYesYesyesSupp 1"eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@+€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeSMultiplexU”>à7D>¾üÅ>`–CÀ6CDeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåSMultiplex„7š>]O>ÀÌ>kC)CðDeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÐeE<k}=proportion positiveePCRYes and noYesYesyesSupp 1åeSeååeeeeeåeåeeeåeååå\”=Ãɇ<>proportion positiveePCRYes and noYesYesyesSupp 1ååeeSåeeeeååÐeE=—¬
;lÁ=proportion positiveePCRYes and noYesYesyesSupp 1åSeeeåeeåÐeE<k}=proportion positiveeYes and noYesYesyesSupp 1Sproportion positiveeYes and noYesYesyesSupp 1S~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å፦>læe>Œ(Ú>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeSn seropositiveePfMSP2yeyesyeååí!?»ø>}72?eåeSeeeeeeeeeeeeeeååeeååeeeeååc ?µ6Ò>l% ?eåPˆ>­eSroportion seropositiveopulationfMSP3eseseseåiêü>'ØÅ>Uþ?eS፦>læe>Œ(Ú>eSKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeeåeeåeeeeeeeåeeeeeeåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeeåbMultiplex»œ‚>~Ø,>:Í®>ÀNC»B àCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeâBYYYINCLUDEDeYbz,=3Ü%>proportion positiveePRYes and noYesYesyeyX[ATãÕBAll agesAn. DiruseåÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?eee@-€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeebMultiplex§àe>ÏH>@<>†CðB€ïCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåbMultiplex»œ‚>~Ø,>:Í®>ÀNC»B àCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÄúÐ=bz,=3Ü%>proportion positiveePCRYes and noYesYesyesSupp 1åebeååeeeeeåeåeeeåeåååӇF>†Âì=5W‹>proportion positiveePCRYes and noYesYesyesSupp 1ååeebåeeeeåå7Ö>>"†=H›L>proportion positiveePCRYes and noYesYesyesSupp 1åbeeeåeeåproportion positiveeYes and noYesYesyesSupp 1b/'<
˜ö<proportion positiveeYes and noYesYesyesSupp 1b~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å¶m[>	=>2O—>n seropositivePfMSP1(1)yesyeseseåÆ«?Œebn seropositiveePfMSP2yeyesyeåå³>4?ü?haK?eåebeeeeeeeeeeeeeeååeeååeeeeååÁË)?£×?ß¿A?eåPˆ>­ebroportion seropositiveopulationfMSP3eseseseå/'?À?JO??ebˆÆz>X—#>Üú¨>ebKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.ìQpA7yo[X[AXãÕBåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeâBYYYINCLUDEDeYeeeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@/€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeSMultiplexÐeE<k}=úB|B@‘CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåSMultiplexÐeE<k}=ÀCjBÀ…Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeSeååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååeeSåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åSeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Sproportion positiveeYes and noYesYesyesSupp 1S~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?ŒeSn seropositiveePfMSP2yeyesyeåå„7š>]O>€ÀÌ>eåeSeeeeeeeeeeeeeeååeeååeeeeåå¹,>²t´=Å7>eåPˆ>­eSroportion seropositiveopulationfMSP3eseseseåV>¼%=΅a>eSeSKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeeeåeâBYYYINCLUDEDeYeåyX[ATãÕBAll agesAn. DiruseåÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@'1€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeYMultiplex¬BtB€}CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåYMultiplexBXBRCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeYeååeeeeeåeåeeeåeåååý¸<à+Z=proportion positiveePCRYes and noYesYesyesSupp 1ååeeYåeeeeååý¸<à+Z=proportion positiveePCRYes and noYesYesyesSupp 1åYeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Yproportion positiveeYes and noYesYesyesSupp 1Y~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?ŒeYn seropositiveePfMSP2yeyesyeååšÚÔ>¦m >È£?eåeYeeeeeeeeeeeeeeååeeååeeeeåå±’•>´fJ>
òÅ>eåPˆ>­eYroportion seropositiveopulationfMSP3eseseseåŠP„>Ù~+>¨á²>eYeYKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@33€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeBMultiplexÿ=x<KÆ6=€æB–B ’CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåBMultiplex@«B‚B †Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeBeååeeeeeåeåeeeåeååå>x=j<G;7ò=proportion positiveePCRYes and noYesYesyesSupp 1ååeeBåeeeeååÿ=ø<R’=proportion positiveePCRYes and noYesYesyesSupp 1åBeeeåeeå.:=ßÄ=proportion positiveeYes and noYesYesyesSupp 1Bproportion positiveeYes and noYesYesyesSupp 1B~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?ŒeBn seropositiveePfMSP2yeyesyeåå |ð>Ö²>?eåeBeeeeeeeeeeeeeeååeeååeeeeååm²I>ÜâÎ=¶ù•>eåPˆ>­eBroportion seropositiveopulationfMSP3eseseseåÊ&>Ç$…=0»s>eBeBKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?å@?5€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeYMultiplexý8=l	ù:Ø2´=ßBÀƒBÀŽCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåYMultiplex>Š= 	{<fÁô=ÞBsB†Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeý8=l	ù:Ø2´=proportion positiveePCRYes and noYesYesyesSupp 1åeYeååeeeeeåeåeeeåeåååý¸=ُù<	å>proportion positiveePCRYes and noYesYesyesSupp 1ååeeYåeeeeååý8=l	ù:Ø2´=proportion positiveePCRYes and noYesYesyesSupp 1åYeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Yproportion positiveeYes and noYesYesyesSupp 1Y~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åý¸<Ö+Z=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeYn seropositiveePfMSP2yeyesyeåå±’•>´fJ>
òÅ>eåeYeeeeeeeeeeeeeeååeeååeeeeååq˜C>`îß=ۜ‹>eåPˆ>­eYroportion seropositiveopulationfMSP3eseseseå“•,>Zã¹=y9|>eY¸<Ö+Z=eYKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@L7€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeecMultiplexª~%=¬ÖÓ:O/¢=ICqBÀCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåcMultiplexUÞN=–mñ;‰Ç¿=@0ClBCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeª~%=¬ÖÓ:O/¢=proportion positiveePCRYes and noYesYesyesSupp 1åeceååeeeeeåeåeeeåeååå7Žã=ŠI=¶+1>proportion positiveePCRYes and noYesYesyesSupp 1ååeecåeeeeååâΐ=D”¥<¦8ø=proportion positiveePCRYes and noYesYesyesSupp 1åceeeåeeåª~%<gô<proportion positiveeYes and noYesYesyesSupp 1cproportion positiveeYes and noYesYesyesSupp 1c~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åª~¥<ëCD=n seropositivePfMSP1(1)yesyeseseåÆ«?Œecn seropositiveePfMSP2yeyesyeååw†Ä>íy“>“õ>eåeceeeeeeeeeeeeeeååeeååeeeeåå
>x>)Ì!>ûW§>eåPˆ>­ecroportion seropositiveopulationfMSP3eseseseåN6Y>º¿>q֕>ecµ~¥<ëCD=ecKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åeåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@X9€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee¬Multiplex6â=¢„ô;Ø3={BBBíBeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå¬Multiplex¯#n=Åɽ<K±¾=ZB4B€¨Beeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe¬eååeeeeeåeåeeeåeåååó‚><ÿ€â<proportion positiveePCRYes and noYesYesyesSupp 1ååee¬åeeeeååó‚><ÿ€â<proportion positiveePCRYes and noYesYesyesSupp 1å¬eeeåeeåproportion positiveeYes and noYesYesyesSupp 1¬proportion positiveeYes and noYesYesyesSupp 1¬~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åó‚>=ófv<¶Ÿ=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe¬n seropositiveePfMSP2yeyesyeåå6eÍ>6ä§>6æò>eåe¬eeeeeeeeeeeeeeååeeååeeeeåålʚ>+Lo>Áî½>eåPˆ>­e¬roportion seropositiveopulationfMSP3eseseseå0è‹>ܝS>r®>e¬YSV=Bœ<ÉQ¯=e¬Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); yesSupp 1kproportion positiveeYes and noYesYesyesSupp 1keâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@d;€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeNMultiplexΉ=’,¦=€úBdBŽCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåNMultiplex
Ò<—´x=ÍBVB€|Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeNeååeeeeeåeåeeeåeååå.
R=Ç;èFÍ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeNåeeeeåå.
R=Ç;èFÍ=proportion positiveePCRYes and noYesYesyesSupp 1åNeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Nproportion positiveeYes and noYesYesyesSupp 1N~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åΉ=,¦=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeNn seropositiveePfMSP2yeyesyeå剝Ø>‡z >F`?eåeNeeeeeeeeeeeeeeååeeååeeeeåå”oy>cã>æ}­>eåPˆ>­eNroportion seropositiveopulationfMSP3eseseseå!
R>Y“ì=Kè–>eNى=,¦=eNKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.x€?€?@q=€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeVMultiplex›²¦>ûg>³gÙ>ÀECoB‡CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåVMultiplex›²¦>ûg>³gÙ>@:CxB@‰Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeVeååeeeeeåeåeeeåeåååó‚><*o=proportion positiveePCRYes and noYesYesyesSupp 1ååeeVåeeeeååó‚><*o=proportion positiveePCRYes and noYesYesyesSupp 1åVeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Vproportion positiveeYes and noYesYesyesSupp 1V~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}僾 >Ò]>÷Ò>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeVn seropositiveePfMSP2yeyesyeåå1è?Añá>¿×&?eåeVeeeeeeeeeeeeeeååeeååeeeeåå¢/è>‚P²>`?eåPˆ>­eVroportion seropositiveopulationfMSP3eseseseåqGÜ>ij¦>í?eVƒ¾ >Ò]>÷Ò>eVKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.å2eeeåeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); concurrentYeseâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@}?€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeTMultiplexçù>},Ã>`Q?^C Cð–CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåTMultiplex?ä@É>Œ_?€CC@çBpŠCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee$C=G;?˾=proportion positiveePCRYes and noYesYesyesSupp 1åeTeååeeeeeåeåeeeåeåå妪ª=UxÆ<œÛ>proportion positiveePCRYes and noYesYesyesSupp 1ååeeTåeeeeåå$Ã<æg=proportion positiveePCRYes and noYesYesyesSupp 1åTeeeåeeå$Ã<æg=proportion positiveeYes and noYesYesyesSupp 1Tproportion positiveeYes and noYesYesyesSupp 1T~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å>Ïó> ½>9??n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeTn seropositiveePfMSP2yeyesyeååÃ0?çs?1J?eåeTeeeeeeeeeeeeeeååeeååeeeeåå¸m?ñ°?}*6?eåPˆ>­eTroportion seropositiveopulationfMSP3eseseseå%I?ïbî>Ó`-?eT=Ïó> ½>9??eTKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ^º€ARatanakiri Province010eâBYYYINCLUDEDeYonorsØ„>uÄ!>eeyX[ATãÕBAll agesAn. DiruseåÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@‰A€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeOMultiplex4?›qò>›ç0?`kC€üB°¦CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåOMultiplex£Ò?:¾ë>'Æ-?@NCÊBàšCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeerdO=KÃ;W¶Ê=proportion positiveePCRYes and noYesYesyesSupp 1åeOeååeeeeeåeåeeeåeåååçwµ=æƒÔ<jç>proportion positiveePCRYes and noYesYesyesSupp 1ååeeOåeeeeåårdO=KÃ;W¶Ê=proportion positiveePCRYes and noYesYesyesSupp 1åOeeeåeeåWdO<6Ó=proportion positiveeYes and noYesYesyesSupp 1Oproportion positiveeYes and noYesYesyesSupp 1O~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åoÂü>ÅOÄ>‹š?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeOn seropositiveePfMSP2yeyesyeååW‹?põÿ>ö7?eåeOeeeeeeeeeeeeeeååeeååeeeeååºZÜ>³s¤>ã 
?eåPˆ>­eOroportion seropositiveopulationfMSP3eseseseå¼ZÜ>³s¤>ã 
?eOnÂü>ÅOÄ>‹š?eOKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@–C€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeJMultiplex„)ò>Dë·>á3?TC€C¡CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåJMultiplexG>ë>]±>–°?€OCôB`‡CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÈgÝ==&7>proportion positiveePCRYes and noYesYesyesSupp 1åeJeååeeeeeåeåeeeåeåååL‘>¶h9>ÞãÅ>proportion positiveePCRYes and noYesYesyesSupp 1ååeeJåeeeeåå¿y>ãú>Q—®>proportion positiveePCRYes and noYesYesyesSupp 1åJeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Jproportion positiveeYes and noYesYesyesSupp 1J~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å¦È>1³>vÌ?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeJn seropositiveePfMSP2yeyesyeååÝ`
?ўÚ>Rr'?eåeJeeeeeeeeeeeeeeååeeååeeeeååÈgÝ>®œ£>r™?eåPˆ>­eJroportion seropositiveopulationfMSP3eseseseåŠ|Ö>îœ>}?eJ¦È>1³>vÌ?eJKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseeeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.©;>€?€?@¢E€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeQMultiplex&´—>”I>CžÊ>‡C€+Cà·CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåQMultiplex&´—>”I>CžÊ>lC@*CÀ¯CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeežEÊ<Ào=proportion positiveePCRYes and noYesYesyesSupp 1åeQeååeeeeeåeåeeeåeååå„EJ=J;IÅÅ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeQåeeeeååžEÊ<Ào=proportion positiveePCRYes and noYesYesyesSupp 1åQeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Qproportion positiveeYes and noYesYesyesSupp 1Q~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å‘2p>F´>nX§>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeQn seropositiveePfMSP2yeyesyeåå´—Ð>GΙ>‘°?eåeQeeeeeeeeeeeeeeååeeååeeeeååùa‘>¶5>>©Ã>eåPˆ>­eQroportion seropositiveopulationfMSP3esesese塽„>1Á'>©šµ>eQ¡½„>1Á'>©šµ>eQKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@®G€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeePMultiplex€=ëì<c¢ì=€zC BC°­CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåPMultiplexš™=õ¢=@_C€C –Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee€=ëì<c¢ì=proportion positiveePCRYes and noYesYesyesSupp 1åePeååeeeeeåeåeeeåeååå33³=ðŒÑ<•>proportion positiveePCRYes and noYesYesyesSupp 1ååeePåeeeeååš™=õ¢=proportion positiveePCRYes and noYesYesyesSupp 1åPeeeåeeåÍÌL<@ì=proportion positiveeYes and noYesYesyesSupp 1Pproportion positiveeYes and noYesYesyesSupp 1P~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åš™=ó¢=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒePn seropositiveePfMSP2yeyesyeååfff>s²>,
¢>eåePeeeeeeeeeeeeeeååeeååeeeeååš™Y>ƒœû=y²š>eåPˆ>­eProportion seropositiveopulationfMSP3eseseseåš™Y>ƒœû=y²š>ePš™=ó¢=ePKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.PCRYes and noYesYesyesSupp 1Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ådeeeåeeå
×#<­ñ<proportion positiveeYes and noYesYesyesSupp 1dproportion positiveeYes and noYesYesyesSupp 1deâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ºI€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee[MultiplexB´=zó<S™>UCÂB`ªCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå[Multiplexa=f <jÐ=À9C€¶Bà–Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe[eååeeeeeåeåeeeåeåååh=¦Ž=proportion positiveePCRYes and noYesYesyesSupp 1ååee[åeeeeåå5´<GhU=proportion positiveePCRYes and noYesYesyesSupp 1å[eeeåeeå54<¿=proportion positiveeYes and noYesYesyesSupp 1[proportion positiveeYes and noYesYesyesSupp 1[~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åu‡=æÚt<…uï=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe[n seropositiveePfMSP2yeyesyeåå؉>¸øY>VÎ>eåe[eeeeeeeeeeeeeeååeeååeeeeå圫¹>o‡>Ç>ì>eåPˆ>­e[roportion seropositiveopulationfMSP3eseseseåA´>RЁ>0Fæ>e[q‡=æÚt<…uï=e[Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeeâBYYYINCLUDEDeYåyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ÇK€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeebMultiplexö¡±>la>âá> JC€¢B`˜CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåbMultiplexoÛ¶>ØH†>nç>À0CŠB°ŠCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee/'<
˜ö<proportion positiveePCRYes and noYesYesyesSupp 1åebeååeeeeeåeåeeeåeååå/'<
˜ö<proportion positiveePCRYes and noYesYesyesSupp 1ååeebåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åbeeeåeeåproportion positiveeYes and noYesYesyesSupp 1bproportion positiveeYes and noYesYesyesSupp 1b~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åoÛ¶>ÙH†>nç>n seropositivePfMSP1(1)yesyeseseåÆ«?Œebn seropositiveePfMSP2yeyesyeååÑX?¤Æ?þê7?eåebeeeeeeeeeeeeeeååeeååeeeeåå?‰PÍ>¼W?eåPˆ>­ebroportion seropositiveopulationfMSP3eseseseåˆÆú>ÅÈ>¦¹?ebnÛ¶>ÙH†>nç>ebKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); 
×£ ALobitoTrapsAug-05xòEÁïÐXAåeeeeeeeeeeeeåeâBYYYINCLUDEDeYeeåeeemELISAyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ÓM€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeOMultiplexLGö>çݽ>YX?qC@GC ˜CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåOMultiplex\Ü?ROÑ>
!?UC€4Cà‹Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeOeååeeeeeåeåeeeåeåååЁ=0B<O•ï=proportion positiveePCRYes and noYesYesyesSupp 1ååeeOåeeeeååЁ=0B<O•ï=proportion positiveePCRYes and noYesYesyesSupp 1åOeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Oproportion positiveeYes and noYesYesyesSupp 1O~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å&Ìï>Ou·>?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeOn seropositiveePfMSP2yeyesyeååxµ8?lg?„R?eåeOeeeeeeeeeeeeeeååeeååeeeeåå£Ò?;¾ë>'Æ-?eåPˆ>­eOroportion seropositiveopulationfMSP3eseseseå¢Ò?;¾ë>'Æ-?eO'Ìï>Ou·>?eOKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeeeeeeee:ELISA˜ÝS?Â5?Ãõh?33³>eeåeeeåeeåeeeeeeeåeâBYYYINCLUDEDeYeeåeeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?n seropos@ßO€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeGMultiplex¦ž?JûÝ>¨?*?ðCÀ{CÀÑCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåGMultiplex¦ž?JûÝ>¨?*?@”CÀiC`ÛCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee­=ŒC¢<—É>proportion positiveePCRYes and noYesYesyesSupp 1åeGeååeeeeeåeåeeeåeååå3~;>í¾¾=x΋>proportion positiveePCRYes and noYesYesyesSupp 1ååeeGåeeeeååˆÍ>ž8J=âQ>proportion positiveePCRYes and noYesYesyesSupp 1åGeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Gproportion positiveeYes and noYesYesyesSupp 1G~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åôdü>1ÚÀ>Ü÷?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeGn seropositiveePfMSP2yeyesyeååH4?Æ?tuO?eåeGeeeeeeeeeeeeeeååeeååeeeeå妞?JûÝ>§?*?eåPˆ>­eGroportion seropositiveopulationfMSP3eseseseå…Í?FÈ>ç’?eG…Í?FÈ>ç’?eGKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseåPˆ>­eJÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.seseåÝ€?€?@ìQ€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeVMultiplex¹#î>L*¸>“?@|C@
CÀ–CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåVMultiplex¹#î>L*¸>“?€pCöB@žCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee6âŽ=t‚<s'ý=proportion positiveePCRYes and noYesYesyesSupp 1åeVeååeeeeeåeåeeeåeååå^SÖ=a¨#=?i->proportion positiveePCRYes and noYesYesyesSupp 1ååeeVåeeeeååó‚>=C;çhº=proportion positiveePCRYes and noYesYesyesSupp 1åVeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Vproportion positiveeYes and noYesYesyesSupp 1V~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åsGÜ>ij¦>í?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeVn seropositiveePfMSP2yeyesyeå姬)?i?å@C?eåeVeeeeeeeeeeeeeeååeeååeeeeåå¹#î>K*¸>“?eåPˆ>­eVroportion seropositiveopulationfMSP3eseseseå¡/è>‚P²>`?eV‰;â>P~¬>aü?eVKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åeeeeåå¶#n>
¬Ù=¶¸·>Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); e+eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@øS€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeCMultiplex‘(>¢“š=¨y> ¡CÀkCÊCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåCMultiplexb	>ÌÀW=’*]>°™C@\C¿Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeª‰t<g4=proportion positiveePCRYes and noYesYesyesSupp 1åeCeååeeeeeåeåeeeåeååå%g7='Á=proportion positiveePCRYes and noYesYesyesSupp 1ååeeCåeeeeååu‰ô<†–=proportion positiveePCRYes and noYesYesyesSupp 1åCeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Cproportion positiveeYes and noYesYesyesSupp 1C~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åZøÕ=ãÞÿ<€ü5>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeCn seropositiveePfMSP2yeyesyeååa	?ÆùÕ>Ý(?eåeCeeeeeeeeeeeeeeååeeååeeeeååZøU>ä=TԜ>eåPˆ>­eCroportion seropositiveopulationfMSP3eseseseå\øU>ä=TԜ>eC‰ô=*
+=ÇI>eCKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eåeåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeâBYYYINCLUDEDeYåyX[ATãÕBAll agesAn. Dirus€ŒCTC€ºCeeåeeeeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.eeee€?€?@V€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeUMultiplexºÀÀ<ã]d=@yC@Cð¥CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåUMultiplexºÀÀ<ã]d=@lC1C•CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeºÀÀ<ã]d=proportion positiveePCRYes and noYesYesyesSupp 1åeUeååeeeeeåeåeeeåeåååéðp=Ø5<.êÞ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeUåeeeeå匐=þž˜=proportion positiveePCRYes and noYesYesyesSupp 1åUeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Uproportion positiveeYes and noYesYesyesSupp 1U~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åºÀ@<x=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeUn seropositiveePfMSP2yeyesyeååððp>c™>?¤¦>eåeUeeeeeeeeeeeeeeååeeååeeeeååððp>c™>?¤¦>eåPˆ>­eUroportion seropositiveopulationfMSP3esesese婨(>cÓ¯=¡gy>eUÁÀÀ<Þ]d=eUKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@X€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeZMultiplex?é“>éîG>
ÛÃ>@…C€C­CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåZMultiplex?é“>éîG>
ÛÃ>ÀtCþB  CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeEŽc=QÛ<ͲÒ=proportion positiveePCRYes and noYesYesyesSupp 1åeZeååeeeeeåeåeeeåeååå7Žã=§)==ÎC4>proportion positiveePCRYes and noYesYesyesSupp 1ååeeZåeeeeååøIŸ=5ß·<N>proportion positiveePCRYes and noYesYesyesSupp 1åZeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Zproportion positiveeYes and noYesYesyesSupp 1Z~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åíîn>t>ë4¤>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeZn seropositiveePfMSP2yeyesyeåå?é?o“ó>Ç.?eåeZeeeeeeeeeeeeeeååeeååeeeeåårÇ>‹“>Æ­ú>eåPˆ>­eZroportion seropositiveopulationfMSP3eseseseårÇ>‹“>Æ­ú>eZïîn>t>ë4¤>eZKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeâBYYYINCLUDEDeYeeeåNMultiplexyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Z€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeNMultiplexŸØ	?+Û>(+&?€ÛC€«CðDeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåNMultiplex?Ø/Ç>h?`ÃCà¢CÀDeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeΉ=’,¦=proportion positiveePCRYes and noYesYesyesSupp 1åeNeååeeeeeåeåeeeåeååå­ª*>ó«=Ò[>proportion positiveePCRYes and noYesYesyesSupp 1ååeeNåeeeeåå3H>Ù:]=¶AO>proportion positiveePCRYes and noYesYesyesSupp 1åNeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Nproportion positiveeYes and noYesYesyesSupp 1N~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å^¾å>æ:­>é ?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeNn seropositiveePfMSP2yeyesyeåå;±?s?ï>¼Â/?eåeNeeeeeeeeeeeeeeååeeååeeeeååi?ÌcÔ>ìî"?eåPˆ>­eNroportion seropositiveopulationfMSP3eseseseåi?ÌcÔ>ìî"?eNÅNì>´©³>ëy?eNKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååeeeâBYYYINCLUDEDeYeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@)\€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeYMultiplexT›Ú>Ÿý¥>ƒœ?@C¦BàÞCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåYMultiplexšÚÔ>¨m >È£?°“C€›B áCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeý8=l	ù:Ø2´=proportion positiveePCRYes and noYesYesyesSupp 1åeYeååeeeeeåeåeeeåeåååäÏ=.£=±'>proportion positiveePCRYes and noYesYesyesSupp 1ååeeYåeeeeååÊf=¡<˜Õ=proportion positiveePCRYes and noYesYesyesSupp 1åYeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Yproportion positiveeYes and noYesYesyesSupp 1Y~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}唕¬>ޙt>7ÞÞ>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeYn seropositiveePfMSP2yeyesyeååÆ3?"\?j8?eåeYeeeeeeeeeeeeeeååeeååeeeeåå
\à>¶”«>±‘
?eåPˆ>­eYroportion seropositiveopulationfMSP3eseseseåS›Ú> ý¥>ƒœ?eYKV²>xP>Zå>eYKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeeeeeeeeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@5^€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeTMultiplex(I=¡kš=€ñBxBà–CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåTMultiplex:Ïs=C<<²‡á=@àB|B —Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee$C=G;?˾=proportion positiveePCRYes and noYesYesyesSupp 1åeTeååeeeeeåeåeeeåeååå½mÛ=¬î'=r1>proportion positiveePCRYes and noYesYesyesSupp 1ååeeTåeeeeåå:Ïs=C<<²‡á=proportion positiveePCRYes and noYesYesyesSupp 1åTeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Tproportion positiveeYes and noYesYesyesSupp 1T~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å(I=›kš=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeTn seropositiveePfMSP2yeyesyeååô<?xè>¬j*?eåeTeeeeeeeeeeeeeeååeeååeeeeååÏó¼>ëˆ>³Éñ>eåPˆ>­eTroportion seropositiveopulationfMSP3eseseseånÛ¶>Œd‚>PRë>eT%I=›kš=eTKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeeeeåeåeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. Dirus~B?¦ö>ÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.s€?€?å!Î@B`€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex‚B"Bà†CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplexrB4B€MCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee!>T4<ù|>proportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeååå1F>%_=	Nª>proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeåå!„=ZŸ>proportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeåå1Æ>Î\>þ?eåeeeeeeeeeeeeeeeååeeååeeeeåå1Æ>Î\>þ?eåPˆ>­eroportion seropositiveopulationfMSP3eseseseåk­µ>_á>>õ?eeKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeVeeâBYYYINCLUDEDeYååyX[ATãÕBAll agesAn. DirusseåqGÜ>ij¦>í?ÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.ƒ¾ >Ò]€?€?@Nb€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee-Multiplexb¶=j¼;Ï*0>ÀB€9Bà‚Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå-MultiplexU¶<W·…=À–BAB vCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe-eååeeeeeåeåeeeåeåååU¶<W·…=proportion positiveePCRYes and noYesYesyesSupp 1ååee-åeeeeååU¶<W·…=proportion positiveePCRYes and noYesYesyesSupp 1å-eeeåeeåproportion positiveeYes and noYesYesyesSupp 1-proportion positiveeYes and noYesYesyesSupp 1-~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œe-n seropositiveePfMSP2yeyesyeååä8?Ò>¿c3?eåe-eeeeeeeeeeeeeeååeeååeeeeåålÁ>iÉq>½ù?eåPˆ>­e-roportion seropositiveopulationfMSP3eseseseåa¶>ß\>:§ý>e-e-Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeNMultiplexΉ=’,¦=€úBdBŽCeeåeeeåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeeeeeeeåNMultiplex
Ò<—´x=ÍBVB€|CeeåeeeeeeåeâBYYYINCLUDEDeYeeeeeeåeeeeeåeeeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Zd€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeIMultiplex3pà=\=5™9>@£CÀkC çCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåIMultiplex3p`=˜);r#Û= žCqC ÎCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee-T(=‰m±=proportion positiveePCRYes and noYesYesyesSupp 1åeIeååeeeeeåeåeeeåeååå3p`=˜);r#Û=proportion positiveePCRYes and noYesYesyesSupp 1ååeeIåeeeeååp`<T%=proportion positiveePCRYes and noYesYesyesSupp 1åIeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Iproportion positiveeYes and noYesYesyesSupp 1I~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?ŒeIn seropositiveePfMSP2yeyesyeåå¢B…>Šr#>ý˸>eåeIeeeeeeeeeeeeeeååeeååeeeeåå;wn>ä->Jà¨>eåPˆ>­eIroportion seropositiveopulationfMSP3eseseseå8p`>*…þ=îΠ>eI8pà<̈́=eIKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeåeeeeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeåeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseeeåeeeeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.ž<xºî=pr€?€?Yes @ff€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeLMultiplex<”×<3=€jC>C€™CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåLMultiplex<”W<½Ô= iCà-C’Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee<”W<½Ô=proportion positiveePCRYes and noYesYesyesSupp 1åeLeååeeeeeåeåeeeåeååå<”W=$;
›Ò=proportion positiveePCRYes and noYesYesyesSupp 1ååeeLåeeeeåå-¯!=ùª=proportion positiveePCRYes and noYesYesyesSupp 1åLeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Lproportion positiveeYes and noYesYesyesSupp 1L~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å<”×<3=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeLn seropositiveePfMSP2yeyesyeååDy
?¶á>z*?eåeLeeeeeeeeeeeeeeååeeååeeeeåå“×Ð>pE˜>Ü´?eåPˆ>­eLroportion seropositiveopulationfMSP3eseseseåQ^Ã>>s‹>dIû>eL6”×<3=eLKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ¬€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeâBYYYINCLUDEDeYeeeeeeeeeNMultiplexyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?å@sh€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeehMultiplex܉=OœÒ<K6>€ŒC1C ÆCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåhMultiplexÃNl=åS<ÔíÑ=€ŠCÀ)C`¯CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeIìÄ=2Å!={>proportion positiveePCRYes and noYesYesyesSupp 1åeheååeeeeeåeåeeeåeåååOì„>Ï3>½°>proportion positiveePCRYes and noYesYesyesSupp 1ååeehåeeeeååOìD>Ì·î=\>‰>proportion positiveePCRYes and noYesYesyesSupp 1åheeeåeeå鉝<â:=proportion positiveeYes and noYesYesyesSupp 1hproportion positiveeYes and noYesYesyesSupp 1h~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åΉ=žÃÄ:Ëvš=n seropositivePfMSP1(1)yesyeseseåÆ«?Œehn seropositiveePfMSP2yeyesyeåå±û>hâÉ>}"?eåeheeeeeeeeeeeeeeååeeååeeeeååÅN?I¤ç>eË$?eåPˆ>­ehroportion seropositiveopulationfMSP3eseseseåvb?J¦Ý>Çñ?ehى=žÃÄ:Ëvš=ehKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.~B?¦ö>n seropositivePfAMA1yeyesesEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); å媪ª>0y>>ÕØ>eåeieeeeeeeeeeeeeâBYYYINCLUDEDeYeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@j€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeUMultiplex£¨¨=6áÃ<ƒ,>€„C€HC@·CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåUMultiplexŒ=o/„<¥
>€C 0CPÈCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeºÀÀ=ÿ>=ñ>proportion positiveePCRYes and noYesYesyesSupp 1åeUeååeeeeeåeåeeeåeåå凄>>Êm=x–M>proportion positiveePCRYes and noYesYesyesSupp 1ååeeUåeeeeååºÀ@=t§;Œ“¼=proportion positiveePCRYes and noYesYesyesSupp 1åUeeeåee匐=þž˜=proportion positiveeYes and noYesYesyesSupp 1Uproportion positiveeYes and noYesYesyesSupp 1U~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}匐=Ÿ˜=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeUn seropositiveePfMSP2yeyesyeå傁?—Ì><·?eåeUeeeeeeeeeeeeeeååeeååeeeeååäää>ËÆ®>
?eåPˆ>­eUroportion seropositiveopulationfMSP3eseseseåÙØØ>W£>®P?eU‘=Ÿ˜=eUKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@‹l€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeemMultiplexÂwá=¸?R=Úç,>mC€CP—CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåmMultiplexÎã»=dÏ=üo>€QC€±BŒCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÎO<ÓÈÝ<proportion positiveePCRYes and noYesYesyesSupp 1åemeååeeeeeåeåeeeåeåååÎO–<L[2=proportion positiveePCRYes and noYesYesyesSupp 1ååeemåeeeeååÎO<ÓÈÝ<proportion positiveePCRYes and noYesYesyesSupp 1åmeeeåeeåproportion positiveeYes and noYesYesyesSupp 1mproportion positiveeYes and noYesYesyesSupp 1m~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åᅃ=^•<¦Æá=n seropositivePfMSP1(1)yesyeseseåÆ«?Œemn seropositiveePfMSP2yeyesyeååØ´Ÿ>#Zf>Ÿ<Ì>eåemeeeeeeeeeeeeeeååeeååeeeeååVg¤>
o>.HÑ>eåPˆ>­emroportion seropositiveopulationfMSP3eseseseåÚO–>éU>¿Â>em߅ƒ=^•<¦Æá=emKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@˜n€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeRMultiplexÁù>Ë\Â>+“?€oC€HC`ŠCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåRMultiplex8?ªÙÎ>›Ñ?@ŒC€iC`›CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeõÍÇ<A©l=proportion positiveePCRYes and noYesYesyesSupp 1åeReååeeeeeåeåeeeåeåååQÔ®=wÜË<¼X>proportion positiveePCRYes and noYesYesyesSupp 1ååeeRåeeeeåå…Ú•=ª‰<K¥>proportion positiveePCRYes and noYesYesyesSupp 1åReeeåeeåproportion positiveeYes and noYesYesyesSupp 1Rproportion positiveeYes and noYesYesyesSupp 1R~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å_‰Ú>¹£>Ó¬?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeRn seropositiveePfMSP2yeyesyeååˆÚ?Yõ>å&1?eåeReeeeeeeeeeeeeeååeeååeeeeååp>?Å$Õ>}ê!?eåPˆ>­eRroportion seropositiveopulationfMSP3eseseseå8?«ÙÎ>›Ñ?eRÎÇà>°È©>vã?eRKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); [b>7é>ç›>proportion positiveePCRYes and noYesYesyesSupp 1eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?yeses@¤p€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeVMultiplex1è??ñá>¿×&?@]Cà,C ƒCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåVMultiplex=â?@è>ØÀ)? ~C`IC0¤Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeVeååeeeeeåeåeeeåeåååó‚><*o=proportion positiveePCRYes and noYesYesyesSupp 1ååeeVåeeeeååó‚><*o=proportion positiveePCRYes and noYesYesyesSupp 1åVeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Vproportion positiveeYes and noYesYesyesSupp 1V~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åèú>yôÃ>¬?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeVn seropositiveePfMSP2yeyesyeåå1è?Añá>¿×&?eåeVeeeeeeeeeeeeeeååeeååeeeeåå¢/è>‚P²>`?eåPˆ>­eVroportion seropositiveopulationfMSP3eseseseå‰;â>P~¬>aü?eV?ÒäÉ>—
?eVKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.ååeeååeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); e-e-eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. Dirus„>1Á'>©šµ>ÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@°r€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeemMultiplex]?o ó>€j)?€C€ÀB€ŽCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåmMultiplex©?°?…=0?À/C€¡B€§CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÕ)>aqÃ=ùzp>proportion positiveePCRYes and noYesYesyesSupp 1åemeååeeeeeåeåeeeåeåååY›>®±]>Ù+Ç>proportion positiveePCRYes and noYesYesyesSupp 1ååeemåeeeeååÎã;>,öâ=G&ƒ>proportion positiveePCRYes and noYesYesyesSupp 1åmeeeåeeåᅃ=d•<ªÆá=proportion positiveeYes and noYesYesyesSupp 1mÎO<ÓÈÝ<proportion positiveeYes and noYesYesyesSupp 1m~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÛO–>éU>¿Â>n seropositivePfMSP1(1)yesyeseseåÆ«?Œemn seropositiveePfMSP2yeyesyeååVg$?µ]
?ùp;?eåemeeeeeeeeeeeeeeååeeååeeeeåå“Š9?‰$?›O?eåPˆ>­emroportion seropositiveopulationfMSP3eseseseåR17?ë‚!?¹ßL?emØ´Ÿ>#Zf>Ÿ<Ì>emKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååeeeeâBYYYINCLUDEDeYeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@¼t€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee;MultiplexŠ a?ä€L?3Àv?àBpB °Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå;MultiplexŠ a?ä€L?3Àv?€CxBlCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeي<VL=proportion positiveePCRYes and noYesYesyesSupp 1åe;eååeeeeeåeåeeeåeåååòØ
=Èþ£=proportion positiveePCRYes and noYesYesyesSupp 1ååee;åeeeeååي<VL=proportion positiveePCRYes and noYesYesyesSupp 1å;eeeåeeåproportion positiveeYes and noYesYesyesSupp 1;proportion positiveeYes and noYesYesyesSupp 1;~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åóØ
?8›Ô>Jd+?n seropositivePfMSP1(1)yesyeseseåÆ«?Œe;n seropositiveePfMSP2yeyesyeååKÝ?ôŒï>ô7?eåe;eeeeeeeeeeeeeeååeeååeeeeååjEÐ>̐>†9?eåPˆ>­e;roportion seropositiveopulationfMSP3eseseseåNê¾>åy>©þ>e;»/?½‚Ý>ž/?e;Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. Dirusproportion positiveePCRÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Év€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeKMultiplexš™?¯nú>Ýû5?yC@Cà©CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåKMultiplex;m ?g?gs<? …C€$C€«Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee tÚ<ŸI=proportion positiveePCRYes and noYesYesyesSupp 1åeKeååeeeeeåeåeeeåeåå午ˆ=Q'<ê&ü=proportion positiveePCRYes and noYesYesyesSupp 1ååeeKåeeeeåå tÚ<ŸI=proportion positiveePCRYes and noYesYesyesSupp 1åKeeeåeeåêsZ<‹ð =proportion positiveeYes and noYesYesyesSupp 1Kproportion positiveeYes and noYesYesyesSupp 1K~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åùÅ?&<ì>ßm/?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeKn seropositiveePfMSP2yeyesyeåå{.?ž
?XI?eåeKeeeeeeeeeeeeeeååeeååeeeeååé´?ðzÉ>X¬?eåPˆ>­eKroportion seropositiveopulationfMSP3eseseseåè´?ðzÉ>X¬?eKùÅ?&<ì>ßm/?eKKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Õx€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeNMultiplex—où>5¤À>{? [C@#C€›CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåNMultiplex—où>5¤À>{?`UC'C€±Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeNeååeeeeeåeåeeeåeååå
Ò<—´x=proportion positiveePCRYes and noYesYesyesSupp 1ååeeNåeeeeåå
Ò<—´x=proportion positiveePCRYes and noYesYesyesSupp 1åNeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Nproportion positiveeYes and noYesYesyesSupp 1N~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å¸|Ë>Öá“>͋?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeNn seropositiveePfMSP2yeyesyeåå/ßò>("º>Î?eåeNeeeeeeeeeeeeeeååeeååeeeeåå¸|Ë>Öá“>͋?eåPˆ>­eNroportion seropositiveopulationfMSP3eseseseå¸|Ë>Öá“>͋?eN¸|Ë>Öá“>͋?eNKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeeeeeeeeeeeeeeeegMultiplexÂÕÆ=Bv#=2ø>Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeågMultipleeâBYYYINCLUDEDeY=$R>€JCÄBÀ«CeeåeeeeeåeeeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.propor€?€? noYesYes@áz€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeGMultiplexôdü>2ÚÀ>Ü÷?€qCC·CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåGMultiplexôdü>2ÚÀ>Ü÷?€iC€C€¢Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee­Âf<©ö)=proportion positiveePCRYes and noYesYesyesSupp 1åeGeååeeeeeåeåeeeåeååå­Âæ<®‚ˆ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeGåeeeeåå­Âf<©ö)=proportion positiveePCRYes and noYesYesyesSupp 1åGeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Gproportion positiveeYes and noYesYesyesSupp 1G~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å³Âæ>²€«>[?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeGn seropositiveePfMSP2yeyesyeåå¼Ô?@Õì>Ö>1?eåeGeeeeeeeeeeeeeeååeeååeeeeååâ.õ>6°¹>ÅV?eåPˆ>­eGroportion seropositiveopulationfMSP3eseseseå´Âæ>²€«>[?eGÊøí>\’²>œ¯?eGKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@î|€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeewMultiplexµ´´>}¾ˆ>îªà>¿BBBÀ™CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåwMultiplexc…Î>\d¡>f¦û>¶BHB`¢Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeej®	<3Ë<proportion positiveePCRYes and noYesYesyesSupp 1åeweååeeeeeåeåeeeåeåååéðp=Վ‡<A
Ï=proportion positiveePCRYes and noYesYesyesSupp 1ååeewåeeeeååéðp=Վ‡<A
Ï=proportion positiveePCRYes and noYesYesyesSupp 1åweeeåeeåj®	<3Ë<proportion positiveeYes and noYesYesyesSupp 1wproportion positiveeYes and noYesYesyesSupp 1w~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åì~£>ý6q>\bÎ>n seropositivePfMSP1(1)yesyeseseåÆ«?Œewn seropositiveePfMSP2yeyesyeåå]?(Ô>­?eåeweeeeeeeeeeeeeeååeeååeeeeåå:?ßxØ>½7?eåPˆ>­ewroportion seropositiveopulationfMSP3eseseseåc>õ>¾IÇ>„™?ew_̧>’<y>uúÒ>ewKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.2eeeåeåeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ú~€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeKMultiplexMè>Þk®>`å?À‘CÀ_C ¶CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåKMultiplexðîî>¾µ>_?€C@aC`¢Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee tÚ<ŸI=proportion positiveePCRYes and noYesYesyesSupp 1åeKeååeeeeeåeåeeeåeååå
×£=I`˜<Ë>proportion positiveePCRYes and noYesYesyesSupp 1ååeeKåeeeeååtZ=";`Õ=proportion positiveePCRYes and noYesYesyesSupp 1åKeeeåeeå tÚ<ŸI=proportion positiveeYes and noYesYesyesSupp 1Kproportion positiveeYes and noYesYesyesSupp 1K~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å®Gá>ªÂ§>Yf
?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeKn seropositiveePfMSP2yeyesyeåå
×#?–?~¦??eåeKeeeeeeeeeeeeeeååeeååeeeeååÍÌÌ>G”>©È?eåPˆ>­eKroportion seropositiveopulationfMSP3eseseseå,ùÅ>‹>Rgþ>eK®Gá>ªÂ§>Yf
?eKKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); å
ò”=1†;~À>proportion positiveePCRYes and noYesYesyesSupp 1eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusPfMSP1(1)yesyÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.tiveePfM€?€?@€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeefMultiplex“ŒŒ=–B <sñ=€CHC¾CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåfMultiplexéðp=MžW<-ýÕ= „C-C¹Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeöðð=‚Åa=8>proportion positiveePCRYes and noYesYesyesSupp 1åefeååeeeeeåeåeeeåeåååøúz>Ä%>;¨>proportion positiveePCRYes and noYesYesyesSupp 1ååeefåeeeeåå•–>¥i =^ø\>proportion positiveePCRYes and noYesYesyesSupp 1åfeeeåeeåñð<¯Æ~=proportion positiveeYes and noYesYesyesSupp 1f‰  <‹ôì<proportion positiveeYes and noYesYesyesSupp 1f~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}夠 =DÊ:dv=n seropositivePfMSP1(1)yesyeseseåÆ«?Œefn seropositiveePfMSP2yeyesyeåå÷õõ>>QÄ>WÍ?eåefeeeeeeeeeeeeeeååeeååeeeeååÂÃÃ>Yz“>/
ô>eåPˆ>­efroportion seropositiveopulationfMSP3esesese忾¾>`´Ž>Éî>ef¡  =DÊ:dv=efKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååeeeåeeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ƒ€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeXMultiplex.:=Éfý:ò8¶=€iC@C¨CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåXMultiplexYtÑ=1˜=MŽ)>€_C€C@ŸCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeš.º<H¢\=proportion positiveePCRYes and noYesYesyesSupp 1åeXeååeeeeeåeåeeeåeååå梋=ô=~<~÷=proportion positiveePCRYes and noYesYesyesSupp 1ååeeXåeeeeåå.:=Éfý:ò8¶=proportion positiveePCRYes and noYesYesyesSupp 1åXeeeåeeåe.:<BA	=proportion positiveeYes and noYesYesyesSupp 1Xproportion positiveeYes and noYesYesyesSupp 1X~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åš.º<@¢\=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeXn seropositiveePfMSP2yeyesyeåå]´>‚C>¬vç>eåeXeeeeeeeeeeeeeeååeeååeeeeåå0º¨> ãl>ÎÛ>eåPˆ>­eXroportion seropositiveopulationfMSP3eseseseåÑE—>OîL>{È>eXŒ.º<@¢\=eXKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@…€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee}MultiplexÍÌL>sþ>“MŠ>@CC€‡BˆCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå}Multiplex/]>žO>L‡“>%C€ƒB}Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee
×#=˹;~F˜=proportion positiveePCRYes and noYesYesyesSupp 1åe}eååeeeeeåeåeeeåeåååB`å=»Lh=M+>proportion positiveePCRYes and noYesYesyesSupp 1ååee}åeeeeååoƒ=ˬ<òÚ=proportion positiveePCRYes and noYesYesyesSupp 1å}eeeåeeåo<ÜxÁ<proportion positiveeYes and noYesYesyesSupp 1}o<ÜxÁ<proportion positiveeYes and noYesYesyesSupp 1}~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å¼t>3ܨ=^{R>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe}n seropositiveePfMSP2yeyesyeååsh?­Zö>£'?eåe}eeeeeeeeeeeeeeååeeååeeeeåå)\?`*ò>"£%?eåPˆ>­e}roportion seropositiveopulationfMSP3eseseseå–C?ÇÒé>ɝ!?e}ã¥>Še¶=\>e}Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åÖü0>èU¹=]§‚>eåPˆ>­eQroportion seropositiveopulationfMSP3eseseEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@+‡€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeFMultiplex¶mÛ>g >‚d?ÀfC@.Cà‹CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåFMultiplex¢ê>YN®>tç?€OC$C €Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee’ê<©qŠ=proportion positiveePCRYes and noYesYesyesSupp 1åeFeååeeeeeåeåeeeåeåååûŠ¯=¤ï¤<í>proportion positiveePCRYes and noYesYesyesSupp 1ååeeFåeeeeåå¬j=~L5;;dä=proportion positiveePCRYes and noYesYesyesSupp 1åFeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Fproportion positiveeYes and noYesYesyesSupp 1F~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å¢ê>ZN®>tç?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeFn seropositiveePfMSP2yeyesyeåå±ø
?1Ú>ÓØ(?eåeFeeeeeeeeeeeeeeååeeååeeeeååê >0wR>†˜Ø>eåPˆ>­eFroportion seropositiveopulationfMSP3eseseseåš™™>EE>¨Ð>eF¡ê>ZN®>tç?eFKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeY~B?¦ö>n seropositivePfAMyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.=ÑɎ>pro€?€?@7‰€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeefMultiplexŒŒŒ>¹i@><ä¸>@ÞB‰BàWCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåfMultiplexŒŒŒ>¹i@><ä¸>¶BrBÀ0Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åefeååeeeeeåeåeeeåeåå剠 <¹†>=proportion positiveePCRYes and noYesYesyesSupp 1ååeefåeeeeå剠 <‹ôì<proportion positiveePCRYes and noYesYesyesSupp 1åfeeeåee剠 <‹ôì<proportion positiveeYes and noYesYesyesSupp 1fproportion positiveeYes and noYesYesyesSupp 1f~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}切‡>¦b7>½]³>n seropositivePfMSP1(1)yesyeseseåÆ«?Œefn seropositiveePfMSP2yeyesyeåå„‚?øXÓ>ŠX?eåefeeeeeeeeeeeeeeååeeååeeeeååÂÃÃ>Yz“>/
ô>eåPˆ>­efroportion seropositiveopulationfMSP3esesese庹¹>Ñó‰>£é>efŒŒ>¸i@>>ä¸>efKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eåeeeåeåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååeâBYYYINCLUDEDeYh9>ÞãÅ>proportion positiveePCYes and noYesYesyX[ATãÕBAll agesAn. Dirusroportion positiveeYes and ÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.on posit€?€?yesSupp@D‹€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeegMultiplexÂÕÆ=Bv#=2ø>ÀVCÝB€°CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeågMultiplexó²=Á…=$R>€JCÄBÀ«Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee>/‹=؏ž<xºî=proportion positiveePCRYes and noYesYesyesSupp 1åegeååeeeeeåeåeeeåeååå#>>rF~=ªêB>proportion positiveePCRYes and noYesYesyesSupp 1ååeegåeeeeååfŸ=—ÓÔ<óv>proportion positiveePCRYes and noYesYesyesSupp 1ågeeeåeeåproportion positiveeYes and noYesYesyesSupp 1gproportion positiveeYes and noYesYesyesSupp 1g~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å>/‹=揞<yºî=n seropositivePfMSP1(1)yesyeseseåÆ«?Œegn seropositiveePfMSP2yeyesyeååw°ß>¥®>î]?eåegeeeeeeeeeeeeeeååeeååeeeeåå©ä>Ȁ³>žè
?eåPˆ>­egroportion seropositiveopulationfMSP3eseseseåÖÆÐ>n/ >¯?eg“ó²=º…=%R>egKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åeåeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@P€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeekMultiplex¿ŠÒ=`9=¢2$>€C—BÈCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåkMultiplex ™=×:Ì<~/ÿ=@PC€B€½Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee±®e=w€L<¢Ì=proportion positiveePCRYes and noYesYesyesSupp 1åekeååeeeeeåeåeeeåeåååC¬=ô=ü>proportion positiveePCRYes and noYesYesyesSupp 1ååeekåeeeeååèf?=íÇÜ;jš±=proportion positiveePCRYes and noYesYesyesSupp 1åkeeeåeeå <×êá<proportion positiveeYes and noYesYesyesSupp 1kproportion positiveeYes and noYesYesyesSupp 1k~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å±®e=V€L<œÌ=n seropositivePfMSP1(1)yesyeseseåÆ«?Œekn seropositiveePfMSP2yeyesyeååŠÒ>S΢>›#?eåekeeeeeeeeeeeeeeååeeååeeeeååƊR>o >z>eåPˆ>­ekroportion seropositiveopulationfMSP3eseseseåÓøH>Ò÷=S‹>ek7û…=Θ<;ïå=ekKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@\€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee_MultiplexV >r¶Š=såR> šC€\C ÒCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå_Multiplex^Â=3Ô=XP>À‹CÀ'CÀÌCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeîX>öÂs=ÁE>proportion positiveePCRYes and noYesYesyesSupp 1åe_eååeeeeeåeåeeeåeååå[b>7é>ç›>proportion positiveePCRYes and noYesYesyesSupp 1ååee_åeeeeåå#í=º¸R=Ýt8>proportion positiveePCRYes and noYesYesyesSupp 1å_eeeåeeåproportion positiveeYes and noYesYesyesSupp 1_v,<yZþ<proportion positiveeYes and noYesYesyesSupp 1_~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å›v,=yvá:¸ð¨=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe_n seropositiveePfMSP2yeyesyeååeÂ>¶>øó>eåe_eeeeeeeeeeeeeeååeeååeeeeå墼?ÈÚ>àp ?eåPˆ>­e_roportion seropositiveopulationfMSP3eseseseå&Ný>!ÔÉ>d?e_¿ç–=ý=­<ÿ?>e_Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.ååEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eropositiveopulationfMSP3eseseseåNê¾>åy>©þ>e;»/?½‚Ý>ž/?e;eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseePfMSP2yeyesyeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.¤¦>€?€?@h‘€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeXMultiplexÓE>¶–=X0c>p¬C`CÀÓCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåXMultiplexÀè¢=¡~¼<åX>`C€rC ÇCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeee.:<BA	=proportion positiveePCRYes and noYesYesyesSupp 1åeXeååeeeeeåeåeeeåeåååe.:<BA	=proportion positiveePCRYes and noYesYesyesSupp 1ååeeXåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åXeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Xproportion positiveeYes and noYesYesyesSupp 1X~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å3ºè==ÙA=àC8>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeXn seropositiveePfMSP2yeyesyeååÀ>î5Œ>Êó>eåeXeeeeeeeeeeeeeeååeeååeeeeåå ‹.>£/¼=tÿ~>eåPˆ>­eXroportion seropositiveopulationfMSP3eseseseåÑE>¶–=[0c>eX>ød=ùÁF>eXKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@u“€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeiMultiplex€*C‚B`‹CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåiMultiplexÀ%C~Bà„Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee¶	=4ùÁ:ß™=proportion positiveePCRYes and noYesYesyesSupp 1åeieååeeeeeåeåeeeåeåååÄ	œ=‘pÐ<«û>proportion positiveePCRYes and noYesYesyesSupp 1ååeeiåeeeeåå’ê< w=proportion positiveePCRYes and noYesYesyesSupp 1åieeeåeeå¶	<è4æ<proportion positiveeYes and noYesYesyesSupp 1iproportion positiveeYes and noYesYesyesSupp 1i~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å¶	œ<ú9=n seropositivePfMSP1(1)yesyeseseåÆ«?Œein seropositiveePfMSP2yeyesyeå媪ª>0y>>ÕØ>eåeieeeeeeeeeeeeeeååeeååeeeeåå%I’>uL>‡¾>eåPˆ>­eiroportion seropositiveopulationfMSP3esesese剈ˆ>us:>W׳>ei¡ê<¥w=eiKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.ååÇÈÈ=$Ž†<÷7>proportion positiveePCRYes and noYesYesyesSupp 1Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); å3eeeåeeåproportion positiveeYes and noYesYesyesSueâBYYYINCLUDEDeYtion positiveeYes and noYesYeyesSupp 13yX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?e010@•€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee_Multiplexv,<yZþ<@4C€áB@`Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå_Multiplexv,<yZþ<À*C°BeCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeev,<yZþ<proportion positiveePCRYes and noYesYesyesSupp 1åe_eååeeeeeåeåeeeåeååå¾ç–=ñ=­<@>proportion positiveePCRYes and noYesYesyesSupp 1ååee_åeeeeåå<”W=…>ý;FÀÇ=proportion positiveePCRYes and noYesYesyesSupp 1å_eeeåeeåv,<yZþ<proportion positiveeYes and noYesYesyesSupp 1_proportion positiveeYes and noYesYesyesSupp 1_~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œe_n seropositiveePfMSP2yeyesyeåå)¯¡>Ó¦c>æŠÑ>eåe_eeeeeeeeeeeeeeååeeååeeeeååV Œ>Áq<>̺>eåPˆ>­e_roportion seropositiveopulationfMSP3esesese墼†>[Ì2>´>e_e_Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@—€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee…MultiplexD`ö<f`‰:Ar=ÍBdBÀYCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå…MultiplexD`v=‚¸¡<òÍ=@ÄBRB`ZCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeD`ö<f`‰:Ar=proportion positiveePCRYes and noYesYesyesSupp 1åe…eååeeeeeåeåeeeåeååå/b©=£= >proportion positiveePCRYes and noYesYesyesSupp 1ååee…åeeeeåå<”W=­Šp<悹=proportion positiveePCRYes and noYesYesyesSupp 1å…eeeåeeåD`ö;üܵ<proportion positiveeYes and noYesYesyesSupp 1…proportion positiveeYes and noYesYesyesSupp 1…~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å3È8=]2!<⡤=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe…n seropositiveePfMSP2yeyesyeåå.{À>hU–>ø ê>eåe…eeeeeeeeeeeeeeååeeååeeeeåå,ȸ>ÉýŽ>“’â>eåPˆ>­e…roportion seropositiveopulationfMSP3eseseseå,±>‰±‡>ÏxÚ>e…>`v=’¸¡<òÍ=e…Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeeeeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååeeååeeeeåå¢/è>‚P²>`?eâBYYYINCLUDEDeYeåPˆ>­eVroportion seropositiveopulayX[ATãÕBAll agesAn. DirusÇ=proportion positiveePCRÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@š™€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeyMultiplex‡Ë=P<=í>ëBŠB€„CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåyMultiplex‡Ë=P<=í>€äBtB`Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeyeååeeeeeåeåeeeåeåååÓg<~ÙÇ<proportion positiveePCRYes and noYesYesyesSupp 1ååeeyåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åyeeeåeeåÓg<~ÙÇ<proportion positiveeYes and noYesYesyesSupp 1yproportion positiveeYes and noYesYesyesSupp 1y~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å‡Ë=T<=ì>n seropositivePfMSP1(1)yesyeseseåÆ«?Œeyn seropositiveePfMSP2yeyesyeåå%ޏ>>¹M>­ß¸>eåeyeeeeeeeeeeeeeeååeeååeeeeåå«g>…2“=6E>eåPˆ>­eyroportion seropositiveopulationfMSP3eseseseåvÜ=.V=ª„&>eyvÜ=.V=ª„&>eyKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruspositiveeYes and noYesYesÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@¦›€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMMultiplex²ü„=Õ""<	µõ=À¢C`€CÀÏCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMMultiplexˆÇT=Rç;@èÏ=À¡C‚C€¼CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeemÇT<ûÆ=proportion positiveePCRYes and noYesYesyesSupp 1åeMeååeeeeeåeåeeeåeåå埕Ÿ=bݓ<ì
>proportion positiveePCRYes and noYesYesyesSupp 1ååeeMåeeeeåå²ü„=Õ""<	µõ=proportion positiveePCRYes and noYesYesyesSupp 1åMeeeåeeåmÇT<ûÆ=proportion positiveeYes and noYesYesyesSupp 1Mproportion positiveeYes and noYesYesyesSupp 1M~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?ŒeMn seropositiveePfMSP2yeyesyeåå¶mÛ>ŽÕ¢>ð
?eåeMeeeeeeeeeeeeeeååeeååeeeeååâ¬>š™m>[÷â>eåPˆ>­eMroportion seropositiveopulationfMSP3esesese圕Ÿ>\:U>
ŽÔ>eMœ•=$O¨=eMKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeeeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eåeeeeee<”×=‹=sq2>proportion positiveePCRYes and noYesYesyesSupp 1eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@²€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeNMultiplex6Hƒ>„U#>§å´>°žC€cCÈCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåNMultiplexò-_>”[>(€ž>à¦C€OC ÆCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeNeååeeeeeåeåeeeåeåååΉ=’,¦=proportion positiveePCRYes and noYesYesyesSupp 1ååeeNåeeeeåå
Ò<—´x=proportion positiveePCRYes and noYesYesyesSupp 1åNeeeåeeå
R<¥Æ=proportion positiveeYes and noYesYesyesSupp 1Nproportion positiveeYes and noYesYesyesSupp 1N~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å 
R>Y“ì=Kè–>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeNn seropositiveePfMSP2yeyesyeåå/ßò>("º>Î?eåeNeeeeeeeeeeeeeeååeeååeeeeååç[¾>úq‡>ÒEõ>eåPˆ>­eNroportion seropositiveopulationfMSP3eseseseå}Ë·>ÔI>&Mî>eN!
R>Y“ì=Kè–>eNKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@¾Ÿ€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeDMultiplexÂÃÃ>/ ˆ>Yçþ> YCCÀ’CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåDMultiplexÂÃÃ>/ ˆ>Yçþ>@RC@C Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeDeååeeeeeåeåeeeåeåååñð<úzŽ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeDåeeeeååñð<úzŽ=proportion positiveePCRYes and noYesYesyesSupp 1åDeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Dproportion positiveeYes and noYesYesyesSupp 1D~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÂÃÃ>. ˆ>Zçþ>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeDn seropositiveePfMSP2yeyesyeååKK?lúÙ>`™)?eåeDeeeeeeeeeeeeeeååeeååeeeeååÂÃÃ>. ˆ>Zçþ>eåPˆ>­eDroportion seropositiveopulationfMSP3eseseseå<<¼>õŽ>ƒéö>eDÄÃÃ>. ˆ>Zçþ>eDKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?eee@Ë¡€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeRMultiplexp>?Ç$Õ>~ê!?@8C€	C†CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåRMultiplexp>?Ç$Õ>~ê!?@7C@Cà‰CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeõÍÇ<A©l=proportion positiveePCRYes and noYesYesyesSupp 1åeReååeeeeeåeåeeeåeåååÎÇ=–Œ=êª%>proportion positiveePCRYes and noYesYesyesSupp 1ååeeRåeeeeåå…Ú•=ª‰<K¥>proportion positiveePCRYes and noYesYesyesSupp 1åReeeåeeåõÍG<ÆA=proportion positiveeYes and noYesYesyesSupp 1Rproportion positiveeYes and noYesYesyesSupp 1R~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åƒó>+¼>m?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeRn seropositiveePfMSP2yeyesyeåå‚ó1?_q?§uK?eåeReeeeeeeeeeeeeeååeeååeeeeåå©]	?ZxÛ>%ÿ$?eåPˆ>­eRroportion seropositiveopulationfMSP3eseseseåÁù>Ë\Â>+“?eRƒó>+¼>m?eRKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeeeeeeeeeåeeåeeâBYYYINCLUDEDeY¸>eeåeeeeeeeåeeeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@×£€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee<Multiplex¦ªª= „[<kò>€±Cà“CàÜCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå<MultiplexÍÌÌ=XWÅ<â!4>@ÂC@žCDeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe<eååeeeeeåeåeeeåeåå嚈ˆ<#óH=proportion positiveePCRYes and noYesYesyesSupp 1ååee<åeeeeå嚈ˆ<#óH=proportion positiveePCRYes and noYesYesyesSupp 1å<eeeåeeåproportion positiveeYes and noYesYesyesSupp 1<proportion positiveeYes and noYesYesyesSupp 1<~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}午ˆ=ܐh;Fæ>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe<n seropositiveePfMSP2yeyesyeåå?Mïá>{*1?eåe<eeeeeeeeeeeeeeååeeååeeeeå媪ª>T0[>,½ç>eåPˆ>­e<roportion seropositiveopulationfMSP3esesese嫪ª>T0[>,½ç>e<‰ˆˆ=ܐh;Fæ>e<Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusJ€ARatanakiri ProvinceÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.orsØ„>u€?€?@㥀ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMMultiplexh`ï=±Ð8=<,A>¥C{C`ÛCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMMultiplexŸ•Ÿ=bݓ<ì
>à¢CbC@ßCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee²ü„=Õ""<	µõ=proportion positiveePCRYes and noYesYesyesSupp 1åeMeååeeeeeåeåeeeåeååå²ü„=Õ""<	µõ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeMåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åMeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Mproportion positiveeYes and noYesYesyesSupp 1M~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åzÇÔ=f=Ô-0>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeMn seropositiveePfMSP2yeyesyeååõâ>üI©>õn
?eåeMeeeeeeeeeeeeeeååeeååeeeeåå×;¦>ô]a>¶ÈÛ>eåPˆ>­eMroportion seropositiveopulationfMSP3eseseseåØ;¦>ô]a>¶ÈÛ>eM­ü>œe`=óßQ>eMKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eåeåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ð§€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeLMultiplex­¡<>¸ÄÆ=ƒðŠ>PÈC ”C€DeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåLMultiplexâ5>ok†=6e>°ÆC€CðDeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee<”×=‹=sq2>proportion positiveePCRYes and noYesYesyesSupp 1åeLeååeeeeeåeåeeeåeåå墼†>o(>m¹>proportion positiveePCRYes and noYesYesyesSupp 1ååeeLåeeeeååñJ>ròÜ=Xޒ>proportion positiveePCRYes and noYesYesyesSupp 1åLeeeåeeå´¡¼=¼íÝ<öã >proportion positiveeYes and noYesYesyesSupp 1L<”W<½Ô=proportion positiveeYes and noYesYesyesSupp 1L~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å-¯!=ôª=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeLn seropositiveePfMSP2yeyesyeåå×PÞ>©B¥>„¯?eåeLeeeeeeeeeeeeeeååeeååeeeeå墼?fÿÓ>‘y#?eåPˆ>­eLroportion seropositiveopulationfMSP3eseseseå?¶qÆ>%Ç?eL(¯¡=F–<_ì>eLKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ü©€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeVMultiplexó‚>=C;çhº=ÀaCÀC`¥CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåVMultiplexó‚>=C;çhº=€XC€Cà•Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeVeååeeeeeåeåeeeåeååå½#î=gÅF=\r<>proportion positiveePCRYes and noYesYesyesSupp 1ååeeVåeeeeåå½#î=gÅF=\r<>proportion positiveePCRYes and noYesYesyesSupp 1åVeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Vproportion positiveeYes and noYesYesyesSupp 1V~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åó‚>=âB;ãhº=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeVn seropositiveePfMSP2yeyesyeååʚ²>~>Í-æ>eåeVeeeeeeeeeeeeeeååeeååeeeeåå¶#n>Jµ>ɤ>eåPˆ>­eVroportion seropositiveopulationfMSP3eseseseåYSV>>ü=J/—>eV<âŽ=t‚<u'ý=eVKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeåeeeeeeeåeeeeeeåeeåeeeeeeeåeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ltiplex>x=j<G;7ò=à‡C_C¸Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYeeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@¬€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeNMultiplexi>€¡‚=N_>]C8C ŠCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåNMultiplex3H>Ù:]=¶AO>ÀYC 'CðŒCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeNeååeeeeeåeåeeeåeååå
R<¥Æ=proportion positiveePCRYes and noYesYesyesSupp 1ååeeNåeeeeåå
R<¥Æ=proportion positiveePCRYes and noYesYesyesSupp 1åNeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Nproportion positiveeYes and noYesYesyesSupp 1N~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å܉=µ‘<8S>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeNn seropositiveePfMSP2yeyesyeåå~Ë·>ÔI>&Mî>eåeNeeeeeeeeeeeeeeååeeååeeeeååò-_>•[>(€ž>eåPˆ>­eNroportion seropositiveopulationfMSP3eseseseåOìD>6¸Ö=A>>eNى=µ‘<8S>eNKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@®€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeoMultiplex²ý?M¯î>¼£&?·B`B€ûBeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåoMultiplex5'?ì®Ò>ôö?@©B~B CeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÕg]=eD<$ÛÄ=proportion positiveePCRYes and noYesYesyesSupp 1åeoeååeeeeeåeåeeeåeåååÛo>ì,>¡D >proportion positiveePCRYes and noYesYesyesSupp 1ååeeoåeeeeååxôJ>þ=¸r‹>proportion positiveePCRYes and noYesYesyesSupp 1åoeeeåeeå|š<ÅÌÙ<proportion positiveeYes and noYesYesyesSupp 1oproportion positiveeYes and noYesYesyesSupp 1o~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}媪ª>ç‡{>b‘×>n seropositivePfMSP1(1)yesyeseseåÆ«?Œeon seropositiveePfMSP2yeyesyeååZ7?sÕ?A™/?eåeoeeeeeeeeeeeeeeååeeååeeeeååÖ
&?yQ?3Ê<?eåPˆ>­eoroportion seropositiveopulationfMSP3eseseseå˜"?±	?;6?eo«ªª>ç‡{>b‘×>eoKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeeååm²I>ÜâÎ=¶ù•>eåPˆ>­eBroportion seropositiveopulationfMSP3eseseseåÊ&>Ç$…=0»s>eâBYYYINCLUDEDeYeByX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@!°€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee_Multiplex(¯!?
Ú?E„:?ÀˆBRB•Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå_Multiplexû=7?ß ?vN?‰BPB”Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe_eååeeeeeåeåeeeåeååå<”W=…>ý;FÀÇ=proportion positiveePCRYes and noYesYesyesSupp 1ååee_åeeeeåå<”W=…>ý;FÀÇ=proportion positiveePCRYes and noYesYesyesSupp 1å_eeeåeeåproportion positiveeYes and noYesYesyesSupp 1_proportion positiveeYes and noYesYesyesSupp 1_~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åìX?Õ7Ï>ï?n seropositivePfMSP1(1)yesyeseseåÆ«?Œe_n seropositiveePfMSP2yeyesyeååEÚ1?6%?VI?eåe_eeeeeeeeeeeeeeååeeååeeeeååÍÌÌ>Q\š>I=ÿ>eåPˆ>­e_roportion seropositiveopulationfMSP3eseseseåiÇ>]4•>ӝù>e_¢¼?ÈÚ>àp ?e_Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeååproportion positiveePCRYes and noYesYesyesSupp 1eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseeeeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.ee€?€?@-²€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee]Multiplex!?IAÔ>k!?`‰C7C€çCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå]Multiplexñ½÷>+½Ã>Zß?’C€ÞBàûCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee!=›‹=proportion positiveePCRYes and noYesYesyesSupp 1åe]eååeeeeeåeåeeeåeååå1Æ=‰C=«  >proportion positiveePCRYes and noYesYesyesSupp 1ååee]åeeeeåå,0=ÎÜè:—ˆ¬=proportion positiveePCRYes and noYesYesyesSupp 1å]eeeåeeå7\=GË<§ýË=proportion positiveeYes and noYesYesyesSupp 1]proportion positiveeYes and noYesYesyesSupp 1]~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÎ9ç>Ÿp³>
?n seropositivePfMSP1(1)yesyeseseåÆ«?Œe]n seropositiveePfMSP2yeyesyeåån8?c!?ÕÇO?eåe]eeeeeeeeeeeeeeååeeååeeeeåå‹&?(¯?ì3?eåPˆ>­e]roportion seropositiveopulationfMSP3eseseseåP?ý>a8É>£?e]<ò>H¾>€?e]Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@9´€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeePMultiplex?mWè>JÔ+?ТC€•BpDeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåPMultiplex?mWè>JÔ+?@¸CÉBÀúCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åePeååeeeeeåeåeeeåeåååÍÌL=µØ;6È=proportion positiveePCRYes and noYesYesyesSupp 1ååeePåeeeeååÍÌL=µØ;6È=proportion positiveePCRYes and noYesYesyesSupp 1åPeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Pproportion positiveeYes and noYesYesyesSupp 1P~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åffæ>-•®>Ð?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒePn seropositiveePfMSP2yeyesyeååff6??<ÊO?eåePeeeeeeeeeeeeeeååeeååeeeeåå >›ýW>3Ô>eåPˆ>­eProportion seropositiveopulationfMSP3eseseseå >›ýW>3Ô>ePš™ù>â„Á>)×?ePKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.
ö(PAAlledEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ü™p?Šb?ÛBy?“Ä>)\>ff?ee…ELISAe´ºÓ>0b¨>±‹?h‘m>sh>´È¶>eeåeeåeeeeeeeåeeeeeeåeeåeâBYYYINCLUDEDeYeeeeeeeeåyX[ATãÕBAll agesAn. DirusØ„>uÄ!>ÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@F¶€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee[MultiplexöK¿>ÝgŒ>0ò>„CuB×Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå[Multiplex\ÍÕ>Hì¡>:×?àvC€MB@çCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee54<¿=proportion positiveePCRYes and noYesYesyesSupp 1åe[eååeeeeeåeåeeeåeååå5´<GhU=proportion positiveePCRYes and noYesYesyesSupp 1ååee[åeeeeåå54<¿=proportion positiveePCRYes and noYesYesyesSupp 1å[eeeåeeåproportion positiveeYes and noYesYesyesSupp 1[proportion positiveeYes and noYesYesyesSupp 1[~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åOìÄ>{¾‘>#ø>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe[n seropositiveePfMSP2yeyesyeååá>‡×¬>N¢
?eåe[eeeeeeeeeeeeeeååeeååeeeeååvw>ëz>Ò¨>eåPˆ>­e[roportion seropositiveopulationfMSP3eseseseåyw>ëz>Ò¨>e[©ŒÊ>'—>+ýý>e[Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@R¸€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee'Multiplex 
Ò=°ð; ‡J>žCÀzC âCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå'Multiplex܉=zh$>àœC@}C`ËCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee~Ë7>Ï×q=™>proportion positiveePCRYes and noYesYesyesSupp 1åe'eååeeeeeåeåeeeåeåååÆNì>,3œ>05?proportion positiveePCRYes and noYesYesyesSupp 1ååee'åeeeeåå 
Ò>ƒ>ԋ?proportion positiveePCRYes and noYesYesyesSupp 1å'eeeåeeå
Ò<š=proportion positiveeYes and noYesYesyesSupp 1'
Ò<š=proportion positiveeYes and noYesYesyesSupp 1'~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å܉={h$>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe'n seropositiveePfMSP2yeyesyeååpù?ZèÞ>³~>?eåe'eeeeeeeeeeeeeeååeeååeeeeåå؉?Ræì>‰ D?eåPˆ>­e'roportion seropositiveopulationfMSP3eseseseåى?Ræì>‰ D?e'!
Ò=û¯ð;¡‡J>e'Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eeeeeeeeåDMultiplexÂÃÃ>/ ˆ>Yçþ>Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); d noYesYesyesSupp 1eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@^º€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex «C@¨CØCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplexÀÃC@¨C òCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeªªª>&å]?proportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeåå媪ª>&å]?proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeååeåeeeeeeeeeeeeeeeååeeååeeeeå媪ª>&å]?eåPˆ>­eroportion seropositiveopulationfMSP3esesese嫪ª>&å]?e«ªª>&å]?eKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@j¼€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex¯C€pC ¶CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplex"I>RÞÍ>€ÆCkCÀÞCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeååå%I’>Ñ?proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeåå%I’>Ñ?proportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeåå%I’>Ñ?eåeeeeeeeeeeeeeeeååeeååeeeeåå%I?½Q>
#p?eåPˆ>­eroportion seropositiveopulationfMSP3eseseseå·mÛ>iÏ}=ÀK?eeKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eåEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååΉ=’,¦=proportion positiveePCRYes and eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@w¾€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee8Multiplex½mÛ="Ö<òª@>0¤C€}CÐÎCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå8Multiplex¯m[=æ= C`rCÀÏCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeelÛ¶=:0o<oè'>proportion positiveePCRYes and noYesYesyesSupp 1åe8eååeeeeeåeåeeeåeååålÛ6>wF =ÑɎ>proportion positiveePCRYes and noYesYesyesSupp 1ååee8åeeeeååJ’$>£#„=^‰ƒ>proportion positiveePCRYes and noYesYesyesSupp 1å8eeeåeeåI’<Š7W=proportion positiveeYes and noYesYesyesSupp 18proportion positiveeYes and noYesYesyesSupp 18~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å½mÛ="Ö<óª@>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe8n seropositiveePfMSP2yeyesyeåå“$	?hÏ>•*?eåe8eeeeeeeeeeeeeeååeeååeeeeåå“$	?hÏ>•*?eåPˆ>­e8roportion seropositiveopulationfMSP3eseseseåI’?˜"Æ>F&?e8>½3=³X>e8Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eeeåeeåeâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ƒÀ€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex–C€LC€ªCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplex@jC€1C€—Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee†ˆ>¬Xœ>proportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeåå冈>¬Xœ>proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeååproportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1ˆˆ=IˆE>proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeååÍÌÌ>1º>AÞ%?eåeeeeeeeeeeeeeeeååeeååeeeeå媪ª>¢Â=×g?eåPˆ>­eroportion seropositiveopulationfMSP3esesese嫪ª>¢Â=×g?eeKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.e€?€?@Â€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee-Multiplex7Žc>ÛVÎ=„ø¯>à°C`…CàDeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå-MultiplexÍÌL>?ª==¢>à—C@vC`DeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeU¶<W·…=proportion positiveePCRYes and noYesYesyesSupp 1åe-eååeeeeeåeåeeeåeååå7Žã=¨ž<ÎO>proportion positiveePCRYes and noYesYesyesSupp 1ååee-åeeeeååb¶=j¼;Ï*0>proportion positiveePCRYes and noYesYesyesSupp 1å-eeeåeeåproportion positiveeYes and noYesYesyesSupp 1-proportion positiveeYes and noYesYesyesSupp 1-~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}冈>‡O=0=n>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe-n seropositiveePfMSP2yeyesyeåå?é“>ô6 >·×>eåe-eeeeeeeeeeeeeeååeeååeeeeå媪ª>þJH>×/ñ>eåPˆ>­e-roportion seropositiveopulationfMSP3eseseseåõIŸ>E4>G‹ä>e-‰ˆ>‡O=0=n>e-Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@œÄ€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex@´C€$CèCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplex"I>RÞÍ>ÀÅC€(CùCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee"I>RÞÍ>proportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeååå%I?ý¼Q>#p?proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeåå%I?ý¼Q>#p?proportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeåå¶mÛ>iÏ}=ÀK?eåeeeeeeeeeeeeeeeååeeååeeeeåå%I’>Ñ?eåPˆ>­eroportion seropositiveopulationfMSP3eseseseå%I’>Ñ?eeKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å3È8=]2!<⡤=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeâBYYYINCLUDEDeYsitiveePfMSP2yeyesyeåyX[ATãÕBAll agesAn. DiruseeeeeeeeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?¨CØCeeå@¨Æ€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex£½„>kmÀ=ê_Ù> ²C@‚CÀDeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplex£½„>kmÀ=ê_Ù>à¨C„C Deeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee7Žã=*k>proportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeååå7Žc>±ò…=Â>proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeåå0¡=>Ö[=²Õ©>proportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å0¡=>ã[=³Õ©>n seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeå径ö>a–>
‚+?eåeeeeeeeeeeeeeeeååeeååeeeeåå7Žã>ø–ƒ>½Â!?eåPˆ>­eroportion seropositiveopulationfMSP3eseseseå9Žã>ø–ƒ>½Â!?e9Žc>°ò…=Â>eKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); åeåeâBYYYINCLUDEDeYeåeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?å@´È€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee+Multiplexʚ²>ÔUS>ªŠû>@ëC€CÐ-Deeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå+MultiplexŠ;â>á;–>˜?0Dà¤CÀ<Deeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee6âŽ=1j>proportion positiveePCRYes and noYesYesyesSupp 1åe+eååeeeeeåeåeeeåeåå僾=ÃKË;›(8>proportion positiveePCRYes and noYesYesyesSupp 1ååee+åeeeeååó‚>=»*à=proportion positiveePCRYes and noYesYesyesSupp 1å+eeeåeeåproportion positiveeYes and noYesYesyesSupp 1+proportion positiveeYes and noYesYesyesSupp 1+~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}囲¦>!ù=>¦hî>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe+n seropositiveePfMSP2yeyesyeåå=â?ÒÄÑ>â4?eåe+eeeeeeeeeeeeeeååeeååeeeeå囲&?«:?‹*K?eåPˆ>­e+roportion seropositiveopulationfMSP3esesese僾 ?I„÷>âºE?e+ú‚¾>zi>Ü=?e+Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ivePfAMA1yeyeseså!ÎJ?}åùÅ?&<ì>ßm/?n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeKn seropositiveePfMSP2yeyesyeeâBYYYINCLUDEDeY?XI?eåyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ÁʀARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee
Multiplex܉>‘0³>€ÒCàµCÀDeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå
MultiplexOìÄ>†ö=?*&?€ãC@¡C1Deeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe
eååeeeeeåeåeeeåeååå܉=¤c>proportion positiveePCRYes and noYesYesyesSupp 1ååee
åeeeeåå܉=¤c>proportion positiveePCRYes and noYesYesyesSupp 1å
eeeåeeåproportion positiveeYes and noYesYesyesSupp 1
proportion positiveeYes and noYesYesyesSupp 1
~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åOìÄ>ƒö=?*&?n seropositivePfMSP1(1)yesyeseseåÆ«?Œe
n seropositiveePfMSP2yeyesyeååŸØ	?ñˆ>º8O?eåe
eeeeeeeeeeeeeeååeeååeeeeåå܉>’0³>eåPˆ>­e
roportion seropositiveopulationfMSP3eseseseåى>’0³>e
ÅNì>C>~‡;?e
Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Í̀ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee
Multiplexš™™>lт<ƒ?`ÜC ÈC Deeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå
Multiplexš™™>lт<ƒ? õCØCpDeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÍÌÌ=úf’>proportion positiveePCRYes and noYesYesyesSupp 1åe
eååeeeeeåeåeeeåeåååÍÌL>Vå>proportion positiveePCRYes and noYesYesyesSupp 1ååee
åeeeeååÍÌÌ=úf’>proportion positiveePCRYes and noYesYesyesSupp 1å
eeeåeeåproportion positiveeYes and noYesYesyesSupp 1
proportion positiveeYes and noYesYesyesSupp 1
~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÍÌL>Vå>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe
n seropositiveePfMSP2yeyesyeåå333?äùÔ>té{?eåe
eeeeeeeeeeeeeeååeeååeeeeååš™?A¼—>Ug?eåPˆ>­e
roportion seropositiveopulationfMSP3eseseseåÍÌÌ>eWÅ=à!4?e
ÍÌL>Vå>e
Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååЁ=0B<O•ï=proportion positiveePCRYes and noYesYesyesSupp 1eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Ù΀ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex33³>W>Q?ÓCà±CˆDeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplexš™™>KË=7?ÐãC°–CÀ(Deeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeåååÍÌL=Ô>proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeååÍÌL=Ô>proportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÍÌL>pGÊ<V(À>n seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeåå33³>„W>R?eåeeeeeeeeeeeeeeeååeeååeeeeååÍÌÌ>c½=>t]?eåPˆ>­eroportion seropositiveopulationfMSP3eseseseåÍÌÌ>c½=>t]?e€>>­v=X*á>eKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@åЀARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplexÂõ=xR}>@—C€dC€×CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplexÂu>›¦”=é˜Ð>À¨CƒC€Deeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee
×£=¹Ñ>>proportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeååå
×£=¹Ñ>>proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeåå
×#=:=ï=proportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å
×£=»Ñ>>n seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeååÂõ>}‘>-?eåeeeeeeeeeeeeeeeååeeååeeeeåå)\>ýùÔ=Óyé>eåPˆ>­eroportion seropositiveopulationfMSP3eseseseåÂu>¦”=è˜Ð>e
×£=»Ñ>>eKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DiruseeÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@òҀARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeTMultiplex1C>%Ú=脌>¼C ›CðýCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåTMultiplex"I>+P‹=5ê^>¹C“Cð÷Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee½mÛ=¬î'=r1>proportion positiveePCRYes and noYesYesyesSupp 1åeTeååeeeeeåeåeeeåeååå÷<O>•‚î=Nœ“>proportion positiveePCRYes and noYesYesyesSupp 1ååeeTåeeeeåå:Ïó=óK=zÒ@>proportion positiveePCRYes and noYesYesyesSupp 1åTeeeåeeåZC<ÂÃ=proportion positiveeYes and noYesYesyesSupp 1TZC<ÂÃ=proportion positiveeYes and noYesYesyesSupp 1T~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å½mÛ=¦î'=r1>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeTn seropositiveePfMSP2yeyesyeååçy?áã?ï9?eåeTeeeeeeeeeeeeeeååeeååeeeeååUU?•¯ô>ßR0?eåPˆ>­eTroportion seropositiveopulationfMSP3eseseseå%I?ïbî>Ó`-?eT1C>#Ú=脌>eTKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@þԀARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee7Multiplexk_=¾Ÿê=>CxB€¾Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå7Multiplex
CPB@˜Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeò=ñʯ=proportion positiveePCRYes and noYesYesyesSupp 1åe7eååeeeeeåeåeeeåeååå
ò”=1†;~À>proportion positiveePCRYes and noYesYesyesSupp 1ååee7åeeeeååò=ñʯ=proportion positiveePCRYes and noYesYesyesSupp 1å7eeeåeeåproportion positiveeYes and noYesYesyesSupp 17proportion positiveeYes and noYesYesyesSupp 17~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åò”<1[=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe7n seropositiveePfMSP2yeyesyeåå.º>º-r>;Fû>eåe7eeeeeeeeeeeeeeååeeååeeeeååM	r>Áþ=Ÿ²>eåPˆ>­e7roportion seropositiveopulationfMSP3eseseseåÍÌL>½Á=ž†œ>e7	ò”<1[=e7Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åºÀeâBYYYINCLUDEDeYePfMSP1(1)yesyeseseåÆ«?ŒeUyX[ATãÕBAll agesAn. Dirusi>€¡‚=N_>]C8ÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@
׀ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee"Multiplexµ´´=fû;>‚C€'C ÅCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå"Multiplexéðp=|9
>@tCC «Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe"eååeeeeeåeåeeeåeåååöðð=”$<¦^g>proportion positiveePCRYes and noYesYesyesSupp 1ååee"åeeeeååöðð=”$<¦^g>proportion positiveePCRYes and noYesYesyesSupp 1å"eeeåeeåproportion positiveeYes and noYesYesyesSupp 1"proportion positiveeYes and noYesYesyesSupp 1"~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åñð<Œ°=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe"n seropositiveePfMSP2yeyesyeå切?(¹>{2?eåe"eeeeeeeeeeeeeeååeeååeeeeååÓÒÒ>ì>|>Ã?eåPˆ>­e"roportion seropositiveopulationfMSP3eseseseåµ´´>öëD>·y?e"ñðð<Œ°=e"Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eåPˆ>­eroportion seropositiveopulationfMSP3eseseseå?Ƙ>31?eى>ñ[x<ùƕ>eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@ـARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeePMultiplexff&>þ<§=N.y>µC@zCõCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåPMultiplexÍÌ>~=WZ>жC|CpõCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÍÌÌ=ËS=Ú·)>proportion positiveePCRYes and noYesYesyesSupp 1åePeååeeeeeåeåeeeåeåååff†>z*>Ä·>proportion positiveePCRYes and noYesYesyesSupp 1ååeePåeeeeååff&>þ<§=N.y>proportion positiveePCRYes and noYesYesyesSupp 1åPeeeåeeåÍÌL<@ì=proportion positiveeYes and noYesYesyesSupp 1Pproportion positiveeYes and noYesYesyesSupp 1P~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÍÌÌ<±ˆr=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒePn seropositiveePfMSP2yeyesyeååÍÌì>
Ü´>È^?eåePeeeeeeeeeeeeeeååeeååeeeeååffÆ>n½>^ý>eåPˆ>­eProportion seropositiveopulationfMSP3eseseseåÀ>Ò®‰>.Qö>eP€=í<]¢ì=ePKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.roportion seropositiveopulationfMSP3eseseseåى>’0³>e
ÅNEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l._åee€?€?@#ۀARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplexΉ=¤(æ=à—C@FC ºCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåMultiplexΉ=¤(æ=@—C@9C`¸Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee܉>Ç[x<úƕ>proportion positiveePCRYes and noYesYesyesSupp 1åeeååeeeeeåeåeeeåeåååOìD>ò-'=Ž°>proportion positiveePCRYes and noYesYesyesSupp 1ååeeåeeeeåå܉=¯§7>proportion positiveePCRYes and noYesYesyesSupp 1åeeeåeeåproportion positiveeYes and noYesYesyesSupp 1proportion positiveeYes and noYesYesyesSupp 1~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÃNì=Qès>n seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositiveePfMSP2yeyesyeå剝Ø>pÄn>nì?eåeeeeeeeeeeeeeeeååeeååeeeeååŸØ	?¦”±>éæ:?eåPˆ>­eroportion seropositiveopulationfMSP3eseseseå?Ƙ>31?eى>ñ[x<ùƕ>eKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.eåeJeeeeeeeeeeeeEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ååeeååeâBYYYINCLUDEDeYeeååL‘>¸h>ÜãÅ>yX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@/݀ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeNMultiplex~Ë·=?×<vÙ>‘CÀdCÉCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåNMultiplex
R<¥Æ=€ŒCTC€ºCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeΉ=’,¦=proportion positiveePCRYes and noYesYesyesSupp 1åeNeååeeeeeåeåeeeåeååå~Ë7>C+Á=­€‡>proportion positiveePCRYes and noYesYesyesSupp 1ååeeNåeeeeååi>€¡‚=N_>proportion positiveePCRYes and noYesYesyesSupp 1åNeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Nproportion positiveeYes and noYesYesyesSupp 1N~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}å.
R=Ç;åFÍ=n seropositivePfMSP1(1)yesyeseseåÆ«?ŒeNn seropositiveePfMSP2yeyesyeåå¸|Ë>Öá“>͋?eåeNeeeeeeeeeeeeeeååeeååeeeeåå¸|Ë>Öá“>͋?eåPˆ>­eNroportion seropositiveopulationfMSP3eseseseåOìÄ>·¤>ç3ü>eN!
R=Ç;åFÍ=eNKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@;߀ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee!Multiplexÿ=ø<•×µ=€kCÀMC@–Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå!MultiplexÀYCCÀwCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe!eååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååee!åeeeeååproportion positiveePCRYes and noYesYesyesSupp 1å!eeeåeeåproportion positiveeYes and noYesYesyesSupp 1!proportion positiveeYes and noYesYesyesSupp 1!~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÿ=ø<›×µ=n seropositivePfMSP1(1)yesyeseseåÆ«?Œe!n seropositiveePfMSP2yeyesyeååÿ=ø<›×µ=eåe!eeeeeeeeeeeeeeååeeååeeeeååÍ&>!ï<6Œ>eåPˆ>­e!roportion seropositiveopulationfMSP3eseseseåÊ&>!ï<6Œ>e!>ø<›×µ=e!Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Há€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee!Multiplex0C€„B€tCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå!Multiplexÿ=ø<•×µ=ùB”BZCeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveePCRYes and noYesYesyesSupp 1åe!eååeeeeeåeåeeeåeåååproportion positiveePCRYes and noYesYesyesSupp 1ååee!åeeeeååproportion positiveePCRYes and noYesYesyesSupp 1å!eeeåeeåproportion positiveeYes and noYesYesyesSupp 1!proportion positiveeYes and noYesYesyesSupp 1!~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œe!n seropositiveePfMSP2yeyesyeåå.º>¦KL>¢?eåe!eeeeeeeeeeeeeeååeeååeeeeååÍ&>!ï<6Œ>eåPˆ>­e!roportion seropositiveopulationfMSP3eseseseåÊ&>!ï<6Œ>e!e!Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); Æ«?ŒeTn seropositiveePfMSP2yeyesyeååô<?xè>¬j*?eåeTeeeeeeeâBYYYINCLUDEDeYeeeeeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@Tã€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee3MultiplexÊÈÈ>x-„>²?¶B~BÀCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå3MultiplexÊÈÈ>x-„>²?«B€B€úBeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee‰  <…-l=proportion positiveePCRYes and noYesYesyesSupp 1åe3eååeeeeeåeåeeeåeåååÇÈÈ=$Ž†<÷7>proportion positiveePCRYes and noYesYesyesSupp 1ååee3åeeeeååÇÈÈ=$Ž†<÷7>proportion positiveePCRYes and noYesYesyesSupp 1å3eeeåeeåproportion positiveeYes and noYesYesyesSupp 13proportion positiveeYes and noYesYesyesSupp 13~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÊÈÈ>w-„>
²?n seropositivePfMSP1(1)yesyeseseåÆ«?Œe3n seropositiveePfMSP2yeyesyeåå°¯/?Â?žIP?eåe3eeeeeeeeeeeeeeååeeååeeeeå奥%??49G?eåPˆ>­e3roportion seropositiveopulationfMSP3esesese妥%??49G?e3ÉÈÈ>w-„>
²?e3Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); eâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.€?€?@`å€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeePMultiplexš™¹>ªƒ>‰ï>‰BHB€²BeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeåPMultiplexš™¹>ªƒ>‰ï>|BPB¯BeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÍÌL<@ì=proportion positiveePCRYes and noYesYesyesSupp 1åePeååeeeeeåeåeeeåeåååš™™=’<Hç>proportion positiveePCRYes and noYesYesyesSupp 1ååeePåeeeeåå€=ëì<c¢ì=proportion positiveePCRYes and noYesYesyesSupp 1åPeeeåeeåproportion positiveeYes and noYesYesyesSupp 1Pproportion positiveeYes and noYesYesyesSupp 1P~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åš™¹>ªƒ>‰ï>n seropositivePfMSP1(1)yesyeseseåÆ«?ŒePn seropositiveePfMSP2yeyesyeååÍÌ,?_†?;G?eåePeeeeeeeeeeeeeeååeeååeeeeåå33ó>ô+»>9?eåPˆ>­eProportion seropositiveopulationfMSP3eseseseåà>nW¨>IÔ?ePš™¹>ªƒ>‰ï>ePKerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.Ellen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); ´È€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee+MuleâBYYYINCLUDEDeYʚ²>ÔUS>ªŠû>@ëC€CÐ-DeeåeyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.e€?€?@mç€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeee_MultiplexNý?÷?¤ö7?@CÀ£B™Ceeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeåeeeeeeeeeeeeeeeåeeeeeeeeeeå_MultiplexÝ'??·•??@C€µB€€Ceeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee<”×=,a2=ñû*>proportion positiveePCRYes and noYesYesyesSupp 1åe_eååeeeeeåeåeeeåeåååÍÌL>šÝô=f•>proportion positiveePCRYes and noYesYesyesSupp 1ååee_åeeeeåå¾ç>sӛ=Éå_>proportion positiveePCRYes and noYesYesyesSupp 1å_eeeåeeåv,<yZþ<proportion positiveeYes and noYesYesyesSupp 1_proportion positiveeYes and noYesYesyesSupp 1_~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}åÀç?w)û>Â:0?n seropositivePfMSP1(1)yesyeseseåÆ«?Œe_n seropositiveePfMSP2yeyesyeåå?·D?çÿ.?•nZ?eåe_eeeeeeeeeeeeeeååeeååeeeeååNý?÷?¥ö7?eåPˆ>­e_roportion seropositiveopulationfMSP3eseseseå¿ç?w)û>Â:0?e_¿ç?w)û>Â:0?e_Kerkhof 20162012-2013Cross-sectionalAsia/GMSCambodiaRatanakiri ProvinceAn. dirusAll ages188 to 321 to 1008438MalaResT project; collected 26929 DBSgSG6-P1; gSG6-P2peptideàMalaria JournalSerological markers to measure recent changes in malaria at population level in CambodiaKerkhof, K.; Sluydts, V.; Willen, L.; Kim, S.; Canier, L.; Heng, S.; Tsuboi, T.; Sochantha, T.; Sovannaroth, S.; Ménard, D.; Coosemans, M.; Durnez, L.åEllen Kearney (2020-07-27 14:25:03)(Select): Could extract MFI data, and could ask them if possible to calculate seropositivity cut off based upon negative controls (not given in supp); biae/trap/nightpopulationCDC Light TrapseâBYYYINCLUDEDeYyX[ATãÕBAll agesAn. DirusÜŽ@<<΍é<An. Dirus s.l.; An. Minimus s.l.e€?€?eå@{ˆAAboboveåeeeeeeeeeeeeMultiplex!„=$<~[[>…ëVB×£BÂ£BeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåôýT=proportion positivepopulationmicroscopyPCDYesYesuredeååeeeåeå5eeeåeåeå
áz ALobitoTrapsJul-05xòEÁïÐXAåeeeeeeeeeeeeåeeåeeemELISAÂu>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeeeeeeeåeeeeee1Æ>\¾_>[?proportion seropositivepopulationPfAMA1MeasuredsN? ?Dìl?proportion seropositivepopulationPfMSP1(19)Measuredeeåq „>–Ïò='kä>proportion seropositivepopulationPfCSPMeasuredeeeeeee®µV?’¨)?²
r?proportion seropositivepopulationPf Schizont extracteYesMeasuredeeeeeeee@ELISAP?333?fff?ÁÊ¡>eeåeeeåeeåeeeeeeeåeeeeeeåeeeeeeåeeåeeåÎ9ç>H܋>›À#?proportion seropositivepopulationPfGLURPconcurrentyesyeseeeeåeåeeåeeeeeeåeåeeåeeeeeeåeeeeeeåeåKoffi 20152013Cross-sectionalAfricaCote d'IvoireAbobo; Korhogo; ManHighnsAll ages9.5; 10.5; 102-54; 1-70; 1-599431; 32; 31gSG6-P1peptideßMalaria journalAnalysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIXâ„¢).Koffi D.; Touré AO.; Varela ML.; Vigan-Womas I.; Béourou S.; Brou S.; Ehouman MF.; Gnamien L.; Richard V.; Djaman JA.; Perraut R.e@@INCLUDEDeYXØ­@¯>ÀAll agesåeeFåeeÝ겘=w¡ù=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@ö(ˆAKorhogoåeeeeeeeeeeee Multiplex >X=»ß§>
ׯB{{BnCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå+‡>proportion positivepopulationmicroscopyPCDYesYesured eååeeeåeå5eeeåeåeåP?0·"?jŒm?proportion seropositivepopulationPfAMA1Measured `?ñÅ5?­w?proportion seropositivepopulationPfMSP1(19)Measurede eå@?â?D¨b?proportion seropositivepopulationPfCSPMeasurede eeeeeeP?0·"?jŒm?proportion seropositivepopulationPf Schizont extracteYesMeasured eåeeå?–C£>5^.?proportion seropositivepopulationPfGLURPconcurrentyesyese eåeåeåKoffi 20152013Cross-sectionalAfricaCote d'IvoireAbobo; Korhogo; ManHighnsAll ages9.5; 10.5; 102-54; 1-70; 1-599431; 32; 31gSG6-P1peptideßMalaria journalAnalysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIXâ„¢).Koffi D.; Touré AO.; Varela ML.; Vigan-Womas I.; Béourou S.; Brou S.; Ehouman MF.; Gnamien L.; Richard V.; Djaman JA.; Perraut R.åå(I’=ÖÌ5<[ì>proportion positiveePCRYes and noYesYesyesSupp 1e@@INCLUDEDeYxrAளÀAll agesÝ@öz=‡Ù=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@q=ˆAManlveåeeeeeeeeeeeeMultiplex!=­V:”+>=
IBìQ B¤BeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåZd;>proportion positivepopulationmicroscopyPCDYesYesuredeååeeeåeå5eeeåeåeåk­µ>¿áD>›Ú?proportion seropositivepopulationPfAMA1Measured\k-?høø>KU?proportion seropositivepopulationPfMSP1(19)Measuredeeå!>±=x¿˜>proportion seropositivepopulationPfCSPMeasuredeeeeeee\k-?høø>KU?proportion seropositivepopulationPf Schizont extracteYesMeasuredeåeeåk­µ>¿áD>›Ú?proportion seropositivepopulationPfGLURPconcurrentyesyeseeåeåeåKoffi 20152013Cross-sectionalAfricaCote d'IvoireAbobo; Korhogo; ManHighnsAll ages9.5; 10.5; 102-54; 1-70; 1-599431; 32; 31gSG6-P1peptideßMalaria journalAnalysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIXâ„¢).Koffi D.; Touré AO.; Varela ML.; Vigan-Womas I.; Béourou S.; Brou S.; Ehouman MF.; Gnamien L.; Richard V.; Djaman JA.; Perraut R.åMeeeåeeåmÇT<ûÆ=proportion positiveeYes and noYesYesyesSupp 1Mproportion positiveeYes and noYesYesyesSupp 1Me@@INCLUDEDeY]~í@LÅñÀAll agesÝÂQò=ø/>An. Arabiensis; An. Funestus; An. Gambiae€?@@@@{AAbobomalaria incidence2010åeeeeeeeeeeee9Multiplex¦³˜>¶<>µ8Þ>:eåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeåçeeper 1000populationPCRclinical malaria incidenceyesyesnoyeseåeå7eeeåeåeå$¸?`{Ý>˜²0?proportion seropositivepopulationPfAMA1yesyesyesåün?÷]??proportion seropositivepopulationPfMSP1(19)yesyesyeseåe嵘Î>×b>Iç?proportion seropositivepopulationPfCSPyesyesyeseåeeeeeeün?÷]??proportion seropositivepopulationPf Schizont extracteYesyesyesåeåeeå@‚û>-¹>©ú?proportion seropositivepopulationPfGLURPconcurrentyesyeseåeåeåeåKoffi 20172010-2013Cross-sectionalAfricaCote d'IvoireAboboHighnsAll ages8; 11; 11; 12.5; 132-12; 6-16; 9-13; 1-52; 2-6823457; 35; 24; 56; 62gSG6-P1peptideáPloS oneLongitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.Koffi D.; Varela ML.; Loucoubar C.; Beourou S.; Vigan-Womas I.; Touré A.; Djaman JA.; Touré AO.; Perraut R.opulationfMSP3eseseseåvÜ=.V=ª„&>eyvÜ=.V=ª„&>eye @INCLUDEDeYXØ­@¯>ÀAll agesÚ¹†=ˆ.è=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@ö(AAbobo (RDT pos)cidence2011åeeeeeeeeeeee#Multiplex’ê<kŽ=:’À>"eåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeåZeeper 1000populationPCRclinical malaria incidenceyesyesnoyeseåeå7eeeåeåeå
®G!ALobitoTrapsJan-06xòEÁïÐXAåeeeeeeeeeeeåeeåeeemELISA33³>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåe%I?á Ð>ÚA<?proportion seropositivepopulationPfAMA1yesyesyeså,¾b?KÂG?º}?proportion seropositivepopulationPfMSP1(19)yesyesyeseåeåÍÌL>Ù2Š=@ª>proportion seropositivepopulationPfCSPyesyesyeseåeeeeee‹¯x?VŽj?bhƒ?proportion seropositivepopulationPf Schizont extracteYesyesyesåeåeeåÍÌL?õß*?¥¹n?proportion seropositivepopulationPfGLURPyesyesyeseåeåeåeåKoffi 20172010-2013Cross-sectionalAfricaCote d'IvoireAboboHighnsAll ages8; 11; 11; 12.5; 132-12; 6-16; 9-13; 1-52; 2-6823457; 35; 24; 56; 62gSG6-P1peptideáPloS oneLongitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.Koffi D.; Varela ML.; Loucoubar C.; Beourou S.; Vigan-Womas I.; Touré A.; Djaman JA.; Touré AO.; Perraut R.ìQ€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeVMultiplex¹#î>L*¸>“?@|C@
CÀ–Ceeåee @INCLUDEDeYeeåeeeeeXØ­@¯>ÀAll agesÛàóƒ=Ô+å=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@q=AAbobo (RDT neg)cidence2011åeeeeeeeeeeeeMultiplex¦ªª=

(<à9Š>#eåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeåZeeper 1000populationPCRclinical malaria incidenceyesyesnoyeseåeå7eeeåeåeåeeåeeemELISA
×#<eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeeeeeeeeee-Multiplex21 French adults®Gá=ÍÌÌ>Âu>eeåeeeåeeåeeeeeeeåeeeeeeåVUÕ>f°`>;)?proportion seropositivepopulationPfAMA1yesyesyesglAta‹Áåå€?€?€?proportion seropositivepopulationPfMSP1(19)yeseeeyesyeseåeeeee:ELeA0»'?¸?®G?媪ª>´4>~?proportion seropositivepopulationPfCSPyesyesyeseåeeåeeeeeeeåeeeeåeee«ªj?â[N?»|ƒ?proportion seropositivepopulationPf Schizont extracteåeYesyesyesåeåeeå ?»ÔÜ>£•Q?proportion seropositivepopulationPfGLURPyesyesyeseåeåeåeåKoffi 20172010-2013Cross-sectionalAfricaCote d'IvoireAboboHighnsAll ages8; 11; 11; 12.5; 132-12; 6-16; 9-13; 1-52; 2-6823457; 35; 24; 56; 62gSG6-P1peptideáPloS oneLongitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.Koffi D.; Varela ML.; Loucoubar C.; Beourou S.; Vigan-Womas I.; Touré A.; Djaman JA.; Touré AO.; Perraut R.~B?¦ö>n seropositivePfAMA1yeyeseså!ÎJ?}冈>‡O=0=n>n seropositivePfMSP1(1)yesyeseseåÆ«?Œe-n seropositiveePfMSP2yeyesyeåå?é“>ô6 >·×>eåe-eeeeeeeeeeeeeee @INCLUDEDeYXØ­@¯>ÀAll agesÛàóƒ=Ô+å=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@ìQAAbobomalaria incidence2012åeeeeeeeeeeee8MultiplexlÛ¶=2ºò<ìæH>(eåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeåDeeper 1000populationPCRclinical malaria incidenceyesyesnoyeseåeå7eeeåeåeåeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee?ó¼>w†!?proportion seropositivepopulationPfAMA1yesyesyeså%Ir?0c?±€?proportion seropositivepopulationPfMSP1(19)yesyesyeseåeåJ’¤>ÉâK>03ã>proportion seropositivepopulationPfCSPyesyesyeseåeeeeee`?;ÓI?Å,v?proportion seropositivepopulationPf Schizont extracteYesyesyesåeåeeå%I?k5â>•w3?proportion seropositivepopulationPfGLURPyesyesyeseåeåeåeåKoffi 20172010-2013Cross-sectionalAfricaCote d'IvoireAboboHighnsAll ages8; 11; 11; 12.5; 132-12; 6-16; 9-13; 1-52; 2-6823457; 35; 24; 56; 62gSG6-P1peptideáPloS oneLongitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.Koffi D.; Varela ML.; Loucoubar C.; Beourou S.; Vigan-Womas I.; Touré A.; Djaman JA.; Touré AO.; Perraut R.eeåeeeeeeåeeeeeeåeeeeee$C=G;?˾=proportion positiveePCRYes and noYesYesyesSupp 1åeTeååe @INCLUDEDeYXØ­@¯>ÀAll ageseeeeeeåܽŠ=1ì=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?eeeeeeeeeå@ffAAbobomalaria incidence2013åeeeeeeeeeeee>Multiplex!„=7H’<ùË >&eåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeå4eeper 1000populationPCRclinical malaria incidenceyesyesnoyeseåeå7eeeåeåeåsÎ>Øî>1|?proportion seropositivepopulationPfAMA1yesyesyesåï½w?¢{l?€?proportion seropositivepopulationPfMSP1(19)yesyesyeseåe嬵Ö>җ>ªÌ
?proportion seropositivepopulationPfCSPyesyesyeseåeeeeeeÇc?îN?€Cw?proportion seropositivepopulationPf Schizont extracteYesyesyesåeåeeåRJ)?¾!?èrG?proportion seropositivepopulationPfGLURPyesyesyeseåeåeåeåKoffi 20172010-2013Cross-sectionalAfricaCote d'IvoireAboboHighnsAll ages8; 11; 11; 12.5; 132-12; 6-16; 9-13; 1-52; 2-6823457; 35; 24; 56; 62gSG6-P1peptideáPloS oneLongitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.Koffi D.; Varela ML.; Loucoubar C.; Beourou S.; Vigan-Womas I.; Touré A.; Djaman JA.; Touré AO.; Perraut R.e @INCLUDEDeYXØ­@¯>ÀAll ageseeeeÝ겘=w¡ù=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?eå@{˜AGoute KoulyJun-05åeeeeeeeeeeeeåeeåeeeåee ELISAeeeeÂu<-²=ee ELISAeeee#Ûy=¼t“;Ûù~>eeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe>½=ï,>Proportion positiveMicroscopyACD + PCDYes and noyesYesnoRaw data provided by Paul;eeeåeeååeååeeeåeå12eeeåeåeåbites/person/nightAn. ArabiensisHLCyesYesnoRaw data provided by Paulåeåeåeåeeeeeee
ìQPAAlledM6ååeeeeeeåee…ELISAee9zå¸>ÕxI?ee…ELISAe`ö?–â>?p?•>,>¼tÓeeåeåeeåeeeeeåeeåeåeåeåeeåeeeeeeeåeåLawaly 20122005LongitudinalAfricaSenegalGoute KoulySeasonalAn. Arabiensisall1710 to 33.50 to 80387711SGEWhole salivaÜInfection and ImmunityImpact of Mosquito Bites on Asexual Parasite Density and Gametocyte Prevalence in Asymptomatic Chronic Plasmodium falciparum Infections and Correlation with IgE and IgG TitersLawaly, R.; Konate, L.; Marrama, L.; Dia, I.; Diallo, D.; Sarr, F. D.; Schneider, B. S.; Casademont, I.; Diallo, M.; Brey, P. T.; Sakuntabhai, A.; Mecheri, S.; Paul, R.åKeeeåeeå tÚ<ŸI=pThe background mentions an EIR and Pf prevalenceKproportion positiveeYes and noYesYesyesSupp 1Ke€@YYYINCLUDEDeNAb levels only; Alternate salivary biomarkerxwkAÍ̄ÁAll agesAn. ArabiensiseeÕ0
#>œ¢c>An. Arabiensis; An. Funestus; An. Gambiae@@n positivee@@ö(˜AGoute KoulyNov-05åeeeeeeeeeeeeåeeåeeeåee+ELISAeeee)\<ÍÌL=ee!ELISAeeee¾ŸJ?)\>ßOÝ?eeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeç¦m=þé=Wíº=Proportion positiveMicroscopyACD + PCDYes and noyesYesnoRaw data provided by Paul6eeeåeeååeååeeeåeå12eeeåeåeå@@bites/person/nightAn. ArabiensisHLCyesYesnoRaw data provided by PaulìQ0ABiscuiterieð]kA®—‹Áåeeeeeeeeeeee<ELISA?¤p½>®G!?V>eeåeeeåeeeeåeeeeeeeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeåeeeeeeåeeeåeåeåeåeeeeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåLawaly 20122005LongitudinalAfricaSenegalGoute KoulySeasonalAn. Arabiensisall1710 to 33.50 to 80387711SGEWhole salivaÜInfection and ImmunityImpact of Mosquito Bites on Asexual Parasite Density and Gametocyte Prevalence in Asymptomatic Chronic Plasmodium falciparum Infections and Correlation with IgE and IgG TitersLawaly, R.; Konate, L.; Marrama, L.; Dia, I.; Diallo, D.; Sarr, F. D.; Schneider, B. S.; Casademont, I.; Diallo, M.; Brey, P. T.; Sakuntabhai, A.; Mecheri, S.; Paul, R.ååThe background mentions an EIR and Pf prevalenceÆNì>,3œ>05?proportion positiveePCRYes and noYesYesyesSupp 1e€@YYYINCLUDEDeNAb levels only; Alternate salivary biomarkerxwkAÍ̄ÁAll agesAn. ArabiensisÕ0
#>œ¢c>An. Arabiensis; An. Funestus; An. Gambiae@@@@q=˜AGoute KoulyJul-05	åeeeeeeeeeeeeåeeåeeeDELISA•£>D‹l>¬Ü>eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåê¼=%îœ=Óùà=Proportion positiveMicroscopyACD + PCDYes and noyesYesnoRaw data provided by PaulÉeeeåeeååeååeeeåeå12eeeåeåeåeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeeeeee'ELISA25 Europå‡?zÇ	?1'?J>7‰>X9ô>eåeeåeeåeeeeeeeåeeeeåeeåeeeeåeeeeeeeeåeeeeeeeeeeeeeeåeåeeåeåeåeåeåLawaly 20122005LongitudinalAfricaSenegalGoute KoulySeasonalAn. Arabiensisall1710 to 33.50 to 80387711SGEWhole salivaÜInfection and ImmunityImpact of Mosquito Bites on Asexual Parasite Density and Gametocyte Prevalence in Asymptomatic Chronic Plasmodium falciparum Infections and Correlation with IgE and IgG TitersLawaly, R.; Konate, L.; Marrama, L.; Dia, I.; Diallo, D.; Sarr, F. D.; Schneider, B. S.; Casademont, I.; Diallo, M.; Brey, P. T.; Sakuntabhai, A.; Mecheri, S.; Paul, R.The background mentions an EIR and Pf prevalencee€@YYYINCLUDEDeNAb levels only; Alternate salivary biomarkerxwkAÍ̄ÁAll agesAn. ArabiensisÕ0
#>œ¢c>An. Arabiensis; An. Funestus; An. Gambiae@@@@ìQ˜AGoute KoulyAug-05
åeeeeeeeeeeeeåeeåeeeBELISA)\ß>
×£>7‰!?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeѺ=îTš=E‘ß=Proportion positiveMicroscopyACD + PCDYes and noyesYesnoRaw data provided by Paul•eeeåeeååeååeeeåeå12eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåLawaly 20122005LongitudinalAfricaSenegalGoute KoulySeasonalAn. Arabiensisall1710 to 33.50 to 80387711SGEWhole salivaÜInfection and ImmunityImpact of Mosquito Bites on Asexual Parasite Density and Gametocyte Prevalence in Asymptomatic Chronic Plasmodium falciparum Infections and Correlation with IgE and IgG TitersLawaly, R.; Konate, L.; Marrama, L.; Dia, I.; Diallo, D.; Sarr, F. D.; Schneider, B. S.; Casademont, I.; Diallo, M.; Brey, P. T.; Sakuntabhai, A.; Mecheri, S.; Paul, R.The background mentions an EIR and Pf prevalencee€@YYYINCLUDEDeNAb levels only; Alternate salivary biomarkerxwkAÍ̄ÁAll agesAn. ArabiensisÕ0
#>œ¢c>An. Arabiensis; An. Funestus; An. Gambiae@@@@Į́AeåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåeLondono-Renteria 20152011longitudinal; cross-sectionalSouth AmericaHaiti; Colombia; USAPort-au-Prince; Caribean Coast of Colombia; Los Patios; North Carolinansnsns4242gSG6-P1peptideßParasites & vectorsAn. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.Londono-Renteria B.; Drame PM.; Weitzel T.; Rosas R.; Gripping C.; Cardenas JC.; Alvares M.; Wesson DM.; Poinsignon A.; Remoue F.; Colpitts TM.å!ÎJ?}ån seropositivePfMSP1(1)yesyeseseåÆ«?Œen seropositivePfMSP2yeyesyeååÍÌÌ>1º>AÞ%?eåeeeeeeeeeeeeeeee@YYNINCLUDEDeNStratified by infection statusåeåååÿÿ€?eå€?{°ATurboveDåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåee˜ELISAeeeer%>.Pï=Æ8>ee˜ELISAeeeeC²>`Dx>],ç>ee˜ELISAeeeez>«I?>³(¬>ee˜ELISAeeee¤>“[Ã=&·†>ee˜ELISAeeee®aP>ÿ–¹=ßì’>eeeåeåeeeåeeåå0•˜>åuf>pï½>proportion positiveePCRACD and PCDyesYesyes˜åeeeåeåentereeeåeåeå\2ADarou Salam 2zlAÑãŠÁåeeeeeeeeeFELISAû
?=
×>Ãõ(?¬Z>eeåeåeeåeeåeåeeeeeåeeååeeåeeeeeeeåeåeeeeeeeeeeeeeåeåeåeeåeåeåeåeåLondono-Renteria 20202016-2017Cross-sectionalSouth AmericaColombiaTurbo; El Bagrelow; moderateAn. Albimanusall agesTurbo 18.8; El Bagre 28.65Turbo 3-78; El Bagre 3-74337 individuals337PEROX-P3; TRANS-P1; TRANS-P2peptideäInternational journal of molecular sciencesIdentification and Pilot Evaluation of Salivary Peptides from Anopheles albimanus as Biomarkers for Bite Exposure and Malaria Infection in Colombia.Londono-Renteria B.; Drame PM.; Montiel J.; Vasquez AM.; Tobón-Castaño A.; Taylor M.; Vizcaino L.; Lenhart AAE.ff€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeLMultiplex<”×<3=€jC>C€™Ceeåeeeåeeåe@INCLUDEDeNAlternate salivary antigeneeåð…Aþt™ÂAll agesAn. Albimanusà‚¨û7÷̒8An. Darlingi€?€?€?ö(°AEl BagreDåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåee¹ELISAeeee
=>ÿ–¹=‚À+>ee¹ELISAeeeeÖêc>M´>ýçî>ee¹ELISAeeee' M>®„>ëã>ee¹ELISAeeee—–>dË=–sT>ee¹ELISAeeeeñ3>HVü=Öêc>eeeåeåeeeåeeååÒ1¼>:Ÿ˜>gÄß>proportion positiveePCRACD and PCDyesYesyes¹åeeeåeåentereeeåeåeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeeeeååeåeeåeeeeeåeeeeåLondono-Renteria 20202016-2017Cross-sectionalSouth AmericaColombiaTurbo; El Bagrelow; moderateAn. Albimanusall agesTurbo 18.8; El Bagre 28.65Turbo 3-78; El Bagre 3-74337 individuals337PEROX-P3; TRANS-P1; TRANS-P2peptideäInternational journal of molecular sciencesIdentification and Pilot Evaluation of Salivary Peptides from Anopheles albimanus as Biomarkers for Bite Exposure and Malaria Infection in Colombia.Londono-Renteria B.; Drame PM.; Montiel J.; Vasquez AM.; Tobón-Castaño A.; Taylor M.; Vizcaino L.; Lenhart AAE.e!e!e@INCLUDEDeNAlternate salivary antigenåaó@Ӝ•ÂAll agesAn. Albimanuseeåeeeeeeeà¬Å'7¬Å§7An. Albitarsis€?€?€?{¸Ahildren <14 yearsMar-05nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 French	G”?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåºw @bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257®G1ACite SOPRIMglAta‹Áåeeeeeeeeeeee:ELISA0»'?¸?®G?•>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.åeåeeeåe@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerrxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@ö(¸Ahildren <14 yearsMay-05nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 Frenchþ±ó?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeå»Li@bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. Gambiaeå…Ú•=ª‰<K¥>proportionÕGÉ+={I£=!An. Gambiae and noYesYesyesSupp 1€?€?@q=¸Ahildren <14 yearsJul-05nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchW­÷?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeå'b?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257åeåeåeåeeeeeeeåeåeeåeå[X[AãÕBåeåeeåeeeeeeeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@ìQ¸Ahildren <14 yearsAug-05nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchqâÉ?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåî*?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257åeåeåeåeeeeeeeeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeååMultiplexeåµ>eeåeeeeeeåeeeeåeeeeeeåeeeeeeåeeeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.veePCRYes and noYesYesyesSupp 1åe!eååe@AYYNINCLUDEDeNAb levels onlye; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@ff¸Ahildren <14 yearsOct-05nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 French6Hè?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåÁ½—?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257{2AMaka Colobane­lA"+‹ÁåeeeeeeeeeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeåeeåeeeeeeåeeeeeåeeeåeeeeeåeeeeeåeåeeeeeeeázAFåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.åeåe@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeÕGÉ+={I£=!An. Gambiae€?€?@áz¸Ahildren <14 yearsDec-05nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchåÞ?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåd°¡?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257q=2ACité Pépinière-'lAd‹Áåeeeeeeeeeeee>ELISAãÇ?…ë>ìQ8?7‰>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeeeeeåeeeeeeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeeeeåeeåeeeåeeeeeeeeåeåeeeeeååMultipexo‹=8<½>eåeeeeeeåeeeeeeeeeeeeåeeeeeeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeeÕGÉ+={I£=!An. Gambiaeee€?€?eå@\¸Ahildren <14 yearsJan-06nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 French
Iò?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeå×·?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257åeåeåeåeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.B`€ARatanakiri Province010åed sedish donorsØ„>uÄ!>eeeeeeeeeeeeeeeeeMultiplex‚B"Bà†Ceeåeeeåeeåeeeeeeeåeeeeeeåe@AYYNINCLUDEDeNAb levels onlyeeåeeee; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@×£¸Ahildren <14 yearsApr-06nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 Frenchª~?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåÑc.@bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257åeåeåeåeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.ååQÔ®=wÜË<¼X>proportion positiveePCRYes and noYesYesyesSupp 1ååeeRåeee@AYYNINCLUDEDeNAb levels onlyee; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeeeÖû"!=ÿ›=!An. Gambiaeeeeee€?€?eee@R¸¸Ahildren <14 yearsJul-06night	åeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 French	øì?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåš?y?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyesseropositivity cut off 0.257åeåeåeåeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeulationmicroscopyPCDYÖû"!=ÿ›=!An. Gambiae€?€?@Í̸Ahildren <14 yearsAug-06night
åeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchB9@eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeål?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyes
ázPAAledM9åeeeeeeeeeeee…ELISA&|?D]r?Pˆ?Ý$&?ö(Ü>¤p]?ee…ELISAee\?~Tó>ÛO&?Õx©>ªñR>-ò>eeåeeåeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.eeeåeeåproportion positiveeYes and noYesYesyesSupp 1¬proportion ositiveeYes and noYesYesyesSupp 1¬e@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@Há¸Ahildren <14 yearsOct-06nightåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 French‰7
@eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeåԂ%?bites/person/nightAn gambiae/trap/nightCDC Light TrapsyesYesyeseeeeeeeeeeee…ELISA&|?D]r?Pˆ?ÙÎ7?´Èö>ázt?ee…ELISAeiu'?n?<?´È¶>´Èv>î|ÿ>eeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.eååeeee@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@Ãõ¸Ahildren <14 yearsDec-06åeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchFƒÞ?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå5eeeåeåeååeåeå{€Aateå[X[eãÕåeeeeeeeeeeeeeeeeeNMultpleeeeeeeeeeeeMultiplex¦ªª=

(<à9Š>#eåeeeååeeeeeeeåeeeåeeeåeeeååeeeeeeeåeåeeeåeeeeåeåeeeeåMarie 20152004-2006LongitudinalAfricaAngolaLobitoSeasonalAn. Gambiaeall ages1-55 years71 individuals852230 individuals cE5recombinant proteinßMicrobes and infectionThe Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Marie A.; Ronca R.; Poinsignon A.; Lombardo F.; Drame PM.; Cornelie S.; Besnard P.; Le Mire J.; Fiorentino G.; Fortes F.; Carnevale P.; Remoue F.; Arcà B.yeseseåÆ«?Œehn seropositiveePfMSP2yeyesyeåå±û>hâÉ>}"?eåeheeeeeeeeeeeeeee@AYYNINCLUDEDeNAb levels only; Alternate salivary biomarkerxòEÁïÐXAAll agesAn. GambiaeÖû"!=ÿ›=!An. Gambiae€?€?@ÍÌÀAeåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåeMontiel 20202017-2018LongitudinalSouth AmericaColombiansnsAn. Albimanus+An. Darlingi63 pos/50 neg113 total113initial cohort of 958 people; all Pf positive (15 microscopic, 48 submicroscopic) and 50 randomly selected negativegSG6-P1/ An. Albimanus SGE/ An. Darlingi SGEpeptide + WSGEäMalaria journalIgG antibody response against Anopheles salivary gland proteins in asymptomatic Plasmodium infections in Narino, Colombia.Montiel J.; Carbal LF.; Tobón-Castaño A.; Vásquez GM.; Fisher ML.; Londono-Rentería B.Ellen Kearney (2020-07-27 12:11:42)(Select): Compares between infected and non-infected (matched); e
@YYNINCLUDEDeNCase Controleeeee-Multiplex21 French adults®Gá=ÍÌÌ>Âu>eeååeeeååÿÿ€?åeeee€?{àADielmoitive2002åeeeeeeeeeeee¸ELISA
Yˆ>KO>Ž©>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå1ì>proportion positivemicroscopyACD+PCDyesYesyesåeååeeeåeå017eeeåeåeå€WCinfectious bites/person/yearpopulationHLC + pyrethrum spray catchesyesYesReported in texteeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeå8½	?d˜î>>.?proportion seropositivepopulationPfAMA1yesyesyeseeeåe!K?
(<?»Z?proportion seropositivePfMSP1(19)yesåyeseyeseåeeeeeåeeeeeeeåeeeeeeåånz3?x‹"?giD?proportion seropositivePfCSPyesyesyeseåeeeeee’…l?Ú¶b?GTv?proportion seropositivePf Schizont extracteYesyesyesåeåeeåYH?'9?ðšW?proportion seropositivePfGLURPyesyesyeseåeåeåeåPerraut 20172002/2011Repeated cross sectionalAfricaSenegalNdiop; DielmoHigh; ModerateAn. Gambiae; An. FunestusAll ages28.2; 28.9; 24.3; 25.7798gSG6-P1peptideáPloS oneSerological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities.Perraut R.; Varela ML.; Loucoubar C.; Niass O.; Sidibé A.; Tall A.; Trape JF.; Wotodjo AN.; Mbengue B.; Sokhna C.; Vigan-Womas I.; Touré A.; Richard V.; Mercereau-Puijalon O.e€@INCLUDEDeY³¦[A.PƒÁAll agesAn. FunestuseÒ͒>Ü=>An. Arabiensis; An. Funestus; An. Gambiae@@tyesyeseå@@ö(àADielmoitive2013åeeeeeeeeeeeeÄELISAlÛ6>çÿ=YÃm>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåproportion positivemicroscopyACD+PCDyesYesyesåj<=proportion positiveePCRACD+PCDyesYesyesååeeeåeå017eeeåeåeåð@infectious bites/person/yearpopulationHLC + pyrethrum spray catchesyesYesReported in textè<>ó‘>֗s>proportion seropositivepopulationPfAMA1yesyesyeså‚—?
â?úL%?proportion seropositivePfMSP1(19)yesyesyeseåeåOÁË>]«¨>=×î>proportion seropositivePfCSPyesyesyeseåeeeeee§à%?™Â?¶þ6?proportion seropositivePf Schizont extracteYesyesyesåeåeeå]N?-ÆÞ>¦9?proportion seropositivePfGLURPyesyesyeseåeåeåeåPerraut 20172002/2011Repeated cross sectionalAfricaSenegalNdiop; DielmoHigh; ModerateAn. Gambiae; An. FunestusAll ages28.2; 28.9; 24.3; 25.7798gSG6-P1peptideáPloS oneSerological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities.Perraut R.; Varela ML.; Loucoubar C.; Niass O.; Sidibé A.; Tall A.; Trape JF.; Wotodjo AN.; Mbengue B.; Sokhna C.; Vigan-Womas I.; Touré A.; Richard V.; Mercereau-Puijalon O.åe>½=ï,>Proportion positiveMicroscopyACD + PCDYes and noyesYesnoRaw data provided by Paul;eeeåeeåe€@INCLUDEDeY³¦[A.PƒÁAll agesAn. FunestusݱŸ<-!=An. Arabiensis; An. Funestus; An. Gambiae€?€?@q=àANdiopsitive2002åeeeeeeeeeeeeÊELISAÞõ³>@’>º«Õ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåƒÀJ>proportion positivemicroscopyACD+PCDyesYesyesåeååeeeåeå017eeeåeåeåÍÌ+Cinfectious bites/person/yearpopulationHLC + pyrethrum spray catchesyesYesReported in textìQpA7yo[X[AXãBåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeee߈?ÅÅá>Ü.?proportion seropositivepopulationPfAMA1yesyesyesåY>?å©.?̈M?proportion seropositivePfMSP1(19)yesyesyeseåeå×Ï?Oq?`.(?proportion seropositivePfCSPyesyesyeseåeeeeeeDI?Ç
;?ÁôW?proportion seropositivePf Schizont extracteYesyesyesåeåeeå?[,?aÌ?ê<?proportion seropositivePfGLURPyesyesyeseåeåeåeåPerraut 20172002/2011Repeated cross sectionalAfricaSenegalNdiop; DielmoHigh; ModerateAn. Gambiae; An. FunestusAll ages28.2; 28.9; 24.3; 25.7798gSG6-P1peptideáPloS oneSerological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities.Perraut R.; Varela ML.; Loucoubar C.; Niass O.; Sidibé A.; Tall A.; Trape JF.; Wotodjo AN.; Mbengue B.; Sokhna C.; Vigan-Womas I.; Touré A.; Richard V.; Mercereau-Puijalon O.嵘Î>×b>Iç?proportion seropositivepopulationPfCSPyesyesyeseåeeeeeeün?÷]??proportion seropositivepopulationPf Schizont extracteYesyesyese€@INCLUDEDeYeåÎÚZAÅ¿‚ÁAll agesAn. GambiaeeÒ`Í>mÅ>>An. Arabiensis; An. Funestus; An. Gambiae@@eeå@@ìQàANdiopsitive2013åeeeeeeeeeeeeØELISA­ª*>ыï=j]>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåproportion positivemicroscopyACD+PCDyesYesyesåh‘í<proportion positiveePCRACD+PCDyesYesyesååeeeåeå017eeeåeåeå @infectious bites/person/yearpopulationHLC + pyrethrum spray catchesyesYesReported in texteeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexœùï=ržb=»Vp>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeoG>Q>”(}>proportion seropositivepopulationPfAMA1yesyesyeså	í?~¿é>Tú?proportion seropositivePfMSP1(19)yesyesyeseåeåÚË>_mª>ÇFí>proportion seropositivePfCSPyesyesyeseåeeeeee´—?3Uÿ>΄!?proportion seropositivePf Schizont extracteYesyesyesåeåeeå
íå>‰öÃ>Æñ?proportion seropositivePfGLURPyesyesyeseåeåeåeåPerraut 20172002/2011Repeated cross sectionalAfricaSenegalNdiop; DielmoHigh; ModerateAn. Gambiae; An. FunestusAll ages28.2; 28.9; 24.3; 25.7798gSG6-P1peptideáPloS oneSerological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities.Perraut R.; Varela ML.; Loucoubar C.; Niass O.; Sidibé A.; Tall A.; Trape JF.; Wotodjo AN.; Mbengue B.; Sokhna C.; Vigan-Womas I.; Touré A.; Richard V.; Mercereau-Puijalon O.ö(˜AGoute KoulyNov-05xwkAÍ̄Áåeeeeeeeeeeeeåeeåeeeåee+ELISAeeee)\<ÍÌL=ee!ELISAeeee¾ŸJ?)\>ßOÝ?eeåeeåeeeeeåeeeeeeeeåe€@INCLUDEDeYeeÎÚZAÅ¿‚ÁAll agesAn. GambiaeÝÆù›<©M=An. Arabiensis; An. Funestus; An. Gambiae€?€?@{èALow bitesitesSep-02åeeeeeeeeeeeebELISA¿‡>¢S->1Ë>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeebELISA¹þá=å‰(=ü¥<>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeån 200eeeåeåe帥?Ãõ¨>@bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesRemoueåeåeåeåeeeeeeeeeeåeeeeeeeeåeåeeeåeeeeååeåeeeeåeeeeeeeeeeåeeeeeåeeeeeåPoinsignon 20082002Cross-sectionalAfricaSenegalNiakharSeasonalAn. GambiaeChildren21 to 36 weeks to 5 years2412411200 children 6 weeks-5yearsgSG6-P1; gSG6-P2peptideØPloS oneNovel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites.Poinsignon A.; Cornelie S.; Mestres-Simon M.; Lanfrancotti A.; Rossignol M.; Boulanger D.; Cisse B.; Sokhna C.; Arcà B.; Simondon F.; Remoue F.eEllen Kearney (2020-08-06 14:08:28)(Select): will only have data on levels not seropositivity; Ellen Kearney (2020-07-30 16:32:35)(Select): need to combine with Remoue 2006; ååeeeåee@@YYNINCLUDEDeNAb  levels onlyښgA:ƒÁChildrenAn. GambiaeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@ö(èAMedium bitessSep-02åeeeeeeeeeeee6ELISAŒäz>!>1tª>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeee6ELISA‹7™=«%õ;30>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeån 200eeeåeåeå†A€AŒAbites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesRemoueeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeeeåeeeeeeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåPoinsignon 20082002Cross-sectionalAfricaSenegalNiakharSeasonalAn. GambiaeChildren21 to 36 weeks to 5 years2412411200 children 6 weeks-5yearsgSG6-P1; gSG6-P2peptideØPloS oneNovel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites.Poinsignon A.; Cornelie S.; Mestres-Simon M.; Lanfrancotti A.; Rossignol M.; Boulanger D.; Cisse B.; Sokhna C.; Arcà B.; Simondon F.; Remoue F.åEllen Kearney (2020-08-06 14:08:28)(Select): will only have data on levels not seropositivity; Ellen Kearney (2020-07-30 16:32:35)(Select): need to combine with Remoue 2006; e@@YYNINCLUDEDeNAb  levels onlyښgA:ƒÁChildrenAn. GambiaeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@q=èAHigh bitestesSep-02åeeeeeeeeeeeeYELISAÈ×Î>]Ž‘>mö?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeYELISAôb>©4=¤>eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeån 200eeeåeåeå×£øAôAš™ýAbites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesRemoueåffAAbobomaaria incience201eåÀåeåeeeeeeeeeMultipexeå!„=7H’eË eeeeeåeeeeåeeeeeeeåeeeeeee\2ADarou Salam 2zlAÑãŠÁåeeeeeeeåeeFELISAeåû
?=
×>Ãõ(?¬eeeåeeåeeåeeeåeeeeeeåeåeeeeeåeeeeeeeåeeåPoinsignon 20082002Cross-sectionalAfricaSenegalNiakharSeasonalAn. GambiaeChildren21 to 36 weeks to 5 years2412411200 children 6 weeks-5yearsgSG6-P1; gSG6-P2peptideØPloS oneNovel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites.Poinsignon A.; Cornelie S.; Mestres-Simon M.; Lanfrancotti A.; Rossignol M.; Boulanger D.; Cisse B.; Sokhna C.; Arcà B.; Simondon F.; Remoue F.Ellen Kearney (2020-08-06 14:08:28)(Select): will only have data on levels not seropositivity; Ellen Kearney (2020-07-30 16:32:35)(Select): need to combine with Remoue 2006; e@@YYNINCLUDEDeNAb  levels onlyښgA:ƒÁChildrenAn. GambiaeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@{ðANiakharSep-02åeeeeeeeeeeee=ELISA<>ƒA>¿ß>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe&~>éR>”£”>proportion positivemicroscopyACD+PCDYes and noyesYesyes“eeeåeeååeååeeeåeån 200eeeåeåeåØf?“±¨>Åǽ?bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyes{€ARatanakiri Province[X[AXãÕBåeeeeeeeeeeeeNMultiplex@sC€ùBà³CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeSMultiplexdCÞBà¬Ceeåeeeeeeåeeeeeeåeeeeeeåeeåeeeeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeee{¸AChildren <14 yeånightxòEÁïÐXAåeåeeeeåeeeeeeeeåeeåeeåeåeeåeååeeeeee7ELISA2 Frenchœ“?eåPoinsignon 20092002Cross-sectionalAfricaSenegalNiakharSeasonalAn. GambiaeChildren21 to 36 weeks to 5 years611221200 children 6 weeks-5yearsgSG6-P1peptideÙMalaria journalHuman IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.Poinsignon A.; Cornelie S.; Ba F.; Boulanger D.; Sow C.; Rossignol M.; Sokhna C.; Cisse B.; Simondon F.; Remoue F.eeååeeåeeeeeeeåeåeeeeeeeeeeeeeåeåeåe@YYNINCLUDEDeNAb  levels onlyeåښgA:ƒÁChildrenAn. GambiaeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@ö(ðANiakharDec-02åeeeeeeeeeeee=ELISAÆb±>§Ói>?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe!Ó0>P
>CVW>proportion positivemicroscopyACD+PCDYes and noyesYesyes„eeeåeeååeååeeeåeån 200eeeåeåeåå™x=YTC>bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyeseeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåPoinsignon 20092002Cross-sectionalAfricaSenegalNiakharSeasonalAn. GambiaeChildren21 to 36 weeks to 5 years611221200 children 6 weeks-5yearsgSG6-P1peptideÙMalaria journalHuman IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.Poinsignon A.; Cornelie S.; Ba F.; Boulanger D.; Sow C.; Rossignol M.; Sokhna C.; Cisse B.; Simondon F.; Remoue F.eeeeeeåeeeeeeåeeeee@YYNINCLUDEDeNAb  levels onlyښgA:ƒÁChildrenAn. GambiaeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@{øAGankette BallaJun-04åeeeeeeeeeeeeWELISAÑñs=ú >eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeç»%=2Ý5<A=proportion positivemicroscopyyesYesyes­eeeåeeååeååeeeåeån 201eeeåeåeåÍÌAbites/person/nightpopulationAn. Funestus bitesHLCyesYesyesåeåeåeåeeeeeeeåeåeeåeåeåeåeåPoinsignon 20102004LongitudinalAfricaSenegalGankette BallaSeasonalAn. FunestusChildren1 to 9 years87261173 childrengSG6-P1peptideÚTropical medicine & international health : TM & IHFirst attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.Poinsignon A.; Samb B.; Doucoure S.; Drame PM.; Sarr JB.; Sow C.; Cornelie S.; Maiga S.; Thiam C.; Rogerie F.; Guindo S.; Hermann E.; Simondon F.; Dia I.; Riveau G.; Konate L.; Remoue F.e@@YYNINCLUDEDeNAb  levels onlyƱAÜ~ÁChildrenAn. FunestusÔsº¬=ð¢>#An. Arabiensis€?€?@ö(øAGankette BallaSep-04åeeeeeeeeeeeeWELISAHŠµ=¤1*>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe)´—=žçô<^.ò=proportion positivemicroscopyyesYesyes‡eeeåeeååeååeeeåeån 201eeeåeåeåêBbites/person/nightpopulationAn. Funestus bitesHLCyesYesyesåeåeåeåeeeeeeeåeåeeåeåeåeåeåPoinsignon 20102004LongitudinalAfricaSenegalGankette BallaSeasonalAn. FunestusChildren1 to 9 years87261173 childrengSG6-P1peptideÚTropical medicine & international health : TM & IHFirst attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.Poinsignon A.; Samb B.; Doucoure S.; Drame PM.; Sarr JB.; Sow C.; Cornelie S.; Maiga S.; Thiam C.; Rogerie F.; Guindo S.; Hermann E.; Simondon F.; Dia I.; Riveau G.; Konate L.; Remoue F.åeåeeeåeeåe@@YYNINCLUDEDeNAb  levels onlyƱAÜ~ÁChildrenAn. FunestusÔsº¬=ð¢>#An. Arabiensiseeåeeee€?€?eeå@q=øAGankette BallaDec-04åeeeeeeeeeeeeWELISAÿ؞=>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåei=<ˆø<ù¯â=proportion positivemicroscopyyesYesyesœeeeåeeååeååeeeåeån 201eeeåeåeåš™ÀBbites/person/nightpopulationAn. Funestus bitesHLCyesYesyesö(AAbobo (RDT ps)cidenc201åeåeåeåeeeeeeeåeåeeåeåeåeåeåPoinsignon 20102004LongitudinalAfricaSenegalGankette BallaSeasonalAn. FunestusChildren1 to 9 years87261173 childrengSG6-P1peptideÚTropical medicine & international health : TM & IHFirst attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.Poinsignon A.; Samb B.; Doucoure S.; Drame PM.; Sarr JB.; Sow C.; Cornelie S.; Maiga S.; Thiam C.; Rogerie F.; Guindo S.; Hermann E.; Simondon F.; Dia I.; Riveau G.; Konate L.; Remoue F.ÁïÐXAåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchB9@eeåeeeeeåeeeeeeeeåee@@YYNINCLUDEDeNAb  levels onlyeeeƱAÜ~ÁChildrenAn. FunestusÔsº¬=ð¢>#An. Arabiensis€?€?@ =
BJack HarboursDry (Sept 16)åeeeeeeeeeeeeJMultiplex40 BritishÕg]=¨û%;ê7Ø=€BBB½BeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeåÍ̌?À@bites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageq=AAbobo (RDT neg)cidence2011XØ­@¯>ÀåeeeeeeeeeeeeMultiplex¦ªª=

(<à9Š>#eåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeåeeeeeeeeåeeeeeeeåeåeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.åeAINCLUDEDeYÖ×Á;0CAll agesAn. Farautià¹ß!;ú
Ò;€?€?€? {BNew MalabitesDry (Sept 16)åeeeeeeeeeeeebMultiplex40 British‹Æú=¶k=ãØ?>ÍB‹B*CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeåffæ? Abites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageeeeeåeeeeeeåeeeeeeåeeeeeeö(¸AChildren <14 yearsay-05nightxeeeeåeeeeeåeåeeåeeeååeeåeeeeeeeåeeeee7LIeå=ò?eeåeeeeeåeeeeeeeeeeeåeåeeåeåeåeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.eAINCLUDEDeYýÁŸCAll agesAn. FarautiàM¾Y<a=An. Farauti s.l.€?€?@ ¸BSaeragi bitesDry (Sept 16)åeeeeeeeeeeeecMultiplex40 British>x=¢á^<ØaÜ=ÃB‰BCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeåÍÌÌ=@bites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeAINCLUDEDeYy¶Á‘ÆCAll agesAn. Farautià.sº<#ga=An. Farauti s.l.€?€?@ ö(BTuguiviliitesDry (Sept 16)åeeeeeeeeeeeeUMultiplex40 Britishµ´4>ÝnÃ=þ؃>ÞB„BMCeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeåš™™>€@bites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageåeåeåeåeeeeeeeåeåeeåeåeåÍ̸AChidren <14 earsAug-06igeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.ååeeeåeeAINCLUDEDeY4Á97CAll agesAn. Farautià8Û\;€`<An. Farauti s.l.€?€?€? 33BJack HarboursWet (March 17)åeeeeeeeeeeeeEMultiplex40 Britishsí=×y%=‘D>ÆBB!CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeå33B@€‹Cbites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageq=˜AGoute KoulyJul-05	xwkAÍ̄Áåeeeeeeeeeeeeåeååeåeåeåeeeeeeeeeåeeåeeeeeeeåeeeeee7ELISA32 French¬
@eeåeeeeeåeeeeeeeeååeeeåeeeeeeååeeåeeeeeåeeeeeåeeeeeåeåeeåeeeeeeeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.eAINCLUDEDeYÖ×Á;0CAll agesAn. Farautieåá¹ß!;ú
Ò;€?€?€? q=BNew MalabitesWet (March 17)åeeeeeeeeeeeezMultiplex40 Britishý—=ÄWà<	ö=€³B|B
CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeåš™?€@bites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageìQ˜AGoute KoulyAug-05
xwkAÍ̄ÁåeeeeeeeeeeeeåeeåeeeBELISA)\ß>
×£>7‰!?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.ååeeeåeeAINCLUDEDeYýÁŸCAll agesAn. FarautiáM¾Y<a=An. Farauti s.l.€?€?@ ®GBSaeragi bitesWet (March 17)åeeeeeeeeeeeeEMultiplex40 British³>ÅP=!ðV>€C»B€<CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeåbites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageåeåeåeåeeeeeeeåeåeeåeåeåeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.5nightxòEÁïÐXAåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchåÞ?eeåeeeeeåeeeeeeeeåeeeeeeeeeAINCLUDEDeYeeåeeeey¶Á‘ÆCAll agesAn. Farautieeåeeeeá.sº<#ga=An. Farauti s.l.eeåeeee€?€?@ ìQBTuguiviliitesWet (March 17)åeeeeeeeeeeeetMultiplex40 Britisha¹'>o„Å=Š°l>üB¬B€=CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeåffÖ@ÐAbites/person/nightpopulationAn. Farauti bitesHLCyesYesyesSupplementary Dataset10 sites per villageåeåeåeåeeeeeeeåeåeeåeåeåeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.åeåeeeåeeåeAINCLUDEDeY4Á97CAll agesAn. Farautiá8Û\;€`<An. Farauti s.l.€?€?€? )\BAll (Averaged)aråeeeeeeeeeeeeÜMultiplex40 British½kå=䁸=¹l>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåM 201eeeåeåeå…"Binfectious bites/person/yearpopulationAn. Farauti bitesHLCno: period 2014-2015NonoBurkot, T.R., Bugoro, H., Apairamo, A. et al. Spatial-temporal heterogeneity in malaria receptivity is best estimated by vector biting rates in areas nearing elimination. Parasites Vectors 11, 606 (2018). https://doi.org/10.1186/s13071-018-3201-1same sitesÍ̸AChildren <14 yearsAug-06night
xòEÁïÐXAåeeeeeeeeeeeeåeeåeeåeeåeeeåeeeeeeELISA32 rench6eåeeeeeeåeeeeeeeeååeeeeåeeeeåeeeeeåeeeeeeåeeeeeeåeeåeåeeåeåeåeåeåPollardEJM 20192016-2017Repeated cross sectionalPacificSolomon IslandsJack Harbour; New Mala; Saeragi; TuguivilliAn. FarautiAll ages208 to 371 to 84686791685 individuals gave 791 sampes (105 villagers gave two)gSG6-P1peptideãMalaria journalHuman exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.Pollard EJM.; Patterson C.; Russell TL.; Apairamo A.; Oscar J.; Arcà B.; Drakeley C.; Burkot TR.eåeeeeeeeåeåeeåeAINCLUDEDeYeåAll agesAn. Farautiàe!=
B5 and underîELISA44 Europeansff?Ì]ë>=
?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÚ¬
?³êó>C?proportion positiveePCRsurveyyesYeseyyesðeé×>~¸>¬­ø>proportion positivemicroscopysurveyyesYesyesùif you subtract PCR from microscopy, we will see how many subclinical infectionseeeåeeååeååeeeåeå2013eeeåeåeåq=¸AChildren <14 yearsJul-05nighteeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 Frenchóv÷?eeeeeåeeeeeetµ%?ݵ?tµ5?proportion seropositivepopulationPfAMA1yesyesyesà,eY>S#>1Œ>proportion seropositivePfMSP1(19)yesyesyeseÔvqÛ>Ù=¹>žþ>proportion seropositiveePfMSP2yesyesyesُär=o=:’Ë=proportion seropositivePfCSPyesyesyeseÛeeeeeeeeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeååeeåeeeeeeeeååMultiplexœùï=rž=»Vp>eåeeåeeeeåeeåeåeeeeeeåeeeeeeåeåProietti 20132010Repeated cross sectionalAfricaUgandaAbediHighnsAll ages3; 7; 352-4; 6-9; 27-50509509Age stratified cohort of 509 participantsgSG6recombinant proteinÝParasite immunologyInfluence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda.Proietti C.; Verra F.; Bretscher MT.; Stone W.; Kanoi BN.; Balikagala B.; Egwang TG.; Corran P.; Ronca R.; Arcà B.; Riley EM.; Crisanti A.; Drakeley C.; Bousema T.YesReported in texteeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåMultiplexœùï=ržb=»Vp>eeåeeeeeeåeeeeeeåeeeeeeåeeeee@@INCLUDEDeYee{þ?×#BAll agesÚÚò>S"ù>An. Arabiensis; An. Funestus; An. Gambiae€?@@@@!{B6-10 yearsyELISA44 Europeans)Ë ?	?ÐÕ6?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee$X?ázD?TRg?proportion positiveePCRsurveyyesYeseyyeszeKY?í
þ>_˜,?proportion positivemicroscopysurveyyesYesyes~if you subtract PCR from microscopy, we will see how many subclinical infectionseeeåeeååeååeeeåeå2013eeeåeåeåeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchîÁ?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÚ¬j?:#Z?¯”u?proportion seropositivepopulationPfAMA1yesyesyesxŏ‘>ƒ/L>¸¯Ã>proportion seropositivePfMSP1(19)yesyesyesef<½B?ºI,?æ®U?proportion seropositiveePfMSP2yesyesyesuÞ¢>².n>˜ÝÓ>proportion seropositivePfCSPyesyesyeseneeeeeeeåeåeeåeåeåeåeåProietti 20132010Repeated cross sectionalAfricaUgandaAbediHighnsAll ages3; 7; 352-4; 6-9; 27-50509509Age stratified cohort of 509 participantsgSG6recombinant proteinÝParasite immunologyInfluence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda.Proietti C.; Verra F.; Bretscher MT.; Stone W.; Kanoi BN.; Balikagala B.; Egwang TG.; Corran P.; Ronca R.; Arcà B.; Riley EM.; Crisanti A.; Drakeley C.; Bousema T.e@@INCLUDEDeY{þ?×#BAll agesÚÚò>S"ù>An. Arabiensis; An. Funestus; An. Gambiae€?@@@@!¸B>20 yearsuELISA44 Europeans“$?¿?þC:?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÀ>ôý”>_î>proportion positiveePCRsurveyyesYeseyyes€eÔ+å=oƒ=k+6>proportion positivemicroscopysurveyyesYesyes†if you subtract PCR from microscopy, we will see how many subclinical infectionseeeåeeååeååeeeåeå2013eeeåeåeåbH?ÓM2?ã6Z?proportion seropositivepopulationPfAMA1yesyesyeswˆc?¼?óŽ3?proportion seropositivePfMSP1(19)yesyesyesezÅ P?:’;?eª`?proportion seropositiveePfMSP2yesyesyes{–²?8g?J{3?proportion seropositivePfCSPyesyesyeseteeeeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåProietti 20132010Repeated cross sectionalAfricaUgandaAbediHighnsAll ages3; 7; 352-4; 6-9; 27-50509509Age stratified cohort of 509 participantsgSG6recombinant proteinÝParasite immunologyInfluence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda.Proietti C.; Verra F.; Bretscher MT.; Stone W.; Kanoi BN.; Balikagala B.; Egwang TG.; Corran P.; Ronca R.; Arcà B.; Riley EM.; Crisanti A.; Drakeley C.; Bousema T.e@@INCLUDEDeYè<>ó‘>֗s>proporti{þ?×#BAll agessitivepopulationPfAMA1yesyesyesÚÚò>S"ù>An. Arabiensis; An. Funestus; An. Gambiae€?@@Pf@@"=
BAll (Averaged)åeeeeeeeeeeeeåeeåeee®ELISA30 Europeansƒ¢3?Ã',?F;?eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåL‘Ï>ò®>¦¢ð>proportion positiveemicroscopycohortyes: clinicalyesYesyeseååeååeeeåeå06eeeåeåeååeåeåeåeeeeeeeeee{ðANiakharSep-02ښgA:ƒÁåeeeeeeeeeeee=ELISAåƒA>¿ß>eeåeeåeeeåeeeeåeeeeeeåeåeeeeeeeeeeåeåeeåeeeeeåRemoue 20062002Cross-sectionalAfricaSenegalNiakharSeasonalAn. Gambiaechildren21 to 32 months - 6 years4484481200 children 6 weeks-5yearsAn. Gambiae WSEWhole salivaÖTransactions of the Royal Society of Tropical Medicine and HygieneEvaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria.Remoue F.; Cisse B.; Ba F.; Sokhna C.; Herve JP.; Boulanger D.; Simondon F.åe&~>éR>”£”>proportion positivemicroscopyACD+PCDYes and noyesYesyes“eeeåeeåe€@YYNINCLUDEDeNAb levels only; Alternate salivary biomarker<˜gAx8ƒÁChildrenAn. GambiaeeeeeeeåÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@"{BLow bitesitesSep-02åeeeeeeeeeeeeåeeåeeeELISA30 Europeansoƒ<eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå06eeeåeåe帥?Ãõ¨>@bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesåeåeåeåeeeeeeìQpA7yeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåRemoue 20062002Cross-sectionalAfricaSenegalNiakharSeasonalAn. Gambiaechildren21 to 32 months - 6 years4484481200 children 6 weeks-5yearsAn. Gambiae WSEWhole salivaÖTransactions of the Royal Society of Tropical Medicine and HygieneEvaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria.Remoue F.; Cisse B.; Ba F.; Sokhna C.; Herve JP.; Boulanger D.; Simondon F.e€@YYNINCLUDEDeNAb levels only; Alternate salivary biomarker<˜gAx8ƒÁChildrenAn. GambiaeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@"¸BMedium bitessSep-02åeeeeeeeeeeeeåeeåeee2ELISA30 Europeans¶ó}=eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå06eeeåeåeå†A€AŒAbites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesR¸¸AChildren <14 yearsJul-06night	xòEÁïÐXAåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeåeeeeee7ELISA32 French¾Zí?eeåeeeeeåeeeeeeeeåeeeeeeeeåeåeåeåeeeeee{èALow bitesitesSep-0ښgA:ƒÁåeåeåeeåeåeåeåeåRemoue 20062002Cross-sectionalAfricaSenegalNiakharSeasonalAn. Gambiaechildren21 to 32 months - 6 years4484481200 children 6 weeks-5yearsAn. Gambiae WSEWhole salivaÖTransactions of the Royal Society of Tropical Medicine and HygieneEvaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria.Remoue F.; Cisse B.; Ba F.; Sokhna C.; Herve JP.; Boulanger D.; Simondon F.eeeeeeeeeeåeeeeeeeeåeåeeeåeeeeåe€@YYNINCLUDEDeNAb levels onlyeå; Alternate salivary biomarker<˜gAx8ƒÁChildrenAn. GambiaeeeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@"ö(BHigh bitestesSep-02åeeeeeeeeeeeeåeeåeeeuELISA30 Europeans`åÐ=eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå06eeeåeåeå×£øAôAš™ýAbites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesee7ELISA32 French6@eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeeeeeee6ELISAŒäz>!>1tª>eeåeeeåeeåeeeeeeeåeeeeeeåeeeeeeåeeeeeeååeeeeeeåeeee6ELSA‹7™åeeeeeeåeeeeeeåeeeeåeeeeeeeeeeeeeeeåeåeeåeåeåeåeåRemoue 20062002Cross-sectionalAfricaSenegalNiakharSeasonalAn. Gambiaechildren21 to 32 months - 6 years4484481200 children 6 weeks-5yearsAn. Gambiae WSEWhole salivaÖTransactions of the Royal Society of Tropical Medicine and HygieneEvaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria.Remoue F.; Cisse B.; Ba F.; Sokhna C.; Herve JP.; Boulanger D.; Simondon F.eeeeeeeeeeee=ELISAÆb±>§Ói>?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeee€@YYNINCLUDEDeNAb levels onlyeeåeeee; Alternate salivary biomarker<˜gAx8ƒÁChildrenAn. GambiaeÒ/i¬>©À>An. Arabiensis; An. Funestus; An. Gambiae@@@@#=
BBarkoundouba (Fulani)Aug-94ƒELISA42 Europeans¨5?
h?¹ü7??Ž>¬ðe?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeîW
?Më>‘¾ ?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeå®Aö(8AìQBbites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesâKCinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per yearâKCinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYeåø KAé&‘¿All agesAn. GambiaeåÊAn. Arabiensis; An. Funestus; An. Gambiae€@#{BBarkoundouba (Fulani)Oct-949ELISA42 Europeansmç+?¸?!°R?Û'*?&Á®>œÖl?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeI?\BÑ>Ú ,?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåq=rA33A)\¥Abites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyes½õÎCinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per year½õÎCinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeåeeåeåeåeåqAbobo (RT eåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.eeåeeeeeeeåeeeeeeåeeåeeeEllen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYeåø KAé&‘¿All agesAn. Gambiae; An. FunestusÊAn. Arabiensis; An. Funestus; An. Gambiae€@#¸BBarkoundouba (Fulani)Mar-95AELISA42 Europeansð§?w¾ß>¤p=?ØUø>‚]…>Ì
1?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe… ò>/:´>¿P?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeå)\?@\¢?R¸–@bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesÊýW@infectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per yearÊýW@infectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYø KAé&‘¿All agesAn. GambiaeËAn. Arabiensis; An. Funestus; An. Gambiae€@#ö(BBarkoundouba (Fulani)Aug-95uELISA42 Europeans¢E6?ç?NbP?§5?Eõ >¾\?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe{f0?Øÿ?ÌÿE?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeå®GEA33«@33›Abites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesWL€Cinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.q=àANdiopsitive2002ÎÚZAÅ¿‚ÁåeeeeeeeeeeeeÊELISAÞõ³>@’>º«Õ>eeåeeeåeeåeeeegiven as bites/night so multiplied by 365 to give bites per yeareeåeeeeeåeeeeeeeeåWL€Cinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYø KAé&‘¿All agesAn. Gambiae; An. FunestusËAn. Arabiensis; An. Funestus; An. Gambiaee€@#33BBarkoundouba (Fulani)Oct-95ELISA42 EuropeansÕç*?*:?ÞB? ?§µ>•Ip?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe¨ø®>8ù†>Š_Õ>proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeå®Gù@
ד@…/Abites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyespBinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per yearpBinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeå 33BJack HaeoursWet (Mare 1)×åeåeeeeeeeeåex40 Britishsí=×%=D>ÆBeåeeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.åeeeåeeåeeeeeeeåeeeeEllen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYeeeeeeø KAé&‘¿All agesAn. Gambiae; An. FunestusåËAn. Arabiensis; An. Funestus; An. Gambiae€@#q=BBarkoundouba (Fulani)Aug-969ELISA42 EuropeansÆÜ%?$¹ü>z¥L?M‚?¾Ü>Ճ†?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe¼$…>•I>̾¾>proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåÃõh?ìQ¸>{®?bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyes
<Ainfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per year
<Ainfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.ö(AAbbo (RDT ps)ciene2011XØ­@¯>Àååeeeeåeeeee#Metiple’ê<kŽ =
BJåDry (Sept 16)×Á;0Cåeåeeeeeeeeeeeeltiplex40 BritishÕg]=¨û%;ê7Ø=€BBB½eeåeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeåeeeeeeeeeååeeeeeeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.åEllen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYø KAé&‘¿All agesAn. Gambiae; An. FunestusÌAn. Arabiensis; An. Funestus; An. Gambiae€@#®GBBarkoundouba (Fulani)Oct-96ŽELISA42 Europeans;p>?‚â'?U?ú[?éXÊ>,eR?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeUƒö>¶É>µ?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeå®ç?ìQ¸=…ëa@bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyes_§\Ainfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per year_§\Ainfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.eeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeåeeåeeeååeeeeeeåeeeeeåeeeeåeeeeeeeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYø KAé&‘¿All agesAn. Gambiae; An. FunestusÌAn. Arabiensis; An. Funestus; An. Gambiae€@#ìQBBarkoumbilen (Mossi)Aug-94ÍELISA42 EuropeansÙ®>¥N€>ˆcÝ>ž¿Å>B#o>Z³=?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeì$K?V‹=?ÙWZ?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåÈ@R¸–@®Gù@bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesáaCinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per yearáaCinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.ښgA:ƒÁååeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeY.JAú`›¿All agesAn. GambiaeÊAn. Arabiensis; An. Funestus; An. Gambiae€@#)\BBarkoumbilen (Mossi)Oct-94†ELISA42 EuropeansÁ¨?aÃó>`v/?ØUø>ú[œ>­Ù>?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe
¡h?g:Z?„ t?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåÍÌ@AA33Abites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesRfDinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.eeeeeeeeeeee=ELISAÆb±>§Ói>?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåegiven as bites/night so multiplied by 365 to give bites per yearåeeåRfDinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.ååEllen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeY.JAú`›¿All agesAn. Gambiae; An. FunestusÊAn. Arabiensis; An. Funestus; An. Gambiaee€@#ffBBarkoumbilen (Mossi)Mar-95bELISA42 Europeans•>®¶">ǺØ>sCŒ>qZ3>¥Ì>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeqPE?ݶ/?¾Z?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåìQ¸>ìQ¸=®G!?bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyes¶Z@infectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per year¶Z@infectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeY.JAú`›¿All agesAn. Gambiae10 ËAn. Arabiensis; An. Funestus; An. Gambiae€@#¤pBBarkoumbilen (Mossi)Aug-95ýELISA42 Europeans$(Þ>˜Ý³>æ??÷‰ê>݃>­Ù>?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe>3U?ufH?@ÿa?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåR¸Ö@\‚@
×Abites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesQQ¬Binfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per yearQQ¬Binfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåAug-05exwAÍeeeeeeeeeeeeeeeeeåeeåeeeeeeeåeeeeee7ELISA32 FrenchîÁ?eeåeeeeeåeeeeeeeeåeeeåeeååeeåeeeeeeåeeeeeeåeeeeåeeeeeåeeeeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeY/L>¸¯Ã>proportion seropositivPfMSP1(19)yesy.JAú`›¿All agesAn. Gambiae; An. FunestuseeeËAn. Arabiensis; An. Funestus; An. Gambiae€@#ázBBarkoumbilen (Mossi)Oct-95¯ELISA42 Europeans3Ä!?ì/?ìQ8?~¢ú>¾Ü>9?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåes¯&?D|?‘9?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeå®Ç…BR¸–@ÃõAbites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesÅ2Binfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per yearÅ2Binfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.åeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.eeeeeeeEllen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYeeeå.JAú`›¿All agesAn. Gambiae; An. Funestusn seropositËAn. Arabiensis; An. Funestus; An. Gambiaertion serop€@#…BBarkoumbilen (Mossi)Aug-96HELISA42 Europeans~Ø>ŒŠ>óŽ?aWá>7Ā>Ā4?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe—+4?á+?Ã^O?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåìQ8>bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.given as bites/night so multiplied by 365 to give bites per yearinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.eeeåeå )\BAll (Averaged)arååeåeeeeeeeeeeeeÜMultiplå½kå=¸=¹l>eeåeeåeeåeeeeeåeeeeeeåeeeeeåeeåeeeeeåeåeeåeåeåeå"{BowbitesieseåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.Ellen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeY.JAú`›¿All agesAn. Gambiae; An. FunestusÌAn. Arabiensis; An. Funestus; An. Gambiae€@#\BBarkoumbilen (Mossi)Oct-96iELISA42 Europeansåò¿>#J{>Üh?pqÚ>(ª‡>ú[?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe5Û4?K¨?†tJ?proportion positivemicroscopysurveyyesYesyesåeeeåeeååeååeeeåeå1eeeåeåeåìQ8>bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesyesinfectious bites/person/yearpopulationPf pos bitespyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.eeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeåeeeeeeåeegiven as bites/night so multiplied by 365 to give bites per yearinfectious bites/person/yearpopulationpyrethrum spray catchesyesYesNoModiano, D., Petrarca, V., Sirima, B.S., Nebie, I., Luoni, G., Esposito, F. and Coluzzi, M., 1998. Baseline immunity of the population and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.eeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeåeåeåeåeeeeeeeeeåeeåeee2ELISA30 Europeans¶ó}=eeåeeeeeeeåeeeeeeåeeååeeåeeeeeeeååeeeåeeeeeeeååeåeeeeeeåeeeeeeåeåeeåeeeeeeåeeeeeeeåRizzo 20111994-1996Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemicAn. Gambiae + An. Funestusall agesAges are provided for each sample, 2066gSG6recombinant proteinÛPloS oneHumoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.Rizzo C.; Ronca R.; Fiorentino G.; Verra F.; Mangano V.; Poinsignon A.; Sirima SB.; Nèbiè I.; Lombardo F.; Remoue F.; Coluzzi M.; Petrarca V.; Modiano D.; Arcà B.ååeeEllen Kearney (2020-08-04 12:11:22)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; Ellen Kearney (2020-07-28 16:39:27)(Select): Ask someone to check wording of including the responders (does this mean seronegative individuals are excluded). Also compare against other Rizzo study to see what info is different.; e`AYYNINCLUDEDeYå.JAú`›¿All agesAn. Gambiae; An. FunestusÌAn. Arabiensis; An. Funestus; An. GambiaeBMedium b€@$=
BBarkoumbilensAug-94tELISA48 RomaneeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeetELISA48 RomanEû>ÙèË>Ø%?
¡’>&`p>õdü>eeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå1eeeåeåeå‘jÌ@w"¾@²Ú@bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilenHyperendemic; seasonalAn. Gambiae (75%) all ages335335gSG6; fSG6recombinant proteinÛMalaria journalWide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa.Rizzo C.; Ronca R.; Fiorentino G.; Mangano VD.; Sirima SB.; Nèbiè I.; Petrarca V.; Modiano D.; Arcà B.eeeåEllen Kearney (2020-08-04 12:08:08)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; e@@YYNINCLUDEDeNAlternate salivary antigen.JAú`›¿All agesAn. GambiaeÊAn. Arabiensis; An. Funestus; An. Gambiae€@${BBarkoumbilensOct-94kELISA48 RomaneeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeekELISA48 Roman×ä?7|×>tE?X[ä>Æo—>Ë{5?eeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå1eeeåeåeåùíJAyª1AÑJeAbites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilenHyperendemic; seasonalAn. Gambiae (75%) all ages335335gSG6; fSG6recombinant proteinÛMalaria journalWide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa.Rizzo C.; Ronca R.; Fiorentino G.; Mangano VD.; Sirima SB.; Nèbiè I.; Petrarca V.; Modiano D.; Arcà B.eeELISA30 Europeansoƒ<eeåeeeeeeeåeeeeeeåeeåeeeEllen Kearney (2020-08-04 12:08:08)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; åeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeee@@YYNINCLUDEDeNAlternate salivary antigen.JAú`›¿All agesAn. Gambiae; An. FunestusÊAn. Arabiensis; An. Funestus; An. Gambiae€@$¸BBarkoumbilensMar-95gELISA48 Roman*é>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeegELISA48 Roman#¢>%k>‚$Ò>NC¨>´Âf><–÷>eeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå1eeeåeåeå+Ñ>€?bites/person/nightAn. Gambiae bitespyrethrum spray catchesyesYesåeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20111994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilenHyperendemic; seasonalAn. Gambiae (75%) all ages335335gSG6; fSG6recombinant proteinÛMalaria journalWide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa.Rizzo C.; Ronca R.; Fiorentino G.; Mangano VD.; Sirima SB.; Nèbiè I.; Petrarca V.; Modiano D.; Arcà B.ååeeeEllen Kearney (2020-08-04 12:08:08)(Select): Analyse the biting rates of the two villages for the mossi/fulani groups, and check references for paper describing other malarial antigens; åe@@YYNINCLUDEDeNAlternate salivary antigene.JAú`›¿All agesAn. GambiaeËAn. Arabiensis; An. Funestus; An. Gambiae€@%=
BBarkoumbilen (Ramaibe)Aug-94åeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeuELISA59 romanpFw?ÎAo?‹Ó?üî>‡òš>ÆtV?eeÏELISA59 romaneeeä¢HA™,±@çAeeÏELISA59 romaneeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeåš™É@ff†@š™ù@bites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesyes ìQBTuguiviliitesWet (March 17)4Á97CåeeeeeeeeeetMultile40Bitisha¹'>o„Å=Š°l>üB¬B€=CeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeåeåeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilenHyperendemic; seasonalAn. Gambiae (75%) All ages1 to 71359gSG6; cE5recombinant proteinÞParasites & vectorsDifferential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors.Rizzo C.; Lombardo F.; Ronca R.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Modiano D.; Arcà B.e@@YYNINCLUDEDeNAlternate salivary antigen.JAú`›¿All agesAn. GambiaeÊAn. Arabiensis; An. Funestus; An. Gambiaeus bites/pe€@%{BBarkoumbilen (Ramaibe)Oct-94åeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeyELISA59 roman¦|h?Ô[?£bv?ÓY?å5”>	îc?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeåš™AAffÖ@ŒAbites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesyes½kå=䁸=¹l>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeR¸¸AChildren <14 yearsJul-06night	xòEÁïÐXAåeeeeeeeeeååeeåeeeåeåeeåeeeeeeåeeeee7ELISA32 Frenchåeeåeeeeeåeeeeeeeeåeeeeeeeeeeeeeåeåeåeeåeåeåq=àAdieå2002ÎÚZÅ¿‚ÁåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilenHyperendemic; seasonalAn. Gambiae (75%) All ages1 to 71359gSG6; cE5recombinant proteinÞParasites & vectorsDifferential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors.Rizzo C.; Lombardo F.; Ronca R.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Modiano D.; Arcà B.and impact of insecticide-treated curtains on malaria infection. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.e@@YYNINCLUDEDeNAlternate salivary antigengivn as bites/night so multiplied .JAú`›¿All agesAn. Gambiae; An. FunestusÊAn. Arabiensis; An. Funestus; An. Gambiaectious bite€@%¸BBarkoumbilen (Ramaibe)Mar-95åeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeyELISA59 roman‰te?á X?§âs?ÜGð>½†r>l(o?eeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeåÍÌÌ>ÍÌL>š™?bites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesyes#=
BBarkoundouba (Fulani)Aug-94ø KAé&‘¿ƒELISA42 Europeans¨5?
h?¹ü7??Ž>ðe?eeeeeeeeeeååeåeeeåeåeeeeeeeåeeeeeeååeåeeeeåeåeeeeeåeeeeeeeeeeeeeeeåeåeeåeåeåeåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilenHyperendemic; seasonalAn. Gambiae (75%) All ages1 to 71359gSG6; cE5recombinant proteinÞParasites & vectorsDifferential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors.Rizzo C.; Lombardo F.; Ronca R.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Modiano D.; Arcà B. The American journal of tropical medicine and hygiene, 59(2), pp.336-340.ښgA:ƒÁååe@@YYNINCLUDEDeNAlternate salivary antigene.JAú`›¿All agesAn. GambiaeåËAn. Arabiensis; An. Funestus; An. Gambiae€@&=
BBarkoumbilen (Mossi)htAug-94å<ELISA44 romaneee
×7AìQx@Â§Aee<ELISA44 romaneee…ë±@Ház?\ÂAeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeåÈ@R¸–@®Gù@bites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesnoRizzo 2011 Plos Oneeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeö(AAbobo (RDT pos)cidence2011XØ­@¯>Àååeeåeeeeeee#Multieexå’ê<kŽ =
BJck HarbousDry (ep 1eåeåeeeeeeeeåJMultiplex40 BritishÕ]=û%;ê7Ø=€eåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemic; seasonalAn. Gambiae (75%) All ages270270gSG6recombinant proteinÞPloS oneIgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.Rizzo C.; Ronca R.; Lombardo F.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Troye-Blomberg M.; Modiano D.; Arcà B.eåeå1eeeåeeÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarker.JAú`›¿All agesAn. GambiaeÊAn. Arabiensis; An. Funestus; An. Gambiae€@&{BBarkoumbilen (Mossi)htOct-94å?ELISA44 romaneeeÍÌ<A®‡@q=Bee?ELISA44 romaneeeAš™¹?ázYBeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeåÍÌ@AA33Abites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesnoRizzo 2011 Plos Oneåeåeåeåeeeeeee#ìQBBarkoumbilen (Mossi)Aug-94.JAú`›¿ÍELISA42 EuropeansÙ®>¥N€>ˆcÝ>ž¿Å>B#o>Z³=?eåeeeeeeeåeeeååeeåeåeeeeeeeåeeeeåeåeeåeeeeåeåeeeeeeåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemic; seasonalAn. Gambiae (75%) All ages270270gSG6recombinant proteinÞPloS oneIgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.Rizzo C.; Ronca R.; Lombardo F.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Troye-Blomberg M.; Modiano D.; Arcà B.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarker.JAú`›¿All agesAn. Gambiae; An. Funestus#ö(ÊAn. Arabiensis; An. Funestus; An. Gambiae¢E6?ç?€@&¸BBarkoumbilen (Mossi)htMar-95å8ELISA44 romaneee…ëa@®Ç@ee8ELISA44 romaneee)\?š™±@eeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeåìQ¸>ìQ¸=®G!?bites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesnoRizzo 2011 Plos One"{BLow bitesitesSep-02<˜gAx8ƒÁåeeeeeeeeeeeeåeeåeeeELISA30 Europeansoƒ<eeåeeåeeeeeåeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeåeeeeeeåeeeeåeåeåeåeeeeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemic; seasonalAn. Gambiae (75%) All ages270270gSG6recombinant proteinÞPloS oneIgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.Rizzo C.; Ronca R.; Lombardo F.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Troye-Blomberg M.; Modiano D.; Arcà B.eeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarker.JAú`›¿All agesAn. GambiaeËAn. Arabiensis; An. Funestus; An. Gambiae€@&ö(BBarkoundouba (Fulani)tAug-94åELISA44 romaneeeHá"Aq=
@ìQØAeeELISA44 romaneee…ë‰A)\?@
×kBeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeå®Aö(8AìQBbites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesnoRizzo 2011 Plos OneeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemic; seasonalAn. Gambiae (75%) All ages270270gSG6recombinant proteinÞPloS oneIgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.Rizzo C.; Ronca R.; Lombardo F.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Troye-Blomberg M.; Modiano D.; Arcà B.åeåeeåeåeåeå"{BowbitesieseåeÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkerø KAé&‘¿All agesAn. GambiaeÊAn. Arabiensis; An. Funestus; An. Gambiae€@&33BBarkoundouba (Fulani)tOct-94å ELISA44 romaneee…ë-AÂõ>š™³Aee ELISA44 romaneee…CB=
×>š™ÙBeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeåq=rA33A)\¥Abites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesnoRizzo 2011 Plos OneåeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemic; seasonalAn. Gambiae (75%) All ages270270gSG6recombinant proteinÞPloS oneIgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.Rizzo C.; Ronca R.; Lombardo F.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Troye-Blomberg M.; Modiano D.; Arcà B.eeeåeeååeÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkerø KAé&‘¿All agesAn. Gambiae; An. FunestushtÊAn. Arabiensis; An. Funestus; An. Gambiaes€@&q=BBarkoundouba (Fulani)tMar-95åELISA44 romaneee×£,A333?33£AeeELISA44 romaneeeHážAš™É@33kBeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå4eeeåeåeå)\?@\¢?R¸–@bites/person/nightAnopheline bites per nightpyrethrum spray catchesyesYesnoRizzo 2011 Plos OneåeåeåeåeeeeeeeåeåeeåeåeåeåeåRizzo 20141994-1995Repeated cross sectionalAfricaBurkina FasoBarkoumbilen; BarkoundoubaHyperendemic; seasonalAn. Gambiae (75%) All ages270270gSG6recombinant proteinÞPloS oneIgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.Rizzo C.; Ronca R.; Lombardo F.; Mangano V.; Sirima SB.; Nèbiè I.; Fiorentino G.; Troye-Blomberg M.; Modiano D.; Arcà B.eÀ@YYNINCLUDEDeNAb levels only; Alternate salivary biomarkerø KAé&‘¿All agesAn. Gambiae_§\AinfectiouËAn. Arabiensis; An. Funestus; An. Gambiaeyes€@'=
BEhania-V1Dec-13åeeeeeeeeeeeedELISAd±g>Å->â[—>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeå)Oct-94.JAú`›¿†ELISA42 EuropeansÁ¨?aÃó>`v/?ØUø>ú[œ>­Ù>?eeeeeeeeeeeeåeeåeeeeeåeeeeeeeeeeeeeååeeåeeeeeåeeeeeeeåeåeeeåeeeeåeeeeeeeeåeeeeeeeeeeeeåeeeeeeåeeeeeeeåeåeeåeåeåeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, Franckå4eeeåeåeeAYYNINCLUDEDeNAb levels onlyson/nightAnopheline bites per nigÝx§@1ÀChildrenAn. GambiaeÅ2BinfecݹN>6|> An. Funestus; An. Gambiaethrum spray cat@@D., Petrarc@@'{BEhania-V5Dec-13åeeeeeeeeeeeeQELISA
›>O	r>lÁ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeå#ö(BBarkoundouba (Fulani)Aug-95ø KAé&‘¿uELISA42 Europeans¢E6?ç?NbP?§5?Eõ >¾\?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeåeeeeeåeeeeeeeeåeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeååeeeeeeåeeeeeeeåeeåeeeeeeåeeeeeåeåeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, FranckåeåeeAYYNINCLUDEDeNAb levels only'Ú©@A}<ÀChildrenAn. GambiaeeåÝ%¯n>ã6Š> An. Funestus; An. Gambiae@@ee@@'¸BN'zikroDec-13åeeeeeeeeeeeecELISA¥Oz>~9>ýc¬>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, FranckeåeeåeåeåeåqAbobo (RT eåeAYYNINCLUDEDeNAb levels onlyI ¬@FÐYÀChildrenAn. GambiaeÝÔñx>`>An. Arabiensis; An. Funestus; An. Gambiae@@@@'ö(BAyébo Dec-13åeeeeeeeeeeeedELISAÖ¹ò=«–n=φ:>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeååeåeåeåeeeeeeeåeåeeå$BBaroumbileneå.JAú`›¿gELISA48 oman1Å>ϓeå>eeeeeeeåeeeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, FranckeAYYNINCLUDEDeNAb levels only{BBarkoumbilensOct-8®@QÀChildrenAn. GambiaeELISA48 RomanÝF…>R~’>An. Arabiensis; An. Funestus; An. Gambiae@@eee@@'33BEhania-V1Jul-14åeeeeeeeeeeeebELISAHn>Ô='>Ž>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeååeåeåeåeeeeeeeuELISA59 romanpFw?ÎAo?‹Ó?üî>‡òš>ÆtV?eeÏELISA59 romaneeeä¢HA™,±@çAeeÏELISA59 romaneeeeeåeeeeeeeeåeåeeeeeåeeeeeeeåeeeeåeeeeeeåeeeeeeeåeåeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, FranckeAYYNINCLUDEDeNAb levels onlyÝx§@1ÀChildrenAn. GambiaeÞ%/>‚Åa> An. Funestus; An. Gambiae@@@@'q=BEhania-V5Jul-14åeeeeeeeeeeeebELISA^|š>5j>¶Óñ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeå#)\BBarkoumbilen (Mossi)Oct-94.JAú`›¿†ELISA42 EuropeansÁ¨?aÃó>`v/?ØUø>ú[œ>­Ù>?eeeeeeeeDry (Sept 16)y¶Á‘ÆCåeeeeeeeeeeeecMultiplex40 British>x=¢á^<ØaÜ=ÃB‰BCeeåeeeåeeåeeeeeeeeeeeeååeeåeeeeåeeeeeeeåeåeeåeeeeeåeeeeeeeeeåeeeeeeeeeeeåeeeeeåeeeeeeeåeåeeåeåeåeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, Franckgiven as bites/night so eAYYNINCLUDEDeNAb levels onlyar'Ú©@A}<ÀChildrenAn. GambiaeÞœPH>ãˆu> An. Funestus; An. Gambiae@@@@'®GBN'zikroJul-14åeeeeeeeeeeeeeELISA†o>,h$>Lñ–>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeå#ffBBarkoumbilen (Mossi)Mar-95.JAú`›¿bELISA42 Europeans•>®¶">ǺØ>sCŒ>qZ3>¥Ì>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeåeeeeeeåeåeåeåeBakoeeOct-94.JAe›¿EISeenv
?‰óã>ó"?æ½Ú
¡’>å=?eeeeåeåeeåeåeåeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, Franckp>õdü>eeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeAYYNINCLUDEDeNAb levels onlyI ¬@FÐYÀChildrenAn. Gambiaepyrethrum spray catchesÞۅf>Ž;…>An. Arabiensis; An. Funestus; An. Gambiae@@@@'ìQBAyébo Jul-14åeeeeeeeeeeeebELISAW@>‡;ð=躍>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåou 20eeeåeåeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeegELISA48 Roman$Ò>NC¨>´Âf><–÷>eeeeåeeeåeåeeåeeeeeeeeeeeåeeeååeeeeeeåeeeeeeåeeeeeeeåeåeeåeåeåeåeåSadia-Kacou 20192013-2014Repeated cross sectionalAfricaCote d'IvoireN'Zikro; Ayebo; Ehania-V5; Ehania-V1An. GambiaeChildren1 to 14775775gSG6-P1peptideãParasite Epidemiol ControlUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to &lt;i&gt;Anopheles&lt;/i&gt; bites in children living near rubber and oil palm cultivations in Côte d&#039;Ivoire.Sadia-Kacou, Cécile Agnimou Malanfoua; Yobo, Céline Mabot; Adja, Maurice Akré; Sagna, André Barembaye; Ndille, Emmanuel Elanga; Poinsignon, Anne; Tano, Yao; Koudou, Benjamin Guibehi; Remoue, FranckåeeAYYNINCLUDEDeNAb levels only8®@QÀChildrenAn. GambiaeÞuås>‰>An. Arabiensis; An. Funestus; An. Gambiae@@eeå@@)=
$BAgniamOct-08åeeeeeeeeeeee)ELISAí
N?qm?i/?jS¡>;Àl>wñÄ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe#Ûù=ꕲ<fˆc>proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeå…ëAbites/person/nightHLCyesYesyes$=
BBarkoumbilesAug-94.JAú`¿tELS48 Roman¦t?à·Ý>b›?9
¡>^êI>™ýù>eeeeeeeeeeeeåeeåeeeåeeeeeeeeeeeeeååeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseeåeåeeeeeeeåeeeeåeåeeåeeeeåeåeeeeeeåeåeÈAINCLUDEDeYÿ1„AQ8lÁChildrenAn. GambiaeØ ¦–=Îp>#An. Arabiensis€?€?@){$BAgniamJan-09åeeeeeeeeeeee)ELISAÙ®>¾0ù>ÞI>o›ÿ=
¼=õ›S>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe®G>t$—=.ÿ¡>proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeåbites/person/nightHLCyesYesyesóã>ó"?æ½Ú>
¡’>å=?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeekELISA48 Roman×ä?7|×>tE?X[ä>Æo—>Ë{5?eeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseÈAINCLUDEDeYÿ1„AQ8lÁChildrenAn. GambiaeeÙâe=o*Ò=#An. Arabiensis€?€?e@)¸$BAgniamJun-09åeeeeeeeeeeee)ELISAÆܕ>/Ý>ä>ýñ>
¼=ÁÀ@>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe9´H=Õçê=proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeå)\Ï?bites/person/nightHLCyesYesyesåeåeåeåeeeeeeeeeeeeeeeeeeedELISAd±g>Å->â[—>eeåeeeåeeåeeeeåeeeeeeåeåeeåeeeeeeåeåeeeeåeeeåeåeeåeeeeeåeeeeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GillesåeåeåeåeeÈAINCLUDEDeYeeeÿ1„AQ8lÁChildrenAn. GambiaeÙâe=o*Ò=#An. Arabiensis€?€?@)ö($BAgniamOct-09åeeeeeeeeeeee)ELISAtFT?ÁÊq?BÏ6?Ú_Œ>šƒQ>1Í«>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeproportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeåHAbites/person/nightHLCyesYesyeseeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeåeeeeeåeåBBarkoundouba (Fulani)eAug-9ø KAé&‘¿ååLISA4 romaneeHá"Aq=
ìQeåaneee…ë‰A)\?@
×kBeeåeeeeeeeeeåeeeååeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GillesåeeÈAINCLUDEDeYÿ1„AQ8lÁChildrenAn. GambiaeISA44 romaneee…ë-AÂõ>š™³Ùâe=o*Ò=#An. Arabiensis×>š™ÙBeeå€?€?@)33$BAgniamJan-10åeeeeeeeeeeee)ELISA#Ûy>R'À>ffæ=o›ÿ=Ɇ=ùF6>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe¦›Ä<£’=proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeå?bites/person/nightHLCyesYesyeseeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeåeeeeeeååeeåeeeeeeeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseÈAINCLUDEDeYÿ1„AQ8lÁChildrenAn. GambiaeåeÚš|3=ò$©=#An. Arabiensis€?€?@)q=$BNiandaneOct-08åeeeeeeeeeeeeGELISAíž?q=*?ÒÞ>åë0>Á>øy›>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåebX>².î=[Ӝ>proportion positiveMicroscopysurveyyesYesyesGeeeåeeååeååeeeåeå3eeeåeåeå…ë]Abites/person/nightHLCyesYesyes&=
BBarkoumbilen (Moss)htAug-94.JAú`›¿å<ELISA44 romaneee
×7AìQx@Â§Aee<ELISA44 romaneee…ë±@Ház?\ÂAeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseÈAINCLUDEDeY¦À„AdÔoÁChildrenAn. GambiaeØ`¼=àg>!An. Gambiae€?€?@)®G$BNiandaneJan-09åeeeeeeeeeeeeGELISAÐDX>[Ӝ>².î=«>j«<sÖ >eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeÂu>`v>j­>proportion positiveMicroscopysurveyyesYesyesGeeeåeeååeååeeeåeå3eeeåeåeåR¸?bites/person/nightHLCyesYesyeseeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GillesåeåeåeÈAINCLUDEDeYeåeee¦À„AdÔoÁChildrenAn. GambiaeÙ
ý“=o>!An. Gambiae€?€?@)ìQ$BNiandaneJun-09åeeeeeeeeeeeeGELISAZd;>`å>Év¾=2åë=«€<ï2&>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe1,=z¶=proportion positiveMicroscopysurveyyesYesyesGeeeåeeååeååeeeåeå3eeeåeåeåÀ?bites/person/nightHLCyesYesyesåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeÈAINCLUDEDeY¦À„AdÔoÁChildrenAn. GambiaeÙ
ý“=o>!An. Gambiae€?€?@))\$BNiandaneOct-09åeeeeeeeeeeeeGELISAV­>B`å>Õxi>>}=WA>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe1,=z¶=proportion positiveMicroscopysurveyyesYesyesGeeeåeeååeååeeeåeå3eeeåeåeå…ë1Abites/person/nightHLCyesYesyesåeåeeåeeeeeeåeåeeåeeeeeeåeeeeeåeåeeeeeeeeeeeeeeåeeeeeeeeåeeeeeeeeåeeååeeåeeeeeeeåeeåeeeeeeeåeeeeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseÈAINCLUDEDeY){$BAgniam¦À„AdÔoÁChildrenAn. GambiaeÙ
ý“=o>!An. Gambiae€?€?@)ff$BNiandaneJan-10åeeeeeeeeeeeeGELISAà->Sc>´Yu=aH¶=DsÖ<†d>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeproportion positiveMicroscopysurveyyesYesyesGeeeåeeååeååeeeåeå3eeeåeåeåbites/person/nightHLCyesYesyesåeåeåeåeeeeeeeeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeegELISA48 Roman#¢>%k>‚$Ò>NC¨>åeeåeeeeeååeåeåeeåeeeeeåeeeåeeeeeeåeeeeeeeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, Gilleså3eeeåeåeåAbites/person/nightHLCyesYesyeseÈAINCLUDEDeY¦À„AdÔoÁChildrenAn. GambiaeÚmâd=)\Ï=!An. Gambiae€?€?@)¤p$BPendaoOct-08åeeeeeeeeeeee%ELISA¥½Á>â?/nc>/§ >ë=@>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe/]=J>proportion positiveMicroscopysurveyyesYesyes%eeeåeeååeååeeeåeå3eeeåeåeåAbites/person/nightHLCyesYesyes'=
BEhania-V1Dec-13Ýx§@1ÀåeeeeeeeeeeeedELISAd±gÅ->â[—>eeåeeeåeeåeeeeeeeåeeeeeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeee-V5Jul-1Ú©@A}Àååeeeeeeeeeeeåe^|š>5j>¶Óñ>eeåeåeeåeeåeååeeeeeeåeeeeåeeeeeåeeeeeeeåe({ BAllopyJun-09åeåeeeeeeeåee6ELISA12 renchê	>²eåeeåeeåeåeeeeeeeeåeeåeåeeeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseåeåeåeÈAINCLUDEDeYèóƒAÇ´pÁChildrenAn. GambiaeØ—ÿÐ=t{)>@@@@)áz$BPendaoJan-09åeeeeeeeeeeee%ELISAl	y>ÜFÃ>=
×=ƒ—Ó=}h,=²>4>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeTã%>3Ä1=;ߏ>proportion positiveMicroscopysurveyyesYesyes%eeeåeeååeååeeeåeå3eeeåeåeåR¸^?bites/person/nightHLCyesYesyeseeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, Gilleseeåeeeeeeeåeproportion positeÈAINCLUDEDeYurveyyesYsyesèóƒAÇ´pÁChildrenAn. GambiaeÙâ¥=h‘
>d±g>Å->â[—>eeåe€?€?@)…$BPendaoJun-09åeeeeeeeeeeee%ELISAˆcÝ=a2U>o<NÁË=­
=x9>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe/Ý<œ3¢=proportion positiveMicroscopysurveyyesYesyes%eeeåeeååeååeeeåeå3eeeåeåeå`@bites/person/nightHLCyesYesyesåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, Gilles'=
BEhania-V1Dec-13Ýx§@1ÀåeÈAINCLUDEDeYeeeeeeeeeeèóƒAÇ´pÁChildrenAn. GambiaeÙâ¥=h‘
>å€?€?@)\$BPendaoOct-09åeeeeeeeeeeee%ELISA¦
¦>O@ó>jÞ1>Çú>NÁK=·m[>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeproportion positiveMicroscopysurveyyesYesyes%eeeåeeååeååeeeåeå3eeeåeåeåR¸^?bites/person/nightHLCyesYesyesåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseÈAINCLUDEDeYèóƒAÇ´pÁChildrenAn. GambiaeÙâ¥=h‘
>€?€?@)š™$BPendaoJan-10åeeeeeeeeeeee%ELISA¦=(->æ¼=}h,=ûÐ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeproportion positiveMicroscopysurveyyesYesyes%eeeåeeååeååeeeåeå3eeeåeåeåR¸?bites/person/nightHLCyesYesyes'q=BEhania-V5Jul-14'Ú@åeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GillesåeeÈAINCLUDEDeYèóƒAÇ´pÁChildrenAn. GambiaeÚñ)€=P6å=€?€?@)×£$BGuedeyOct-08åeeeeeeeeeeee)ELISAKÈÇ>¬
?Ûù~>Ú_>1Í«=ñðp>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe®Ç=‰ÒÞ;îë@>proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeå
×ã@bites/person/nightHLCyesYesyes'®GBN'zikroJul-14I ¬@FÐYÀåeeeeeeeeeeeeeELISA†o>,h$>Lñ–>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeeeåeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, Gilles)33$BAgniamJan-10ÿ1„AQ8lÁåeeeeeeeeeÈAINCLUDEDeY#Ûy>R'À>ffæ=o›ÿ=Ɇ=ùF6>eeåÓ}„AQ¿lÁChildrenAn. GambiaeتHÅ=Xâ!>#An. Arabiensis€?€?@)®$BGuedeyJan-09åeeeeeeeeeeee)ELISAâé•=šw>{œ§=T_¸<É>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeÓM¢>ä2>–Cë>proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeåbites/person/nightHLCyesYesyeseeåeeeeeeåeeeeeeåeeeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeå&=Bareåi)htAug-94.Aú`›¿åeå<LIA44 romneeå<ELISA44 romaneee…ë±@Hz?\ÂAeeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeÈAINCLUDEDeYåeÓ}„AQ¿lÁChildrenAn. GambiaeQ8lÁåÙŽ#–=Õ[>#An. Arabiensise€?€?eee@)R¸$BGuedeyJun-09åeeeeeeeeeeee)ELISAœÄ`> A±>í
¾=P´Õ=ߧê<1Í+>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe•=ё>proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeå€>bites/person/nightHLCyesYesyes)ö($BAgniamOct-09ÿ1„AQ8lÁåeeeeeeeeeee)tFT?Êq?BÏ?ڌ>šƒQ>1«>eåeeåeeåeeeeeeåeeeåeeeåeeeeeåeeeeeeeeåeåeeeeeeeeeåeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GillesåeåeåeåeeeeeeeÈAINCLUDEDeYeÓ}„AQ¿lÁChildrenAn. GambiaeÙŽ#–=Õ[>#An. Arabiensis€?€?@)Â$BGuedeyOct-09åeeeeeeeeeeee)ELISAœÄà>9E?Åþ’>$/>{œ'=P´U>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeproportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeå…ëAbites/person/nightHLCyesYesyeseeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåaneOct-9¦À„AdoÁeåeeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseÈAINCLUDEDeYÓ}„AQ¿lÁChildrenAn. GambiaeÙŽ#–=Õ[>#An. Arabiensis€?€?@)ÍÌ$BGuedeyJan-10åeeeeeeeeeeee)ELISAµ¦ù=fˆc>ꕲ<šƒÑ=L	s=¢Ù>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe9´H=Õçê=proportion positiveMicroscopysurveyyesYesyes)eeeåeeååeååeeeåeå3eeeåeåeåà?bites/person/nightHLCyesYesyes){$BAgniamJan-09ÿ1„AQ8lÁåeeeeeeeeeeee)ELSAÙ®>¾0ù>ÞI>o›ÿ=
=õ›S>eeåeåeåeåeåeeeeeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeåeeeeeåeeeeåeåeeåeeeeeåeeeeeåeeeeeeåeeeeeåeåeeeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, Gilles&33BBarkoundouba (FueÈAINCLUDEDeYKAé&‘¿åÓ}„AQ¿lÁChildrenAn. GambiaeeeåÚ&j=ðPÔ=#An. Arabiensiseeåeeeee€?€?eeå@)
×$BFanayeOct-08åeeeeeeeeeeeeKELISA¿=ë">®Gá<eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe
×#>¡g³=¦›„>proportion positiveMicroscopysurveyyesYesyesKeeeåeeååeååeeeåeå3eeeåeåeå0@bites/person/nightHLCyesYesyes)¸$BAgniamJun-09ÿ1„AQ8lÁåeeeeeeeeeeee)ELISAÆܕ>/Ý>ä>ýñ>
¼=ÁÀ@>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, Gilleså3eeeåeåeåR¸?bites/person/nightHLCyeseÈAINCLUDEDeYªF„Aï©sÁChildrenAn. GambiaeØYÀ„=Ë-í=#An. Arabiensis€?€?e@)Há$BFanayeJan-09åeeeeeeeeeeeeKELISA,"É;eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeî|?>^ºÉ=±¿Œ>proportion positiveMicroscopysurveyyesYesyesKeeeåeeååeååeeeåeå3eeeåeåeåbites/person/nightHLCyesYesyesåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseÈAINCLUDEDeYªF„Aï©sÁChildrenAn. GambiaeååeeÙ¤SW=‚sÆ=#An. Arabiensis€?€?@)…ë$BFanayeJun-09åeeeeeeeeeeeeKELISA>èY<. =¢Ù–<eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe/Ý<o=proportion positiveMicroscopysurveyyesYesyesKeeeåeeååeååeeeåeå3eeeåeåeå@?bites/person/nightHLCyesYesyesåeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GillesåeeÈAINCLUDEDeYªF„Aï©sÁChildrenAn. GambiaeÙ¤SW=‚sÆ=#An. Arabiensis€?€?@)Ãõ$BFanayeOct-09åeeeeeeeeeeeeKELISA,"É;eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeôýT<. =proportion positiveMicroscopysurveyyesYesyesKeeeåeeååeååeeeåeå3eeeåeåeå®w@bites/person/nightHLCyesYesyesåeåeåeåeeeeeeq=BBarkondouba (Fula)¤p$BPendaoectåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, GilleseåeåeÈAINCLUDEDeYªF„Aï©sÁChildrenAn. GambiaeÙ¤SW=‚sÆ=#An. Arabiensis€?€?@)%BFanayeJan-10åeeeeeeeeeeeeKELISA>èY<. ={œ'<eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeproportion positiveMicroscopysurveyyesYesyesKeeeåeeååeååeeeåeå3eeeåeåeå¤p½>bites/person/nightHLCyesYesyes)ìQ$BNiandaneJun-09¦À„AdÔoÁåeeeeeeeeeeeeGELISAZd;>`å>Év¾=2åë=«€<ï2&>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeåeeeeeeeåeeeeeeeeeeee%ELISAl	y>ÜFÃ>=
×=ƒ—Ó=}h,=²>4>eeåeeeåeeåeeeeeeeåeeeeeåeeeeåeeeeeeåeeåeeeeeeeeåeeåeeeeeåeeeeeeåeeeeeeeeeeeeåeeeeeeeåeåeeåeåeåeåeåSagna 20132008-2010LongitudinalAfricaSenegalAgniam; Niandane; Ndiayene Pendao; Guede; FanayeVery lowAn. GambiaeChildrenA:4.4; N: 5.17; P: 4.49; G: 5.84; F: 5.32A:2.48; N: 2.42; P: 2.61; G: 3.06; F: 2.461 TO 92651325410 children in a longitudinal cohortgSG6-P1peptideÝParasites & VectorsgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areasSagna, André Barembaye; Sarr, Jean Biram; Gaayeb, Lobna; Drame, Papa Makhtar; Ndiath, Mamadou Ousmane; Senghor, Simon; Sow, Cheikh Saya; Poinsignon, Anne; Seck, Modou; Hermann, Emmanuel; Schacht, Anne-Marie; Faye, Ngor; Sokhna, Cheikh; Remoue, Franck; Riveau, Gillesåou 20eeeåeåeåeÈAINCLUDEDeYªF„Aï©sÁChildrenAn. GambiaeÚµl-=E/£=#An. Arabiensis€?€?@*=
(BGuet NdaråeeeeeeeeeeeeçELISAzn9?¹P?Ú4?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå9eeeåeåeåeeeeeGELISAV­>B`å>Õxi>>}=WA>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeåeeeeeåeeeeåeeåeåeåeåeåSagna 20192014Cross-sectionalAfricaSenegalPSD; LEO; GND; NDInschildrenPSD 2.42; LEO 2.58; GND 2.25; NDI 2.885 months to 5 years809809gSG6-P1peptideãThe Journal of infectious diseasesSpatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.Sagna AB.; Kassié D.; Couvray A.; Adja AM.; Hermann E.; Riveau G.; Salem G.; Fournet F.; Remoue F.))\$BNiandaneOct-09¦À„AdÔoÁåeeeeeeeeeeeeGELISAV­>B`å>Õxi>>e€@YYNINCLUDEDeNAb levels onlyeeåâ-€Að„ÁChildrenÞó<¸<Œ„6=åÿÿ€?€?@*{(BLéonaåeeeeeeeeeeee©ELISAQÂ#?ÛÞ>ÿN?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå9eeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåSagna 20192014Cross-sectionalAfricaSenegalPSD; LEO; GND; NDInschildrenPSD 2.42; LEO 2.58; GND 2.25; NDI 2.885 months to 5 years809809gSG6-P1peptideãThe Journal of infectious diseasesSpatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.Sagna AB.; Kassié D.; Couvray A.; Adja AM.; Hermann E.; Riveau G.; Salem G.; Fournet F.; Remoue F.eåeåeåe€@YYNINCLUDEDeNAb levels onlyÊ €A-òƒÁChildrenÞÁ­»<À>:=#An. Arabiensis€?€?€?@*¸(BNdioloffèneåeeeeeeeeeeeeÚELISAË;?[]?•Ku?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå9eeeåeåeååeåeåeåeeeeeee)Â$BGuedeyOct-09Ó}„AQ¿lÁåeeeeeeeeeeee)ELISAœÄà>9E?Åþ’>$/>{œ'=P´U>eåeeåeåeeåeeeeeeeeåeeeåeeåeeeåeeeeeeeeåeåeeeåeeeeeåSagna 20192014Cross-sectionalAfricaSenegalPSD; LEO; GND; NDInschildrenPSD 2.42; LEO 2.58; GND 2.25; NDI 2.885 months to 5 years809809gSG6-P1peptideãThe Journal of infectious diseasesSpatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.Sagna AB.; Kassié D.; Couvray A.; Adja AM.; Hermann E.; Riveau G.; Salem G.; Fournet F.; Remoue F.eeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe•=ё>proportion positiveMicroscopysurveyyesYesyese€@YYNINCLUDEDeNAb levels onlyè,€A
âƒÁChildreneeeeeeeåeeeeÞÁ­»<À>:=#An. Arabiensiseeå€?€?€?eeå@*ö((BPikine Sor Diagne åeeeeeeeeeeee¿ELISAzn9?+æè>?‚?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå9eeeåeåeååeåeåeåeeeeeeeeeåeeeeeeåeåeeåeåeåeåeåSagna 20192014Cross-sectionalAfricaSenegalPSD; LEO; GND; NDInschildrenPSD 2.42; LEO 2.58; GND 2.25; NDI 2.885 months to 5 years809809gSG6-P1peptideãThe Journal of infectious diseasesSpatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.Sagna AB.; Kassié D.; Couvray A.; Adja AM.; Hermann E.; Riveau G.; Salem G.; Fournet F.; Remoue F.åeåeåeåeeeeeeee€@YYNINCLUDEDeNAb levels only ÕA@ìƒÁChildreneÞÔ·Ì<ÌîI=#An. Arabiensiseå€?€?€?@+=
,BMboulaSep-04åeeeeeeeeeeeeHELISA30 EuropeansO@S>0Œê=G²š>e9´=eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe‘ã8>[л=wï‰>proportion positivemicroscopysurveyYesHeeeåeeååeååeeeåeåeeeåeåeå@@bites/person/nightHLCyesyesreported in textDia I, Konate L, Samb B, et al. Bionomics of malaria vectors and relationship with malaria transmission and epidemiology in three physiographic zones in the Senegal River Basin. Acta Trop. 2008;105(2):145-153. doi:10.1016/j.actatropica.2007.10.010)\$BPendaoOct-09èóƒAÇ´pÁåeeeeeeeeeeee%ELISA¦
¦>O@ó>jÞ1>Çú>NÁK=·m[>eeåeeeåeeåeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeeååeåeåeå2Æ?žó>”8?proportion seropositiveeyesyesyese>?ÄFÀ>žÜ?proportion seropositiveeyesyesyese>ê•R?œ<:?­ìj?proportion seropositivePf Schizont extract Total IgGeYesnonoSarr JB, Remoue F, Samb B, Dia I, Guindo S, Sow C, Maiga S, Tine S, Thiam C, Schacht AM et al: Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors. Malaria Journal 2007, 6.>`?qL?pŽs?proportion seropositiveeyesyesyesHŽãX?LC?Ò)n?proportion seropositiveePf Shizont Extract IgG3eyesyesyesHeåeåeåeåSarr 20122004-2006Repeated cross sectionalAfricaSenegalMboula; Gankettenschildren3 to 8 years401 samplesgSG6-P1peptideÜTransactions of the Royal Society of Tropical Medicine and HygieneDifferential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites.Sarr JB.; Samb B.; Sagna AB.; Fortin S.; Doucoure S.; Sow C.; Senghor S.; Gaayeb L.; Guindo S.; Schacht AM.; Rogerie F.; Hermann E.; Dia I.; Konate L.; Riveau G.; Remoue F.åee€@YNNINCLUDEDeYååeeî¾zAÃêvÁChildrenÔU>£¯@>An. Arabiensis; An. Funestus; An. Gambiae€?@@@@+{,BMboulaDec-04åeeeeeeeeeeeecELISA30 Europeans8øB>ú,ê=9û‰>u“>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe
>x>+Ì!>ûW§>proportion positivemicroscopysurveyYesceeeåeeååeååeeeåeåeeeåeåeå
×£=bites/person/nightHLCyesyesreported in textDia I, Konate L, Samb B, et al. Bionomics of malaria vectors and relationship with malaria transmission and epidemiology in three physiographic zones in the Senegal River Basin. Acta Trop. 2008;105(2):145-153. doi:10.1016/j.actatropica.2007.10.010åeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeå)Â$BGudeyOc-0eåö?"å>[+?proportion seropositiveeyesyesyeseMâ¬ü>ÐÃ>ùì?proportion seropositiveeyesyesyeseMê•R?œ<:?­ìj?proportion seropositiveeeePf Schizont extract Total IgGeYesnonoSarr JB, Remoue F, Samb B, Dia I, Guindo S, Sow C, Maiga S, Tine S, Thiam C, Schacht AM et al: Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors. Malaria Journal 2007, 6.>rG?X%2?\?proportion seropositiveeyesyesyesc4$f?òñV?uVu?proportion seropositiveePf Shizont Extract IgG3eyesyesyesceåeåeåeåSarr 20122004-2006Repeated cross sectionalAfricaSenegalMboula; Gankettenschildren3 to 8 years401 samplesgSG6-P1peptideÜTransactions of the Royal Society of Tropical Medicine and HygieneDifferential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites.Sarr JB.; Samb B.; Sagna AB.; Fortin S.; Doucoure S.; Sow C.; Senghor S.; Gaayeb L.; Guindo S.; Schacht AM.; Rogerie F.; Hermann E.; Dia I.; Konate L.; Riveau G.; Remoue F.e€@YNNINCLUDEDeYî¾zAÃêvÁChildrenÔU>£¯@>An. Arabiensis; An. Funestus; An. Gambiae€?@@@@+¸,BGanketteSep-04åeeeeeeeeeeeeqELISA30 Europeans?ÒÓ>»?“>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe*¬t>¬($>ԗ¢>proportion positivemicroscopysurveyYesqeeeåeeååeååeeeåeåeeeåeåeåêBbites/person/nightHLCyesyesreported in texteeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeååeeåeeeeeeåeeeeeåeeeeeåeeeeeeeåeeeeeeåeå~h¬>‚y>ºPÜ>proportion seropositiveeyesyesyesebž‚?ƒ2ý>øk0?proportion seropositiveeyesyesyesebñô:?eå²A?OÙ÷>½–*?proportion seropositiveeyesyesyesqHàm?Åa?‹ûy?proportion seropositiveePf Shizont Extract IgG3eyesyesyesqeåeåeåeåSarr 20122004-2006Repeated cross sectionalAfricaSenegalMboula; Gankettenschildren3 to 8 years401 samplesgSG6-P1peptideÜTransactions of the Royal Society of Tropical Medicine and HygieneDifferential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites.Sarr JB.; Samb B.; Sagna AB.; Fortin S.; Doucoure S.; Sow C.; Senghor S.; Gaayeb L.; Guindo S.; Schacht AM.; Rogerie F.; Hermann E.; Dia I.; Konate L.; Riveau G.; Remoue F.å3eeeåeåeå
×ã@bites/person/nightHLCyesYesyese€@YNNINCLUDEDeYÍ°A^Û~ÁChildreneeeeeeåeeeeÖŒ==î=#An. Arabiensiseeåeeee€?€?€?@+ö(,BGanketteDec-04åeeeeeeeeeeeeuELISA30 EuropeansW[ñ>
aÂ>„~?ã¥>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåe6Hƒ>
‹5>äÊ«>proportion positivemicroscopysurveyYesueeeåeeååeååeeeåeåeeeåeåeåö¨ÀBbites/person/nightHLCyesyesreported in textDia I, Konate L, unpublished dataåeåeåeå[b>7é>ç›>proportion seropositiveeyesyesyese_2Ò?G‚ê>?c(?proportion seropositiveeyesyesyese_n4@?eå4H?1Ø>ãw?proportion seropositiveeyesyesyesuîg?«dZ?Rxu?proportion seropositiveePf Shizont Extract IgG3eyesyesyesueåeåeåeåSarr 20122004-2006Repeated cross sectionalAfricaSenegalMboula; Gankettenschildren3 to 8 years401 samplesgSG6-P1peptideÜTransactions of the Royal Society of Tropical Medicine and HygieneDifferential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites.Sarr JB.; Samb B.; Sagna AB.; Fortin S.; Doucoure S.; Sow C.; Senghor S.; Gaayeb L.; Guindo S.; Schacht AM.; Rogerie F.; Hermann E.; Dia I.; Konate L.; Riveau G.; Remoue F.eeeeeeeee€@YNNINCLUDEDeYeeåeeeeÍ°A^Û~ÁChildren'ÖŒ==î=#An. ArabiensisJul-14'Ú@€?€?€?@,=
0BAll villages - childrenåeeeeeeeeeeee‰ELISAunexposed (details not given)‡øc?̕V?C[q?¦Í>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeånnD>¢Î)>3_>proportion positivemicroscopysurveyYesyesYesyesqeååeennD>¢Î)>3_>proportion positiveemicroscopysurveyyesyesyesyesqeåeeeåeåeååeåeåeåeeeeeeeåeåeeìQåJun-09¦À„AdÔoåeåeeåeeeeeeeGELSAeåZd;>`å>Év¾=2å=«€<ï2&>eåeeåSoma 20182013Cross-sectionalAfricaBurkina FasoDogona; Yeguere; Tounouma; Secteur 25An. GambiaeChildren; Adults5 months to 5 years881; 847273gSG6-P1peptideâParasites & vectorsUneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.Soma DD.; Kassié D.; Sanou S.; Karama FB.; Ouari A.; Mamai W.; Ouédraogo GA.; Salem G.; Dabiré RK.; Fournet F.*ö((BPikine Sor Diagne  ÕA@ìƒÁåeeeeeeeeeeee¿ELISAzn9?+æè>?‚?eeåeeeåeÀ@YNNINCLUDEDeYeeeeeåeeeeeeåü²2Að‡‰ÀChildrenAn. GambiaeeeeÝÓV>Ό>An. Arabiensis; An. Funestus; An. Gambiae@@@@,{0BAll villages - adultåeeeeeeeeeeee‰ELISAunexposed (details not given)FC|?w?ij€?/á>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå“í2=Úõ<Ok=proportion positivemicroscopysurveyYesyesYesyesOeååee“í2=Úõ<Ok=proportion positiveemicroscopysurveyyesyesyesyesOeåeeeåeåeå)ÍÌ$BGuedeyJan-10Ó}„AQ¿lÁåeeeeeeeeeeee)ELISAµ¦ù=fˆc>ꕲ<šƒÑ=L	s=¢Ù>eeåeeeåeeåeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSoma 20182013Cross-sectionalAfricaBurkina FasoDogona; Yeguere; Tounouma; Secteur 25An. GambiaeChildren; Adults5 months to 5 years881; 847273gSG6-P1peptideâParasites & vectorsUneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.Soma DD.; Kassié D.; Sanou S.; Karama FB.; Ouari A.; Mamai W.; Ouédraogo GA.; Salem G.; Dabiré RK.; Fournet F.eåeåeÀ@YNNINCLUDEDeYü²2Að‡‰ÀAdultsAn. GambiaeÝÓV>Ό>An. Arabiensis; An. Funestus; An. Gambiae@@@@,¸0BYeguereåeeeeeeeeeeee;ELISAunexposed (details not given)©ûr?á¡d?¹ª€?*ÛÚ>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåAOÎ=dl’=>proportion positivemicroscopysurveyYesyesYesyes—eååeeAOÎ=dl’=>proportion positiveemicroscopysurveyyesyesyesyes—eåeeeåeåeå0?bites/person/nightAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyes4 CDC traps, 4 insecticide sprayingHBR calculated as n mosquitoes divided by number of catches (8) divided by number of nights (2)infectious bites/person/yearpopulationAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyeseeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee4 CDC traps, 4 insecticide sprayingEIR calculated as n pos for pf divided by n mosquitoes divided by number of catches (8) divided by number of nights (2) multiplied by 365åeåeåeåeeeeeeeåeå¨neeè,€A
âƒÁåeåeeeeåeeeeeÚLISAeåÃ;?[]?•KueeåeeåeåeeeeeeåSoma 20182013Cross-sectionalAfricaBurkina FasoDogona; Yeguere; Tounouma; Secteur 25An. GambiaeChildren; Adults5 months to 5 years881; 847273gSG6-P1peptideâParasites & vectorsUneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.Soma DD.; Kassié D.; Sanou S.; Karama FB.; Ouari A.; Mamai W.; Ouédraogo GA.; Salem G.; Dabiré RK.; Fournet F.åeååeeeÀ@YNNINCLUDEDeYeÈ43A…RŠÀAll agesAn. GambiaeeeeÝÓV>Ό>An. Arabiensis; An. Funestus; An. Gambiae@@@@,ö(0BSecteur 25åeeeeeeeeeeeeMELISAunexposed (details not given)˜X?-]C?Øl?m¯ª>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå/µ¿=ׇ=W“÷=proportion positivemicroscopysurveyYesyesYesyes¶HBR calculated as n mosquitoes divided by number of catches (8) divided by number of nights (2)eååee/µ¿=ׇ=W“÷=proportion positiveemicroscopysurveyyesyesyesyes¶eåeeeåeåeå?bites/person/nightAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyes4 CDC traps, 4 insecticide sprayingHBR calculated as n mosquitoes divided by number of catches (8) divided by number of nights (2)infectious bites/person/yearpopulationAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyes4 CDC traps, 4 insecticide sprayingEIR calculated as n pos for pf divided by n mosquitoes divided by number of catches (8) divided by number of nights (2) multiplied by 365åeåeå)ìQ$BNandaeJn-eåÔoÁåeeeeeeeeeeeeeeeGELISAeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeåeeeeeeeeåeeeåeåeåeåeåSoma 20182013Cross-sectionalAfricaBurkina FasoDogona; Yeguere; Tounouma; Secteur 25An. GambiaeChildren; Adults5 months to 5 years881; 847273gSG6-P1peptideâParasites & vectorsUneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.Soma DD.; Kassié D.; Sanou S.; Karama FB.; Ouari A.; Mamai W.; Ouédraogo GA.; Salem G.; Dabiré RK.; Fournet F.åeåeåeåeeeeeeeeeåeeeåeÀ@YNNINCLUDEDeYeeeåeeeeeeåç3AdõˆÀAll agesAn. GambiaeeÝœÄ`>ùƒ‘>An. Arabiensis; An. Funestus; An. Gambiae@@@@,330BTounoumaåeeeeeeeeeeee<ELISAunexposed (details not given)vww?¿Ök?Œ?
ð>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåB›÷=÷]¼=Fl>proportion positivemicroscopysurveyYesyesYesyesèHBR calculated as n mosquitoes divided by number of catches (8) divided by number of nights (2)eååeeB›÷=÷]¼=Fl>proportion positiveemicroscopysurveyyesyesyesyesèeåeeeåeåeåVAbites/person/nightAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyes4 CDC traps, 4 insecticide sprayingHBR calculated as n mosquitoes divided by number of catches (8) divided by number of nights (2)ê	?infectious bites/person/yearpopulationAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyes4 CDC traps, 4 insecticide sprayingEIR calculated as n pos for pf divided by n mosquitoes divided by number of catches (8) divided by number of nights (2) multiplied by 365å*{(BLéonaÊ €A-ƒÁåeåeeeeeåeeeeeELISAeåQÂ#?ÛÞ>ÿN?eeåeeeeeåeeeeåeeeeeeåeeeeeåeåeåeeåeåeåeåeåSoma 20182013Cross-sectionalAfricaBurkina FasoDogona; Yeguere; Tounouma; Secteur 25An. GambiaeChildren; Adults5 months to 5 years881; 847273gSG6-P1peptideâParasites & vectorsUneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.Soma DD.; Kassié D.; Sanou S.; Karama FB.; Ouari A.; Mamai W.; Ouédraogo GA.; Salem G.; Dabiré RK.; Fournet F.å9eeeåeåeåeÀ@YNNINCLUDEDeY³ã2A¾0‰ÀAll agesAn. GambiaeåÝœÄ`>ùƒ‘>An. Arabiensis; An. Funestus; An. Gambiae@@@@,q=0BDogonaåeeeeeeeeeeeeMELISAunexposed (details not given)€?€?€?!ö>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåee塁(> >óM>proportion positivemicroscopysurveyYesyesYesyes‹HBR calculated as n mosquitoes divided by number of catches (8) divided by number of nights (2)eååee¡(> >óM>proportion positiveemicroscopysurveyyesyesyesyes‹eåeeeåeåeå4@bites/person/nightAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyes4 CDC traps, 4 insecticide sprayingHBR calculated as n mosquitoes divided by number of catches (8) divided by number of nights (2)infectious bites/person/yearpopulationAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyes4 CDC traps, 4 insecticide sprayingEIR calculated as n pos for pf divided by n mosquitoes divided by number of catches (8) divided by number of nights (2) multiplied by 365)%BFanayeJan-10ªF„ï©sÁåeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåSoma 20182013Cross-sectionalAfricaBurkina FasoDogona; Yeguere; Tounouma; Secteur 25An. GambiaeChildren; Adults5 months to 5 years881; 847273gSG6-P1peptideâParasites & vectorsUneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.Soma DD.; Kassié D.; Sanou S.; Karama FB.; Ouari A.; Mamai W.; Ouédraogo GA.; Salem G.; Dabiré RK.; Fournet F.eeåeeeeeeeåeåeÀ@YNNINCLUDEDeYeY¥2A~ƇÀAll agesAn. GambiaeÝ2¥>I.¿>An. Arabiensis; An. Funestus; An. Gambiae@@@@-=
4BKorogwe|ELISA39 Europeansè>š&ü=ƒ7>áz”>¬Z>33?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeå*=
(BGuet Ndarâ-€Að„ÁåeeeeeeeeeeeeçELISAzn9?¹P?Ú4?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeåeeeeeeåeeeeeeåeeeeeåeeeeeešˆˆ<çOÀ;ýà<proportion seropositivepopulationPfAMA1ÿ6Å=ìA’=,ø=proportion seropositivePfMSP1(19)eeå8|W>/^5>Ašy>proportion seropositivePfCSPe?eeeeeeeåeåeeåeåndÃ=?ӑ=õô=proportion seropositivepopulationPfMSP3yesyesyese6eåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.eåeåeå[b>7é>ç›>proportion seropositiveeyesyesyese_2Ò?G‚ê>?c(?proportion seropositiveeyesyesyese_n4@?ee€AYYYINCLUDEDeYChildrenAn. GambiaeÔe-{4BMnyuziELISA39 EuropeansùNì=%\È<scš>J‚>Ë¡E>ªñ’>q­Ž=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåóšh@bites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes6 householdseeåeåeåeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.e€AYYYINCLUDEDeYq=§À%XBChildrenAn. GambiaeeeåÔ«²?}	?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-¸4BMsambazi-ELISA39 Europeansrˆ>!O=w-‰>=
W>Ï÷S>+‡Ö>Öì´=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåyäg@bites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes14 householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.e€AYYYINCLUDEDeYÝM¥ÀQÝBChildrenAn. Gambiaeå4H?1Ø>ãwÔvl´>æyÀ>An. Arabiensis; An. Funestus; An. Gambiae@@f Shizont E@@-ö(4BManunducELISA39 Europeansª~%=$6<VDÍ=X9t>î|?>‰A >E;k=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeå\>£@bites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes25 householdsåeåeåeåeeeeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.,{0BAll villages - adultü²2Að‡‰Àåeeeeeeeeeeee‰ELISAunexposed (details not given)FC|?w?ij€?/á>eeåeeeåeeåeeeeeeeåeeeeeeåe€AYYYINCLUDEDeYeeåeeeeeåeeeeeeee[¦À‘BChildrenAn. GambiaeÔê²?â#?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-334BMasuguruELISA39 EuropeansI>ÒƑ<¹3Û>ßO­>é&1>%?禮=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåFòô@bites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes5 households+{,BMboulaDec-04î¾zAÃêvÁåeeeeeeeeeeeecELISA30 Europeans8øB>ú,ê=9û‰>u“>eeåeeåeeåeåeåeåeeeeeeeåeåeeåeåeåeå,ö(0BSeceur 25eåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.åeåeeeåee€AYYYINCLUDEDeYÝM¥ÀQÝBChildrenAn. GambiaeÔvl´>æyÀ>An. Arabiensis; An. Funestus; An. Gambiae@@@@-q=4BMajengo[ELISA39 EuropeansOÍU>øÅ>¼>;ßÏ>%>þÔ?|>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeålÛAbites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes35 householdsSep-06Í°A^Û~ÁåeeeeeeeeeeeeqELISA30 Europeans?ÒÓ>»?“>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeåeeeeeeåeeeeee)Â$BGuedeyOct-09Ó}„AQ¿lÁå,{0BAll villages - adultü²2Að‡‰Àåeeeeeeeåe‰ELISAunexposed details nt given)FC|?w?Ā?/á>eåeåeeååeeåeeeeeeåeåeeeeeåeeeeeeåeeeeeeeeunexposed (details not given)vww?¿Ök?Œ?
ð>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeååeåeåeeeeeåeeeeåeeåeeeeåeeeeeeeeeeeåeåeeåeeeeeeeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.åeåeee€AYYYINCLUDEDeYe[¦À‘BChildrenAn. Gambiaeroportion positiveÔê²?â#?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-®G4BKwasemangube/ELISA39 Europeans±D>(`»='Jª>Zd»>ö(œ>“$?IÓ
>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåyw$Abites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes22 householdseeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.e€AYYYINCLUDEDeYÝM¥ÀQÝBChildrenAn. GambiaeÔvl´>æyÀ>An. Arabiensis; An. Funestus; An. Gambiae@@@@-ìQ4BLwengeraELISA39 Europeans€>«&È=o)ï>
×ã>oƒ>!°?|>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåe塍-Abites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes5 householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.eåeåeeeeeeee€AYYYINCLUDEDeYåeÝM¥ÀQÝBChildrenAn. GambiaeÔvl´>æyÀ>An. Arabiensis; An. Funestus; An. Gambiae@@@@-)\4BLusangaELISA39 EuropeansÍÌÌ=ý¬<öӇ>mç{>=
W>‘í|>m¬”=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåÓ-IAbites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes15 householdsåeåeåeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.oes divided by number of catches (8) divided by number of nights (2)eååee¡(> >óM>proportion positiveemicroe€AYYYINCLUDEDeYyesyesyesyesq=§À%XBChildrenAn. GambiaeÔ«²?}	?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-ff4BMandera=ELISA39 Europeans~qÉ=^c=Ó½N>PW>Zd;>²ï>V­=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåo[sAbites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes23 households,ö(0BSecteur 25ç3AdõˆÀåeeeeeeeeMELISAunexpse (eails not given)˜X?-]C?Øl?m¯ª>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeåeåeåeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.eååeeeåe€AYYYINCLUDEDeYÁ¬ÀÿVBChildrenAn. GambiaeÔCâ6?èÙ?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-¤p4BMkwakwaniELISA39 EuropeansÏÜS>¢¸£=õcË>X9t>^ºI>‰Aà>˜Óé=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåe妖Abites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes17 householdsŒ?
ð>eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeå*=
BGuet NdaeåÁåeåeeeeeeeeeELISAeåezn?¹eeeeeåeeeeåeeeeeeeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.e€AYYYINCLUDEDeYq=§À%XBChildrenAn. GambiaeeÔ«²?}	?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-áz4BKwagunda-ELISA39 Europeansp6>zà£=¤>ìQx>ã¥[>åТ>ã}É=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåɎžAbites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes18 householdsåeåeåeåeeeeeeeåeåDec-04eî¾zAÃêvÁåeåeeeåeeeeeeeELIS3 Eeå8øB>ú,ê=9û‰u“>eeåeeåeeåeåeeeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.eåeå0?ites/person/nightAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyese€AYYYINCLUDEDeYÍ¥À-^BChildrenAn. GambiaeÔ:u?¹p?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-…4BShambakaporiELISA39 EuropeansÁ>*Xã<¥ù«>š™™>j¼t>HáŠ?•úõ=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeå[®Abites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes8 households-ö(4BManundu[¦À‘BåELISA39 EuropeansE;k=eeeeeeeeeeeeåeeåeeåeeåeeeeeeeååeeåeeåeåeeåeeeeeeeååeeeeeåeeeeeeeeeeeeeåeeeeeeåeeeeeeåeeÓ}„AQ¿lÁå,{0BAll villages - adultü²2Að‡‰Àåeeeeeeeeeeee‰ELISAunexposedåiven)FC|?w?ij€?/áeeåeeåeeåeeeeeeeåeeeeeåeåeeåeeeeåeåeeeeeåeåeeeeeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.4 CDC traps, 4 insecticide sprayingHBR calculated as n mosquitoes divided by number of catches (8) divided by number of nighs (2)ê	?infectious bites/person/yearpopulationAn. gambiae (s.l.)CDC traps and insecticide sprayingyesYesyese€AYYYINCLUDEDeYq=§À%XBChildrenAn. GambiaeeeeÔ«²?}	?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-\4BGereza
ELISA39 EuropeansµNì>wØD>Û§??7‰¡>®G>X9ô>eF>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeå@àAbites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes7 householdsåeåeåeåeeeeeee-ìQ4BLwengeraÝM¥ÀQÝBåELISA39 Europeans|>eeeeeeeåeeåeåeeeåeeåeeeeeeeåeeeeåeåeeeeeåeeeeeeeåeåeeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.eåɎžAbites/person/nightmean household female Anoph during peak (MY) CDC Light TrapsyesYesyese€AYYYINCLUDEDeYq=§À%XBChildrenAn. GambiaeÔ«²?}	?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-š™4BKiloleAELISA39 EuropeansüÈ
>~ƅ=¬Ž|>Â?áz”>Év>?Wé=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåtëAbites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes34 households-ö(4BManundu[¦À‘BåELISA39 EuropeansE;k=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeeeeåeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeeeåeeeeeååeåeåeåeeeeeeeeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.-ö(4BManundu[¦À‘cELISA39 Europeansª~%=$6<VDÍ=X9t>î|?>‰A >E;k=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåe€AYYYINCLUDEDeYe[¦À‘BChildrenAn. GambiaeÔê²?â#?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@-×£4BMagugaELISA39 Europeans-Ïs>)ç‹='gÐ>¼t“>VŽ>)\?I>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeå2eeeåeåeåyg-Bbites/person/nightmean household female Anoph during peak (MAY) CDC Light TrapsyesYesyes12 householdseeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåStone 20122004-2008Cross-sectionalAfricaTanzaniaKorogwemoderateAn. GambiaeChildrenparticipants were sampled at 9 month immunisation6366361280 infantsgSG6recombinant proteinÜPloS oneIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.Stone W.; Bousema T.; Jones S.; Gesase S.; Hashim R.; Gosling R.; Carneiro I.; Chandramohan D.; Theander T.; Ronca R.; Modiano D.; Arcà B.; Drakeley C.e€AYYYINCLUDEDeYÍ¥À-^BChildrenAn. GambiaeÔ:u?¹p?An. Arabiensis; An. Funestus; An. Gambiae@@@@€@.=
8BUrbanAug-14åeeeeeeeeeeee&ELISAZɵ?–^?”ðä?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåØP^?ÍB?’Ôy?proportion positivemicroscopyyesYesyes&eååeeeåeå018eeeåeåeåpAbites/person/nightAnopheles bitesHLCyesYesyes3 houses in each siteåeåeåeåeeeeeeeåeåeeåeåeåeåeåTraoré 20182014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam, Kennedy and N'Gattakaro (Urban); Petessou and Allokokro (Rural)SeasonalAn. GambiaeChildren6 months to 14 years89178gSG6-P1peptideâThe American journal of tropical medicine and hygieneEvaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Lingué KN.; Coulibaly I.; N'Cho Tchiekoi B.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.åeåeeeeeeeåe€@YNNINCLUDEDeNAb levels onlyeChildrenAn. GambiaeÞe@.{8BRuralAug-14åeeeeeeeeeeee3ELISA„~?Y?ñBÅ?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåçæf??R?Ë{?proportion positivemicroscopyyesYesyes3eååeeeåeå018eeeåeåeåhBbites/person/nightAnopheles bitesHLCyesYesyes3 houses in each siteåeåeåeåeeeeeeeåeåeeåeåeåeåeåTraoré 20182014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam, Kennedy and N'Gattakaro (Urban); Petessou and Allokokro (Rural)SeasonalAn. GambiaeChildren6 months to 14 years89178gSG6-P1peptideâThe American journal of tropical medicine and hygieneEvaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Lingué KN.; Coulibaly I.; N'Cho Tchiekoi B.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.e€@YNNINCLUDEDeNAb levels onlyChildrenAn. GambiaeeeÞe@.¸8BUrbanApr-15åeeeeeeeeeeee&ELISA“;<ÒXt=eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåóJ?æë(?Jk?proportion positivemicroscopyyesYesyes&eååeeeåeå018eeeåeåeå @bites/person/nightAnopheles bitesHLCyesYesyes3 houses in each siteeeeeeeeeeeeeMELISAunexposed (details not given)˜X?-]C?Øl?m¯ª>eeåeeeåeeeeeåeeeeeåeeååeeåeeeeeeeåeåeeeeeeåeeeåeåeeåeeeeeeeeeåe-e4Bkwkweeq=§À%BåELISA9 EuropeanseåeåeeåeåeåeåeåTraoré 20182014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam, Kennedy and N'Gattakaro (Urban); Petessou and Allokokro (Rural)SeasonalAn. GambiaeChildren6 months to 14 years89178gSG6-P1peptideâThe American journal of tropical medicine and hygieneEvaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Lingué KN.; Coulibaly I.; N'Cho Tchiekoi B.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.e€@YNNINCLUDEDeNAb levels onlyChildrenAn. Gambiaeßeeå@.ö(8BRuralApr-15åeeeeeeeeeeee3ELISA	ؖ<îÓe<YXë=eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÓÒR?ñ	8?¶›m?proportion positivemicroscopyyesYesyes3eååeeeåeå018eeeåeåeåBbites/person/nightAnopheles bitesHLCyesYesyes3 houses in each site-ff4BManderaÁ¬ÀÿVBåELISA39 EuropeansV­=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeeeeeeeåeåeeeeeååeeeåeeeeåeeeeeeåeeeeeeåeeeeåeeeeeeeeeeeeeåeåeeåeåeåeåeåTraoré 20182014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam, Kennedy and N'Gattakaro (Urban); Petessou and Allokokro (Rural)SeasonalAn. GambiaeChildren6 months to 14 years89178gSG6-P1peptideâThe American journal of tropical medicine and hygieneEvaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Lingué KN.; Coulibaly I.; N'Cho Tchiekoi B.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.eeåe€@YNNINCLUDEDeNAb levels onlyeeåeeeeeåeeeeChildrenAn. Gambiaeße@/=
<BDar-es-salamAug-14åeeeeeeeeeeeeaELISAFrench–'?¦Òï>Øe*?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåÝÎ?ÁŸï>ÜÍ)?proportion positivemicroscopysurveyyesYesyesceååeeeåeå019eeeåeåeå@bites/person/nightAnopheles bitesHLCyesYesnoTraoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B, Assi SB, Poinsignon A, Dagnogo M et al: Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites. The American journal of tropical medicine and hygiene 2018, 98(5):1353-1359.3 houses in each siteeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeåeåeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeååeåeeåeåeåeåeåTraoré 20192014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam; Kennedy; N’gattakronschildren6 months to 14 years442 = 280 in Rainy 162 in DrygSG6-P1peptideãMalaria journalExploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Adou KA.; Lingué KN.; Coulibaly I.; Tchiekoi NB.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.eÀ@INCLUDEDeY=
÷@¸¡ÀChildrenåÞ£@=ýjŽ=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?eeå@/{<BKennedyAug-14åeeeeeeeeeeeeSELISAFrenchHSg?OW??”w?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåéçg?ÀX?Ìw?proportion positivemicroscopysurveyyesYesyesUeååeeeåeå019eeeåeåeåBbites/person/nightAnopheles bitesHLCyesYesnoTraoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B, Assi SB, Poinsignon A, Dagnogo M et al: Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites. The American journal of tropical medicine and hygiene 2018, 98(5):1353-1359.3 houses in each siteåeåeåeåeeeeeeeåeåeeå.=
8BUrbanAug-4eåeåeeeeeeeeeeåZµ?–^?”ä?eåTraoré 20192014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam; Kennedy; N’gattakronschildren6 months to 14 years442 = 280 in Rainy 162 in DrygSG6-P1peptideãMalaria journalExploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Adou KA.; Lingué KN.; Coulibaly I.; Tchiekoi NB.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.-ff4BManderaÁ¬ÀÿVBåELISA39 EeÀ@INCLUDEDeYV­=eeeeÂõ@ö( ÀChildrenÞt=Ï,‰=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@/¸<BN'gattakroAug-14åeeeeeeeeeeee]ELISAFrenchúi?¶c[?I‘x?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeåUUm?À`?é¥z?proportion positivemicroscopysurveyyesYesyes`eååeeeåeå019eeeåeåeåAbites/person/nightAnopheles bitesHLCyesYesnoTraoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B, Assi SB, Poinsignon A, Dagnogo M et al: Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites. The American journal of tropical medicine and hygiene 2018, 98(5):1353-1359.3 houses in each siteåeåeåeåeeeeeeeeeåeeeeeåeeeeeeeeåeeeeeeeeååeeåeeeåeeeeeeåeeeeeeeåeeeåeeeeeeeåeåeåeåTraoré 20192014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam; Kennedy; N’gattakronschildren6 months to 14 years442 = 280 in Rainy 162 in DrygSG6-P1peptideãMalaria journalExploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Adou KA.; Lingué KN.; Coulibaly I.; Tchiekoi NB.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.ååeeeåeeÀ@INCLUDEDeY
³õ@]¡ÀChildrenÞ¸#=c‹=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@/ö(<BDar-es-salamApr-15åeeeeeeeeeeeeELISAFrench?KÌs>íC?7Ü;eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå1¹?0F¼>JO'?proportion positivemicroscopysurveyyesYesyes/eååeeeåeå019eeeåeåeå€?bites/person/nightAnopheles bitesHLCyesYesnoTraoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B, Assi SB, Poinsignon A, Dagnogo M et al: Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites. The American journal of tropical medicine and hygiene 2018, 98(5):1353-1359.3 houses in each site-š™4BKilole[¦À‘BåELISA39 EuropeansWé=eeeeeeeeeeååeåeåeåeeeeeeeeeeeeåeeåeåeeåeåeåeåeåTraoré 20192014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam; Kennedy; N’gattakronschildren6 months to 14 years442 = 280 in Rainy 162 in DrygSG6-P1peptideãMalaria journalExploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Adou KA.; Lingué KN.; Coulibaly I.; Tchiekoi NB.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.åeåeeeåeeåeÀ@INCLUDEDeY=
÷@¸¡ÀChildrenßiW!=Ô·Œ=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@/33<BKennedyApr-15åeeeeeeeeeeeeELISAFrenchÇq?°V?o†?úé<eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeå%Ir?0c?±€?proportion positivemicroscopysurveyyesYesyes8eååeeeåeå019eeeåeåeå@Abites/person/nightAnopheles bitesHLCyesYesnoTraoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B, Assi SB, Poinsignon A, Dagnogo M et al: Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites. The American journal of tropical medicine and hygiene 2018, 98(5):1353-1359.3 houses in each site-×£4BMagugaÍ¥À-^BåELISA39 EuropeansI>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeåeeeeeeåeåeåeåeeeeeeeåeåeeåeåeåeåeåTraoré 20192014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam; Kennedy; N’gattakronschildren6 months to 14 years442 = 280 in Rainy 162 in DrygSG6-P1peptideãMalaria journalExploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Adou KA.; Lingué KN.; Coulibaly I.; Tchiekoi NB.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.erson/nightAnopheles bitesHLCyesYesyeseÀ@INCLUDEDeYÂõ@ö( ÀChildreneeeeeåß3P=ª·†=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@/q=<BN'gattakroApr-15åeeeeeeeeeeeeELISAFrench¾„v??Hd?¢`„?¨Ÿ~?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåee加a?ä€L?3Àv?proportion positivemicroscopysurveyyesYesyes;eååeeeåeå019eeeåeåeå@bites/person/nightAnopheles bitesHLCyesYesnoTraoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B, Assi SB, Poinsignon A, Dagnogo M et al: Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites. The American journal of tropical medicine and hygiene 2018, 98(5):1353-1359.3 houses in each siteåeåe.¸8BUrbanAprååeåeeeeeeeeeeee&ELeAee“;<ÒXt=eeåeeeeåeåeeåeåeåeåeåTraoré 20192014-2015Repeated cross sectionalAfricaCote d'IvoireDar-es-Salam; Kennedy; N’gattakronschildren6 months to 14 years442 = 280 in Rainy 162 in DrygSG6-P1peptideãMalaria journalExploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.Traoré DF.; Sagna AB.; Adja AM.; Zoh DD.; Adou KA.; Lingué KN.; Coulibaly I.; Tchiekoi NB.; Assi SB.; Poinsignon A.; Dagnogo M.; Remoue F.-334BMasuguruÝM¥ÀQÝBELISA39 EuropeansI>ÒƑ<¹3Û>ßO­>é&1>%?禮=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeÀ@INCLUDEDeYeeeee
³õ@]¡ÀChildrenß²… =ÔH‹=An. Arabiensis; An. Funestus; An. Gambiae€?€?€?@0ff@BeåeeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeååeåeåeåeeeeeeeåeåeeåeåeåeåeåeWaitayakul 2006nsCross-sectionalAsia/GMSThailandMae SotnsAn. DirusAll ages139139An. Dirus WGEWhole salivaÖActa tropicaNatural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand.Waitayakul A.; Somsri S.; Sattabongkot J.; Looareesuwan S.; Cui L.; Udomsangpetch R.eeeåeåeeåeeeeeeeeeåe-e4Bkwkweeq=§À%BåELISA9 Europeanseåeåee
@@INCLUDEDeNCase Controleååeeååÿÿ2HBTPN - Htoo Pyin NyarMay-13åeeeeeeeeeeeeELISA16 French and 1 bangkok citizenŠ;â>Í4Ã>$¡?«ª*?Ò 
?ù–o?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeNN>ì+$>©Òx>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1jeåeeeåeeåå6²º>O¡>SÔ>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1jåeeeåK¹)>y>óP>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1j 2018eeeåeåeåìQ AºIAZ.Abites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsìQð@Ø@ÓMAinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsìQð@Ø@ÓMAinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights„'?!Dí>÷¬?proportion seropositivepopulationPfAMA1yesyesnoO'Flaherty et al., unpublished data*ö>€åÂ>ÈÈ?proportion seropositivePfMSP1(19)yesyesyesej:æ>HOÉ>ǒ?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data*½@?=2«<9t”=proportion seropositivePfCSPyesyesyeseeeeeeeeeeeeeeeeeeeerELISA16 French and 1 bangkok citizen\è?$C?•?eeåeeeåeeåeeeeeeeåeeeeåeåeeeeeeeeeeeeeeåeeåeeeååeåeeeeeeåeeeeeeeeeeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.a: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1%åeeeåZ±Q>v`">"€>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. PeàAYYYINCLUDEDeY:10.12688/wellcomeopenres.1220.1%¿)‰AT–ÄBAll agesAn. Minimus; An. Maculatusݬŧ7¬Å'8An. Dirus s.l.; An. Minimus s.l.
€?€?€?2HBTPN - Htoo Pyin NyarAug-13åeeeeeeeeeeeeELISA16 French and 1 bangkok citizen0?åe?z¼%?OìD?
Ò ?5Hƒ?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeåå
g7<«Æ·ºªãÂ<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeee媉ô;È6:»®‹‘<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeåö(ü@–Cã@+‡
Abites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsÏ÷AázA¼t!Ainfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsÏ÷AázA¼t!Ainfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsíÀ?Ñ	?x+?proportion seropositiveePfAMA1yesyesnoO'Flaherty et al., unpublished data$Dñ>š?È&?proportion seropositivePfMSP1(19)yesyesyeseæÚ?˂å>fô?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataP›Z>’F(>x†>proportion seropositiveeeeePfCSPyeseeyesyeseeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.ååeeeåeeàAYYYINCLUDEDeY¿)‰AT–ÄBAll agesAn. Minimus; An. Maculatuseݬŧ7¬Å'8An. Dirus s.l.; An. Minimus s.l.
€?€?ee€?2HBTPN - Htoo Pyin NyarNov-13åeeeeeeeeeeee,ELISA16 French and 1 bangkok citizen/–ü>¿žß>ÏÆ?Hƒ4?i?'vb?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeó</UD»™Œ™<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1þeåeeeåeeååU*>—zÑ=_—A>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1þåeeeå
>µeµ=La/>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1þ 2018eeeåeåeå¸AL7A%+Abites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights×£¶AJ¬Ad;ÁAinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights×£¶AJ¬Ad;ÁAinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsï€#?0ñ?¯2?proportion seropositivePfAMA1yesyes HtonoO'Flaherty et al., unpublished dataF?Þ×ß>Bª?proportion seropositivePfMSP1(19)yesyeseyese+´—P?»D?Kt\?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data
×#=ò’<«~=proportion seropositiveePfCSPyesyeseeåyese,eåeeeeeeeeåeeeeåeeeeeåeeeeeeeeååeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.yesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal studyin four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4eàAYYYINCLUDEDeY¿)‰AT–ÄBAll agesAn. Minimus; An. Maculatusݬŧ7¬Å'8An. Dirus s.l.; An. Minimus s.l.
€?€?€?2HBTPN - Htoo Pyin NyarJan-14åeeeeeeeeeeee3ELISA16 French and 1 bangkok citizen¤ÏÝ>>nÁ>1ú>B$?i?¾å[?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÍ«ß;Q†*»æ&…<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1%eåeeeåeeååá¦m>'<>^“>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1%åeeeåZ±Q>v`">"€>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1% 2018eeeåeåeå
×C@ÍÌ$@Háb@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.41=
DBTPN - Htoo Pyin Nyar50 person nightsåeeeeeeeeeeeerELISA16 Frencinfectious bites/person/yearpopulationHLCeyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsáÍ#??þ2?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataœòG?eÆ>àˆõ>proportion seropositivePfMSP1(19)yesyesyese2 ÝQ?ÈfF?yT]?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data•k=ƒUP<ÉÁV=proportion seropositivePfCSPyesyesyese3eeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eeeåeåeeåeåeåeàAYYYINCLUDEDeYeå¿)‰AT–ÄBAll agesAn. Minimus; An. MaculatusÞ¬Å'7¬Å§7An. Dirus s.l.; An. Minimus s.l.
€?€?å€?2HBTPN - Htoo Pyin NyarApr-14åeeeeeeeeeeeeELISA16 French and 1 bangkok citizenGn$?íƒ?¡X3?ìÄN?pù?Oì„?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1!eåeeeåeeååÌÚi>^K8>µ>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1!åeeeåþàB>͈>/9q>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1! 2018eeeåeåeå×£p@¢EN@‰@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4eeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee50 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights33C?Åj5?¢ûP?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataðm²I?eÎ?)1?proportion seropositivePfMSP1(19)yesyesyesec
?
€ú>6‡?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataïÿ=ø<ë°<ÅÑP=proportion seropositivePfCSPyesyesyeseeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eàAYYYINCLUDEDeY¿)‰AT–ÄBAll agesAn. Minimus; An. MaculatusÞ¬Å'7¬Å§7An. Dirus s.l.; An. Minimus s.l.
€?€?€?2%HBTPN - Htoo Pyin NyarJul-14åeeeeeeeeeeeeéELISA16 French and 1 bangkok citizen{I?Ñ;?2V?ƒ4H?
Ò ?.ßr?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåóe;_õ[»J÷)<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeååeB>^n>eœp>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeåý=7>ú«	>ùÏd>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå{®@B`™@´ÈÂ@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights¶
a?wâU?ø2l?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data׫,E?dK;?’ÕV?proportion seropositivePfMSP1(19)yesyesyeseë‘ùR?ænE?;„`?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataÇ·Œ<¥þ9‡
=proportion seropositivePfCSPyesyesyeseêeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.l S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. oi:10.12688/wellcomeopenres.14761.4eàAYYYINCLUDEDeY¿)‰AT–ÄBAll agesAn. Minimus; An. MaculatusÞ¬Å'7¬Å§7An. Dirus s.l.; An. Minimus s.l.
€?€?€?2+HBTPN - Htoo Pyin NyarOct-14åeeeeeeeeeeee	ELISA16 French and 1 bangkok citizenñS?WãG?Œ<_?!
R?B$?¤?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeóå;ô?/»»áˆ<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeåå[b>o1>i؉>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeåÆÕ:>(ë>cÀh>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeåö(œ?çûi?øSÃ?bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights>ŸO?òKC?ˆò[?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataþ4áO?öŠG?í”_?proportion seropositivePfMSP1(19)yesyesyese
ÄÃC?ï÷5?™Q?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataî+ü=ékq<[w=proportion seropositivePfCSPyesyesyese
eeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ÖeåeeeåeeåeàAYYYINCLUDEDeY¿)‰AT–ÄBAll agesAn. Minimus; An. MaculatuseÞ¬Å'7¬Å§7An. Dirus s.l.; An. Minimus s.l.blished 
€?€?portion ser€?21HBTOT - Tar Au TaJun-13åeeeeeeeeeeee”ELISA16 French and 1 bangkok citizen€I'?ih?˜*3?Iô??¼Ò>äe?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeep–r=º$=„¦=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1·eåeeeåeeååÃìæ>ŸÏ>ãÁþ>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1·åeeeå_™O>z)>Dv>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1· 2018eeeåeåeå¤p½?ÓM’?u“è?bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsìQð@Ø@ÓMAinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights¦??Xv4?ñŒJ?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data…b"=?6K?ÍG2?proportion seropositivePfMSP1(19)yesyesyese’=T?Í7ç>”
?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data…F>ûFÊ=ß(>proportion seropositivePfCSPyesyesyese’eeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eeeeeeeeôELISA16 French and 1 bangkok citizen…ëQ?LI?zŠZ?¤A?ى?.ßr?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeàAYYYINCLUDEDeYeeåeeeeeewu<;¾žÔ<proportion sɂA2&ÅBAll agesAn. Minimus; An. Maculatus; An. Dirusݍî;g,š<An. Dirus s.l.; An. Minimus s.l.€?€?e€?27	HBTOT - Tar Au TaSep-13åeeeeeeeeeeeeBELISA16 French and 1 bangkok citizen.>?!È1?<>J?ôº?ÂT½>%TZ?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeAÂf;W»\»b*<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeåå­Âf<]ÏÆ9o§ã<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeå-<`ë­ºÒð·<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå
×ÓA˜nÈA}?ßAbites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.42HBTPN - Htoo Pyin NyarNov-13åeeeeeeeeeeee,ELISA16 French and 1 bangkok citizen/–ü>¿žß>ÏÆ?50 person nightseåeeåeeeeeeeåeeeeeeåeeåinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4eeå50 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsdüv?ˆq?Ay|?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data—?¤r0?¹“K?proportion seropositivePfMSP1(19)yesyesyeseBüv)?la?ŒŒ7?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data‘©>•—Q>W‡š>proportion seropositivePfCSPyesyesyese4eeeeeee2%HBTPN - Htoo Pyin NyarJul-14ååeåeeeeeeeeeeéåench and 1 bangkok citzen{I?Ñ?2V?eeeåeeåeåeeeeeeeåeeeeeeåeåeeåeeeeeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eeeeeeeeeeeeELISA16 French and 1 bangkok citizen8:ý>Õß>ϯ
?ÏÐA?9¿
?y?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeàAYYYINCLUDEDeYeeåeeeeeeåeeeeesɂA2&ÅBAll agesAn. Minimus; An. Maculatus; An. Dirusݍî;g,š<An. Dirus s.l.; An. Minimus s.l.€?€?€?2=
HBTOT - Tar Au TaNov-13åeeeeeeeeeeeeÉELISA16 French and 1 bangkok citizenÛ;I?y¸:?@¿W?d?úÕ>1<?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeºÀ@<П‘»ä(å<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ªeåeeeåeeååÊÆF>™ä	>zԁ>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ªåeee帺:>¹”þ=+v>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ª 2018eeeåeåeå×£Ð@çû¹@ÇKç@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4eeåeeeeee50 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights×£¶AJ¬Ad;ÁAinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsiWb?9ÍU?œán?proportion seropositiveeePfAMA1yesyes FrenoO'Flaherty et al., unpublished data¤m±2?z9?>qY?proportion seropositiveeePfMSP1(19)yesyesyeseÊSLP?‰æ@?²_?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data¡GÞ>–í®=ÃE6>proportion seropositiveeeåPfCSPyeseyeseeeåyeseÍeeeeeeeeeeeåeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.ation to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcmeopenres.12240.1öåeeeåèý2>Xd>—c>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot teàAYYYINCLUDEDeY Eastern Myanmar. Wellcome Oen Res. 2017;2:81. Published 20sɂA2&ÅBAll agesAn. Minimus; An. Maculatus; An. Dirusݍî;g,š<An. Dirus s.l.; An. Minimus s.l.rvey€?€?andier J, K€?2DHBTOT - Tar Au TaFeb-14åeeeeeeeeeeee$ELISA16 French and 1 bangkok citizen8ð>héÒ>iÃ?jÚ>9³>™r$?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee]_µ<Êp—;_q"=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeåå’~f>h“3>ᴌ>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeåº&9>°:
>Åh>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå=
×>Âu>š™?bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsj„e?\?Îùn?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data®~P?YÙ>Z‹?proportion seropositivePfMSP1(19)yesyesyese#¹‘?!`?SÃ*?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataêÕ+>Eãÿ=8ºW>proportion seropositivePfCSPyesyesyese$eeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.ec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 019 Jun 17. doi:10.12688/wellcomeopenres.14761.4eàAYYYINCLUDEDeYsɂA2&ÅBAll agesAn. Minimus; An. Maculatus; An. DirusÞ\,;÷uà;An. Dirus s.l.; An. Minimus s.l.€?€?€?2JHBTOT - Tar Au TaMay-14åeeeeeeeeeeeeùELISA16 French and 1 bangkok citizenU?tX?7À#?´Ñ>)±>	?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeõÍG<ßNǺãBÔ<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1öeåeeeåeeåålñd>½ />!>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1öåeeeåèý2>Xd>—c>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ö 2018eeeåeåeåHáú?L7É?¢E@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights£X?!4L?(Ýc?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data풂I?Z?R!?proportion seropositivePfMSP1(19)yesyesyeseù#?o?êÆ2?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataí1¬=®8K=þsò=proportion seropositivePfCSPyesyesyeseúeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.nfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-mnth longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2eàAYYYINCLUDEDeY9 Jun 17. doi:10.12688/wellcoeopenres.14761.450 person nightsɂA2&ÅBAll agesAn. Minimus; An. Maculatus; An. DirusÞ\,;÷uà;An. Dirus s.l.; An. Minimus s.l.€?€?eå€?2P
HBTOT - Tar Au TaAug-14åeeeeeeeeeeee3ELISA16 French and 1 bangkok citizen§m?¾Df?|
u?s­V?D?æ˜?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee€€=?=âu½=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ÿeåeeeåeeååÁÀÀ>8N¢>G3ß>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ÿåeee匌Œ>6a>þ—¨>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ÿ 2018eeeåeåeå×£‡BòƒB¼4ŒBbites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsR¸¯AøS¥A¬ºAinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsÓMê@ÓMÒ@é&Ainfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsMu?ÉYn?Ϭ{?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataéÇ¡J?¡b?–Iy?proportion seropositivePfMSP1(19)yesyesyese3qG\?ükP?è"h?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data×&)ÿ=Õ@³=´ˆ%>proportion seropositivePfCSPyesyesyese1eeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1!åeeeåþàB>͈>/9q>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1!eàAYYYINCLUDEDeY 2018eeeåsɂA2&ÅBAll agesAn. Minimus; An. Maculatus; An. DirusÞ\,;÷uà;An. Dirus s.l.; An. Minimus s.l.€?€?€?2VHBTOT - Tar Au TaOct-14åeeeeeeeeeeeeÃELISA16 French and 1 bangkok citizen–Z)?øY?5[:?#^?塺>ßx+?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÊæ<äz;{V=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1²eåeeeåeeååûя>—\>' ±>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1²åeeeåP›Z>Ìö>îŒ>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1² 2018eeeåeåeå×£“BBàŽBmg˜Bbites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsÏ÷ë@;ßÓ@1Ainfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.427	HBTOT - Tar Au TaSep-13åeeeeeeeeeeeeBELISA16 French and 1 bangkok citizen.>?!È1?<>J?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåee50 person nightseeeeeeeeinfectious bites/person/yearpopulationHLCeeåeeeeyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights>‚{?£xv?íE€?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data«³>4?šþ?“¶9?proportion seropositivePfMSP1(19)yesyesyeseÄ·’Z?>M?.!h?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data«á¼=xŽR=Jq>proportion seropositivePfCSPyesyesyeseÄeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.åeeeåeeåeàAYYYINCLUDEDeYsɂA2&ÅBAll agesAn. Minimus; An. Maculatus; An. DirusÞ\,;÷uà;An. Dirus s.l.; An. Minimus s.l.€?€?e€?2\HBKNH - Ka Nu HtaJun-13åeeeeeeeeeeeeEELISA16 French and 1 bangkok citizenŸØ	?0ñ÷>£¸?äšf?ÐC"?w¤?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee3G <_â;mû=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1Ìeåeeeåeeååh`o>Ôù>>ã>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ÌåeeeåÛ;&>—ø=ãgP>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1Ì 2018eeeåeåeå×£AÅ è@L7
Abites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights¶ókAyéZAÛù|Ainfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights¶ókAyéZAÛù|Ainfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights\B?Ä5?ôP?proportion seropositiveeeåPfAMA1yesyesenoO'Flaherty et al., unpublished dataú¡6?”]ú>q‚?proportion seropositiveåeePfMSP1(19)yeseeyesyeseAX94?ؼ%?صB?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataúMŸ}=½ö==proportion seropositivePfCSPyesyesyeseCeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eeeeeeeeeeeeerELISA16 French and 1 bangkok citizen\è?$C?•?eeåeeeåeeåeeeeeeeåeeeeåeåeeeeeeeeeeeeeeåeeåeeeååeåeàAYYYINCLUDEDeYeeåeeeeeeeeeå¤p‰AázÄBAll agesAn. Minimus; An. Maculatus; An. DirusÝÊõ:K< ;An. Dirus s.l.; An. Minimus s.l.yes€?€?7?proportio€?2bHBKNH - Ka Nu HtaSep-13åeeeeeeeeeeeeELISA16 French and 1 bangkok citizen8:ý>Õß>ϯ
?ÏÐA?9¿
?y?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeŸ9<e;iÃ=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeååH4>ýë>>¤a>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeee壞>¨AÇ=xœ5>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå\@˜nÒ?mç@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights^Cy?ªVt?0~?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data
<<<?bâ>2	?proportion seropositivePfMSP1(19)yesyesyese6–A?Ò¼3?œoO?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataò§é‡>ÍaZ>h¢¢>proportion seropositivePfCSPyesyesyeseeeeeeee21HBTOT - Tar Au TaJun-13ååeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.Anopheles bitesHLCyesYesnoTraoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B Assi SB, Poinsignon A, Dagnogo M et al: Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites. The American journal of tropical medicine and hygiene 2018, 98(5):1353-1359.eàAYYYINCLUDEDeY¤p‰AázÄBAll agesAn. Minimus; An. Maculatus; An. DirusÝÊõ:K< ;An. Dirus s.l.; An. Minimus s.l.€?€?€?2hHBKNH - Ka Nu HtaDec-13åeeeeeeeeeeeeELISA16 French and 1 bangkok citizen"û?ž®?§G"?\à@?žŸ?½D„?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeø“g;ý‚]»P*+<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeååhdC>ƒ>ÇEr>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeåæL1>}(>Gq^>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå×£°?yé†?5^Ú?bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights%í@`åÔ@—Ainfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights%í@`åÔ@—Ainfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsö(\?&Q?Ü+g?proportion seropositiveePfAMA1yesyesnoO'Flaherty et al., unpublished dataú.ôB?i¸?Ú= ?proportion seropositiveeeeeeeePfMSP1(19)yesyesyese§…n?“€f?¼Šv?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataùŸy´=u\=„èú=proportion seropositivePfCSPyesyesyeseeeåeeeeeeeeeeåeeeeeeeeeeeeåeeeeeeeåeåeeåeå2\BKNH  K N HeååeåeeeeeeeeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.au V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. ublished 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4eeå50 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 peàAYYYINCLUDEDeYproportion seropositivePfAMA1yesyesnoO'Flaher¤p‰AázÄBAll agesAn. Minimus; An. Maculatus; An. DirusÝÊõ:K< ;An. Dirus s.l.; An. Minimus s.l.€?€?€?2oHBKNH - Ka Nu HtaMar-14åeeeeeeeeeeee-ELISA16 French and 1 bangkok citizensXø>þoÛ>t 
?Å3?Mg?W÷s?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeyÎ;÷E»÷gu<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1>eåeeeåeeååJî=½¦=²;>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1>åeeeå†Î=É^Š=)ç>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1> 2018eeeåeåeåìQXAHA¾ŸhAbites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights×¨B}¿£Bžï­Binfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4LISA1650 person nights×¨B}¿£Bžï­Binfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights}%s?l?ï;z?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataï`?‹Oå>¯°?proportion seropositivePfMSP1(19)yesyesyese00²6?1¤'?.ÀE?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataãx.‡=EÙ=MpÀ=proportion seropositivePfCSPyesyesyese/eeeeeeeeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeåeeeååeeåeeåeeeeeeeeeåeeeeeeåeeeeeeeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eeeeeeeåeåeeåeàAYYYINCLUDEDeYeå¤p‰AázÄBAll agesAn. Minimus; An. Maculatus; An. DirusÞŸqa:÷Ì;An. Dirus s.l.; An. Minimus s.l.ty and e€?€?drug admini€?2uHBKNH - Ka Nu HtaMay-14åeeeeeeeeeeee*ELISA16 French and 1 bangkok citizen„äÏ>#X³>äpì>Ή+?ê
?‚RO?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeåå6@<Áí¿ºÜþË<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeå<¡ÑB»4Z˜<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå¤p%A/A-²3Abites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4ngkok citizenŸØ	?0ñ÷>£¸?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeå50 person nightseeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightse9i?Ö³`?õ¾q?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished datan S?ö¹>Óå>proportion seropositivePfMSP1(19)yesyesyese,¡§?ró>8–?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data¢L=úÚÎ<ãg˜=proportion seropositivePfCSPyesyesyese-eeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eàAYYYINCLUDEDeY¤p‰AázÄBAll agesAn. Minimus; An. Maculatus; An. DirusÞŸqa:÷Ì;An. Dirus s.l.; An. Minimus s.l.€?€?hdC>€?2{HBKNH - Ka Nu HtaAug-14åeeeeeeeeeeee,ELISA16 French and 1 bangkok citizen§
t?mñm?â)z?ˆª™?avN?CÌ?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeêý;Š»‡EV<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1âeåeeeåeeåå#¼ý<Úe	<’b[=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1âåeeeå´ý<º8:ìè=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1â 2018eeeåeåeå=
wA²eAd;„Abites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsD‹nA‹l]Aü©Ainfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsD‹nA‹l]Aü©Ainfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights£·o?1ph?ÿv?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataƒEA?…¢g?d<€?proportion seropositivePfMSP1(19)yesyesyese.^vY?d¸N?V4d?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished datašSs=HN=ƒ,°=proportion seropositivePfCSPyesyesyese/eeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.åeeeåeeåeàAYYYINCLUDEDeYå¤p‰AázÄBAll agesAn. Minimus; An. Maculatus; An. DirusÞŸqa:÷Ì;An. Dirus s.l.; An. Minimus s.l.€?€?€?2HBKNH - Ka Nu HtaNov-14åeeeeeeeeeeeeELISA16 French and 1 bangkok citizenQßY?
<O?š‚d?ÐB0?«ˆ?ÛFd?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÕ};Îóq»^;<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeååÕý<× <,ÓT=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeå…%ž<£õ&;F¶=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå…k@ÕxI@´È†@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsáq{?Ý|w?åf?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataiG?ŠM?ž4f?proportion seropositivePfMSP1(19)yesyesyese€”e?Ry\?¯¯n?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data¸=>ß`<‰8g=proportion seropositivePfCSPyesyesyeseeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eàAYYYINCLUDEDeY¤p‰AázÄBAll agesAn. Minimus; An. Maculatus; An. DirusÞŸqa:÷Ì;An. Dirus s.l.; An. Minimus s.l.€?€?€?2‡HBHKT - Htee Kaw Taw Jul-13åeeeeeeeeeeeeêELISA16 French and 1 bangkok citizen—Sp?käj?ÃÂu?i?ßò-?!
’?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee[=ÈßG=ÅL¼=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeåå?é“>V€>ÿ{§>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeå¹»;>JP>)']>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå×£A?5‡AošAbites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights¶CÅ@C…+Cinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsÇKBD‹
BJBinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights%FíBj<çBßOóBinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsP5?R+?-N??proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data	¤Í?«=e?†i{?proportion seropositivePfMSP1(19)yesyesyeseèj¥?aÑ?sy!?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataþ˜›=CÎV=ÚÊË=proportion seropositivePfCSPyesyesyeseçeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V./¸<BN'gattakroAug-14
³õ@]¡Àåeeeeeeeeeeee]ELISAFrnchúi?¶c[?I‘x?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeàAYYYINCLUDEDeYåeeÍ̆A¤ðÄBAll agesAn. Minimus50 person nightsÝð¢/:ͯæ:An. Dirus s.l.; An. Minimus s.l.	€?€?€?2HBHKT - Htee Kaw Taw Oct-13åeeeeeeeeeeeeELISA16 French and 1 bangkok citizen4—\?ýU?md?ŠX?ßò-?¸|‹?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÌd=Z¤¤<†wT=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeåå}ð>>Þ]>Ûñ”>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeåæ¢K>ÞÅ(>ïn>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeåš™™?B`e?ƒÀ?bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights2{HBKNH - Ka Nu HtaAug-14åinfectious bites/person/yearpopulationHLCeyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsÖÔT?(ƒL?&]?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataþ¶î?>ÛQ?-Sg?proportion seropositivePfMSP1(19)yesyesyeseM:F?¯<?‡ÅO?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataã„êX>5>é½|>proportion seropositivePfCSPyesyesyeseHBKNH - Ka Nu HtaeAg-4eeåeeeeeeeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.itizen T_?N¬W?ñüf?UUU?«ª*?5Hƒ?eeåeeeåeeåeeeeeeeåeeeeeeåeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee‹
f<œ¡;.£½<eàAYYYINCLUDEDeYsurveyyesYesnoLandier J, Kajeechiwa L, Thwin Í̆A¤ðÄBAll agesAn. MinimusyesyeseÄ·’Z?>M?.!hÝð¢/:ͯæ:An. Dirus s.l.; An. Minimus s.l.aherty e	€?€?ta«á¼=xŽR€?2“HBHKT - Htee Kaw Taw Jan-13åeeeeeeeeeeeeôELISA16 French and 1 bangkok citizen…ëQ?LI?zŠZ?¤A?ى?.ßr?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeewu<;¾žÔ<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ÔeåeeeåeeååÝO>æ‹*>.u>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1Ôåeeeå܉>D!ø=?>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1Ô 2018eeeåeåeå)\/@çû@j¼L@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4eeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee50 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsº"2?rV'?ï<?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataÉøÞ?êìF?!ê\?proportion seropositivePfMSP1(19)yesyesyeseð’¿I?4@?òaS?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataÅR?=­å<¬…=proportion seropositiveeePfCSPyesyesyeseíeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.yesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longiudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4ngkok citizenŸØ	?0ñ÷>£¸?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeàAYYYINCLUDEDeYeeeeÍ̆A¤ðÄBAll agesAn. MinimusÝð¢/:ͯæ:An. Dirus s.l.; An. Minimus s.l.	€?€?€?2šHBHKT - Htee Kaw Taw May-14åeeeeeeeeeeeeÞELISA16 French and 1 bangkok citizen T_?N¬W?ñüf?UUU?«ª*?5Hƒ?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee‹
f<œ¡;.£½<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1eåeeeåeeååªR1>šS>ºQO>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1åeeeå¨b	>µ»Ü=ng$>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1 2018eeeåeåeå…#AXA-²1Abites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights-M?MñC?
W?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished data´÷ï!?GT?!bj?proportion seropositivePfMSP1(19)yesyesyeseßP(?­¬?ó‹3?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data²>=u®¨<%`=proportion seropositivePfCSPyesyesyeseÞeeeeeeeåeåe2{HBKNe- a u å14åeåeeeeeåeeeee,LISA1 Frenh nd 1 bagkeåm?â)z?eeåeeeeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.ransmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 prson nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights>‚{?£xv?íE€?proportion seropositivePfAMA1yesyeseàAYYYINCLUDEDeYpublished data«³>4?šþ?“¶9?poportion seropositiveÍ̆A¤ðÄBAll agesAn. MinimusÞɎ94€7:An. Dirus s.l.; An. Minimus s.l.	€?€?€?2 HBHKT - Htee Kaw Taw Jun-14åeeeeeeeeeeeeELISA16 French and 1 bangkok citizen½÷^?ø£W?„Kf?¸|K?ى?Oì„?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeproportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1õeåeeeåeeååˆÏ‚<½£;"»Ü<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1õåeeeå<ëd<	r;%¨Æ<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1õ 2018eeeåeåeå¸å@B`Í@/Ýü@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights¶+Q?ÞlH?‹êY?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataìã9?ñS?eþi?proportion seropositivePfMSP1(19)yesyesyese½»›>5©†>Eΰ>proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataàà<ˍX<Ü)=proportion seropositivePfCSPyesyesyeseeeeeeeeHtee Kaw Taw May-14åeeeeeeeeeeeeÞELISA16 French and 1 bangkok citizen T_?N¬W?ñüf?eeåeåeåeeeeeeeåeeeeeeåeåeeåeeeeeåeåeåeeeeeåeeeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eàAYYYINCLUDEDeYÍ̆A¤ðÄBAll agesAn. Minimusd effectiveness of mass dÞɎ94€7:An. Dirus s.l.; An. Minimus s.l. of arte	€?€?ciparum mal€?2¦HBHKT - Htee Kaw Taw Sep-14åeeeeeeeeeeeeúELISA16 French and 1 bangkok citizenx}T?¯L?AÞ\?}Ë7?Ò 
?¾å[?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeo;¦%ûºØÛÁ;proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ôeåeeeåeeåå‡Ù=Ó¡=¿,>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ôåeeeåìQ¸=5ò„=¢±ë=proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1ô 2018eeeåeåeå×£0@33@{N@bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsš™é@Ë¡Ñ@´ÈAinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsš™é@Ë¡Ñ@´ÈAinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nights‘Ï:?Œ¦0?–øD?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataá
.?dJ?Œå^?proportion seropositivePfMSP1(19)yesyesyeseúÏHE?‡.;?cO?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished data´(I=x؟<ú¥T=proportion seropositivePfCSPyesyesyeseøeeeeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.åeåeeeåeeå%Ir?0c?±€?proportion positivemicroscopysurveyyesYesyeseàAYYYINCLUDEDeYÍ̆A¤ðÄBAll agesAn. MinimusÞɎ94€7:An. Dirus s.l.; An. Minimus s.l.vey	€?€?noLandier €?2¬HBHKT - Htee Kaw Taw Dec-14åeeeeeeeeeeeeÓELISA16 French and 1 bangkok citizenž Y?ÒVQ?kêa?ìÄN?«ª*?€?eeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeep‹;¨›Õº€#&<proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1Öeåeeeåeeåå³>bÏ=µh&>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1Öåeeeå̓Õ=Ôîœ=d>proportion positiveeuPCRsurveyyesYesnoLandier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81. Published 2017 Sep 6. doi:10.12688/wellcomeopenres.12240.1Ö 2018eeeåeåeå)\?j¼´>ZD?bites/person/nightHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationPf + Pv positiveHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.42 HBHKT - Htee Kaw Taw Jun-14å50 person nightseeeeeeeeeeeELISA16 French and 1 bangkok citizen½÷^?ø£W?„Kf?eeåeinfectious bites/person/yearpopulationHLCeeeeeeyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoChaumeau V, Fustec B, Nay Hsel S, et al. Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsój?´ˆc?1­p?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataÈjL$?¸„N?…¼d?proportion seropositivePfMSP1(19)yesyesyeseÕÓY?etQ?Æ1b?proportion seropositiveePfMSP2yesyesnoO'Flaherty et al., unpublished dataÈyí­<¹<J=proportion seropositivePfCSPyesyesyese×eeeeeeeåeåeeåeåeåeåeåYa-Umphan 20182013-2014Repeated cross sectionalAsia/GMSMyanmarHtoo Pyin Nyar (TPN); Tar Au Ta (TOT); Ka Nu Hta (KNH); Htee Kaw Taw (HKT)An. Minimus; An. MaculatusAll ages2602: TPN 452; TOT 659; KNH 459; HKT 10329425: TPN 1906; TOT 1970; KNH 2046; HKT 3503gSG6-P1peptideâThe American journal of tropical medicine and hygieneAnopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.Ya-Umphan P.; Cerqueira D.; Cottrell G.; Parker DM.; Fowkes FJI.; Nosten F.; Corbel V.eàAYYYINCLUDEDeYÍ̆A¤ðÄBAll agesAn. MinimusåÞɎ94€7:An. Dirus s.l.; An. Minimus s.l.	€?€?/person/nig€?3=
LB2 years19999ELISApooled swedish donors™Á>£¢ý=g:A?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee‹ò)?â’>Kßk?proportion seropositivePfAMA1yesyesyeså''?%N‘>Œøg?proportion seropositivePfMSP1(19)yesyesyeseåiz>iú ?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeåêƒÂ>iú=»eA?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.Ellen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; eåÑa?2WJ?D‡{?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåe€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÏAn. Arabiensis; An. Funestus; An. Gambiae€@ @3{LB4 years19999ELISApooled swedish donorsë$Û>>çž?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeåÜY?rµ3?«ƒ?proportion seropositivePfAMA1yesyesyesåë]L?¿(?°Òr?proportion seropositivePfMSP1(19)yes2¬yesKT -yeseå²Í(?âþì>ó[?proportion seropositiveePfMSP2yesyesyesåeeeeeeeeeåA16 French and 1 begkk itee?eeåeeeeeåeeåeeeeeeeååeåeeåeåXÝ2?Ó?ó[?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.eeåeeeeeåeeeeeeeeåeEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; eeåeeeeeeåeeeeeeee€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÏAn. Arabiensis; An. Funestus; An. Gambiae€@ @3¸LB6 years19999ELISApooled swedish donorsÝ><¼–>?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeåeeeeeåeeeeeeeeåeeeeeeeeåeeåîÐW?Z1?w{u?proportion seropositiveeeåPfAMA1yesyesyeseeåeeeeeeåå„@A?Dü?ä6b?proportion seropositivePfMSP1(19)yesyesyeseåHÀD?Ç6#?÷gg?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeåœd.?uË?îO?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsinfectious bites/person/yearpopulationHLCyesYesnoCEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; 19;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.450 person nightsMu?ÉYn?Ϭ{?proportion seropositivePfAMA1yesyesnoO'Flaherty et al., unpublished dataéÇ¡J?¡b?–Iy?proportion seropositive€AINCLUDEDeYyesyese3qG\?ükP?"h?proportion seropositiveePfMSúøÀ‡BChildrenAn. Gambiae; An. Funestusblished datÏAn. Arabiensis; An. Funestus; An. Gambiae€@se1 @3ö(LB8 years19999ELISApooled swedish donorseބ>A@
>9Ï>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå&g?s¯L?ï½y?proportion seropositivePfAMA1yesyesyeså/9B?*¿&?¸ã_?proportion seropositivePfMSP1(19)yesyesyeseå":\?¢C?*Òt?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeåÿì<?ܟ?7£V?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.4-month longitudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4Ellen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; e€AINCLUDEDeY50 person nightsúøÀ‡BChildrenAn. Gambiae; An. FunestusÏAn. Arabiensis; An. Funestus; An. Gambiae€@ @333LB10 years19999ELISApooled swedish donors€°>qÁX>i£ô>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå3ö(LB8 years1999úøÀ‡B9ELISApooled swedish donorseބ>A@
>9Ï>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeRü}?jšn?2	…?proportion seropositivePfAMA1yesyesyesåD‰h?SM?9{?proportion seropositivePfMSP1(19)yesyesyeseå*Òt?ݲ`?€?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeå®”_?9I?žwq?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.åeEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; åeeeåeåe€AINCLUDEDeYåúøÀ‡BChildrenAn. Gambiae; An. FunestusÏAn. Arabiensis; An. Funestus; An. Gambiae€@ISApooled s @3q=LB12 years19999ELISApooled swedish donorsSò>È5¥>x†?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeåeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee€?=Yx?€?proportion seropositivePfAMA1yesyesyesåBêb?g$D?Êw?proportion seropositivePfMSP1(19)yesyesyeseåoYp?ÄýY?€?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeå3q=LB12 yearseåúøÀ‡B9ELISApoeed swedish donorsSò>Èe>x?åeeeeeeeeåÄýY?ÿì<?n?proportion seropositivepopulationPfMSP3yesyesyeseåeeåeeeåeåeeeeeeeåeeeeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.Ellen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; e€AINCLUDEDeY3š™LB14 yeaúøÀ‡BChildrenAn. Gambiae; An. FunestusÏAn. Arabiensis; An. Funestus; An. Gambiae€@ @3®GLB14 years19999ELISApooled swedish donorsFí¯>æø[>Ÿmø>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå€?€?€?proportion seropositivePfAMA1yesyesyeså¯*g?‹þN?|?proportion seropositivePfMSP1(19)yesyesyeseåiz?÷gg?€?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeåeeeeeåeeåeå™+e?îÏN?·,x?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.eeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; eeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeee€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÏAn. Arabiensis; An. Funestus; An. Gambiae€@ @3ìQLB16 years19999ELISApooled swedish donorsC>?­ÄÒ>ßþ=?eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå€?Ät?€?proportion seropositivePfAMA1yesyesyesån†l?JZT?å~?proportion seropositivePfMSP1(19)yesyesyeseå€?Ñá~?€?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeåÑa?2WJ?D‡{?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiHoloendemicAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.tudinal study in four villages. Wellcome Open Res. 2019;3:109. Published 2019 Jun 17. doi:10.12688/wellcomeopenres.14761.4Ellen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; e€AINCLUDEDeY50 person núøÀ‡BChildrenAn. Gambiae; An. FunestusÏAn. Arabiensis; An. Funestus; An. Gambiae€@ @3)\LB2 years2010cELISApooled swedish donors?=ëÇw;[b:>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå3)\LB2 years2010úøÀ‡BcELSApooled swedisÇw;[b:>e3ìQLB16yearsRڍ>o$>˜ñê>proportion seropositiveooled swePfAMA1yesyes?­Äyes=?åN6Y>÷·–=õe¼>proportion seropositiveeePfMSP1(19)yeseåyesyeseåâ¬|>łæ=äþÖ>proportion seropositiveePfMSP2yesyesyeseeeååeeåeeeeeåeeeååeeeeeeeeåeeeeeåeeåeåeeåeåÍ¡>RÚ
>yuú>proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.eåeEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; åeeeåe€AINCLUDEDeYåeúøÀ‡BChildrenAn. Gambiae; An. FunestusÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@@@3ffLB4 years2010cELISApooled swedish donorsÀý”=íÇ÷;<øX>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå3ffLB4 years2010úøÀ‡BcELISApooled swedish donorsÀý”=íÇ÷;<øX>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeeeeåeeeeeåeeeeeåeeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee ¥]>RÚ
<óâ>proportion seropositivePfAMA1yesyesyeså ¥Ý>ób>nÛ6?proportion seropositivePfMSP1(19)yesyesyeseåõe¼>Ê&>Ø;&?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåe厀”>÷·–=â¬ü>proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.Ellen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; e€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@@@3¤pLB6 years2010cELISApooled swedish donors&Ka>•£¥=V¼>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå/ºè>Rڍ>ºè"?proportion seropositivePfAMA1yesyesyeså¹??»?ób?proportion seropositivePfMSP1(19)yesyesyeseåb?Pˆ³>Pˆ3?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeåłæ>Rڍ>Q± ?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.Ellen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; e€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@@@3ázLB8 years2010cELISApooled swedish donors‹q>$‚›=/ñv>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeåÉý-?RÚ
?m²I?proportion seropositivePfAMA1yesyesyesåÇÔ@?# %?RZ?proportion seropositivePfMSP1(19)yesyesyese帖H?«ª*? ¥]?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeå`ï?=Ïó>Pˆ3?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.Ellen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; e€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@@@3…LB10 years2010cELISApooled swedish donorsØ„>uÄ!>?½»>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå~B?¦ö>×9?proportion seropositivePfAMA1yesyesyeså!ÎJ?}/?>ø`?proportion seropositivePfMSP1(19)yesyesyeseåÆ«S?Œ.:?˜ñj?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeåPˆ³>­ü„>j`ï>proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.eeeåeeåEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; åe€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusøÀ‡BcELIÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@eee@@3\LB12 years2010cELISApooled swedish donorst­M>uŒÎ="~ž>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå3š™LB14 years2010úøÀ‡BcELISApooled swedish donors;l>‡Øù=Ãv´>eeeeeeeeeeeeåeeåeeeåeåeeee?!N?}/?>ø`?proportion seropositivePfAMA1yesyesyesåÉý-?»?{G?proportion seropositivePfMSP1(19)yesyesyeseå?!N?›l2?‰Ü_?proportion seropositiveePfMSP2yesyesyesåeåeeeeeeeåeåeeåeåm²É>Rڍ>øà?proportion seropositivepopulationPfMSP3yesyesyeseåeåars2010úøÀ‡BcLIApooledsweåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.eåeeåEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; åe€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@å@@3š™LB14 years2010cELISApooled swedish donors;l>‡Øù=Ãv´>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå2010úøÀ‡BcELISApooled swedish donors›Çï=J!Ó<h¦k>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee|p?‰Ü_?Kä~?proportion seropositivePfAMA1yesyesyeså?!N?¤4?§/c?proportion seropositive2010PfMSP1(19)yesBcELyesooleyeseå¶Dn?k‰\?-‘{?proportion seropositiveePfMSP2yesyesyeseeeeeeeåeeeåeåeeåeeeeeeeeeeeeeeåeeeeeeåeeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeååeåeeeeåeeeåeåԗñ>}¯>¬Ó?proportion seropositivepopulationPfMSP3yesyesyeseåeeeeeåeeeeeåeåeeeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.åeåEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ; eåeåe€AINCLUDEDeYúøÀ‡BChildrenAn. Gambiae; An. FunestusÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@@@3×£LB16 years2010cELISApooled swedish donors›Çï=J!Ó<h¦k>eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeeåeåeeeåeeååeååeeeåeåeeeåeåeå3×£LB16 years2010úøÀ‡BcELISApooled swedish donors›Çï=J!Ó<h¦k>eeeeeeeeeeeeå§/c?å'D?>x?proportion seropositiveeeåPfAMA1yesyesyeseeååRZ?|ðA?>x?proportion seropositiveeeåPfMSP1(19)yeseyesyeseå/ºh?ÖéK?-‘{?proportion seropositiveePfMSP2yesyesyeseeåeeeeeeeeååeeåeeeeeeeeeeeåeeeeåeeeeeeeeeeåeåeeåeåڍ?As¨>As(?proportion seropositivepopulationPfMSP3yesyesyeseåeåeåYman 20161999; 2010Repeated cross sectionalAfricaTanzaniaNyamisatiperennialAn. Gambiae + An. FunestusChildren2 to 161999: 313; 2010: 355668gSG6recombinant proteinàScientific ReportsAntibody acquisition models: A new tool for serological surveillance of malaria transmission intensityYman, V.; White, M. T.; Rono, J.; Arca, B.; Osier, F. H.; Troye-Blomberg, M.; Bostrom, S.; Ronca, R.; Rooth, I.; Farnert, A.eeeåEllen Kearney (2020-07-28 13:29:38)(Select): Potentially meets criteria: Will have to somehow extract or ask authors to provide the actual observed seroprevalence estimates for 1996 and 2009 ;  ¥]>RÚ
<óâ>proportion seropositivePfAMA1yesyesyeså ¥Ý>ób>nÛ6?proportion seropositivePfMSP1(19)yesyesyeseåõe¼>Ê&>Ø;&?proportion seropoe€AINCLUDEDeYåúøÀ‡BChildrenAn. Gambiae; An. FunestusÚ.V4>ßàk>An. Arabiensis; An. Funestus; An. Gambiae@@@@4ffPBOu ChraåELISAã‹
=Í´w<“*]=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee¸=b÷<!³=proportion positiveePCRåeåeeeåeeååeååeeeå¸=b÷<!³=proportion positiveePCRåeeeåeåeåß*@mean number per nightåeåeåeåeeeeeeeåeåeeåeåeåeåeåeCharlwood 20172013-2014Repeated cross sectionalAsia/GMSCambodia2 villages Mondolkiri ProvinceendemicAn. dirusAll ages4541180gSG6recombinant proteináWorld Malaria JournalSpatial repellents and malaria transmission in an endemic area of Cambodia with high mosquito net usageJacques D. Charlwood, Tom Hall, Somalay Nenhep, Emily Rippon, Ana Branca-Lopes, Keith Steen, Bruno Arca, Chris Drakeleyåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee¸=b÷<!³=proportion positiveePCReÀ@YYNINCLUDEDeNAb levels onlyƒÅCAF²ÕBAll agesAn. DirusÝÀϸ:¶-Ê;An. Dirus s.l.; An. Minimus s.l.€?€?€?4ÍÌPBOu ChraåELISA¡d–<â‹
;(=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÂõ<¦›Ä;/†²=proportion positiveePCRåeåeeeåeeååeååeeeåÂõ<¦›Ä;/†²=proportion positiveePCRåeeeåeåeå©Zþ?mean number per nightåeåeåeåeeeeeeeåeåeeåeåeåeåeåeCharlwood 20172013-2014Repeated cross sectionalAsia/GMSCambodia2 villages Mondolkiri ProvinceendemicAn. dirusAll ages4541180gSG6recombinant proteináWorld Malaria JournalSpatial repellents and malaria transmission in an endemic area of Cambodia with high mosquito net usageJacques D. Charlwood, Tom Hall, Somalay Nenhep, Emily Rippon, Ana Branca-Lopes, Keith Steen, Bruno Arca, Chris DrakeleyeÀ@YYNINCLUDEDeNAb levels onlyåLISAƒÅCAF²ÕBAll agesAn. DirusÝÀϸ:¶-Ê;An. Dirus s.l.; An. Minimus s.l.€?€?€?433QBOu ChraåELISAQæ<Y B<våO=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeý¸<Ï3; p¡=proportion positiveePCRåeåeeeåeeååeååeeeåý¸<Ï3; p¡=proportion positiveePCRåeeeåeåeåY}À?mean number per nightåeåeåeåeeeeeeeåeåeeåeåeåeåeåeCharlwood 20172013-2014Repeated cross sectionalAsia/GMSCambodia2 villages Mondolkiri ProvinceendemicAn. dirusAll ages4541180gSG6recombinant proteináWorld Malaria JournalSpatial repellents and malaria transmission in an endemic area of Cambodia with high mosquito net usageJacques D. Charlwood, Tom Hall, Somalay Nenhep, Emily Rippon, Ana Branca-Lopes, Keith Steen, Bruno Arca, Chris DrakeleyåeåeeåeåeåeåeåeeÀ@YYNINCLUDEDeNAb levels onlyƒÅCAF²ÕBAll agesAn. DiruseeÝÀϸ:¶-Ê;An. Dirus s.l.; An. Minimus s.l.€?€?€?4š™QBPu ChaåELISAÜî°<â‹
;våO=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåB
<Q*†:üö<proportion positiveePCRåeåeeeåeeååeååeeeååB
<Q*†:üö<proportion positiveePCRåeeeåeåeåþ3¼>mean number per nightåeåeåeåeeeeeeeåeåeeåeåeåeåeåeCharlwood 20172013-2014Repeated cross sectionalAsia/GMSCambodia2 villages Mondolkiri ProvinceendemicAn. dirusAll ages4541180gSG6recombinant proteináWorld Malaria JournalSpatial repellents and malaria transmission in an endemic area of Cambodia with high mosquito net usageJacques D. Charlwood, Tom Hall, Somalay Nenhep, Emily Rippon, Ana Branca-Lopes, Keith Steen, Bruno Arca, Chris DrakeleyeÀ@YYNINCLUDEDeNAb levels only“PCA̶ÕBAll agesAn. DirusÝ[”Y:K< ;An. Dirus s.l.; An. Minimus s.l.€?€?€?4RBPu ChaåELISA¡d–<â‹
;;[5=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeee8Ù<dق:)ôð<proportion positiveePCRåeåeeeåeeååeååeeeå8Ù<dق:)ôð<proportion positiveePCRåeeeåeåeåª]?mean number per nightåeåeåeåeeeeeeeåeåeeåeåeåeåeåeCharlwood 20172013-2014Repeated cross sectionalAsia/GMSCambodia2 villages Mondolkiri ProvinceendemicAn. dirusAll ages4541180gSG6recombinant proteináWorld Malaria JournalSpatial repellents and malaria transmission in an endemic area of Cambodia with high mosquito net usageJacques D. Charlwood, Tom Hall, Somalay Nenhep, Emily Rippon, Ana Branca-Lopes, Keith Steen, Bruno Arca, Chris DrakeleyeÀ@YYNINCLUDEDeNAb levels only“PCA̶ÕBAll agesAn. DiruseÝ[”Y:K< ;An. Dirus s.l.; An. Minimus s.l.€?€?€?4ffRBPu ChaåELISAyË<Y B<δw=eeeeeeeeeeeeåeeåeeeåeeåeeeeeeeåeeeeeeåeeåeeeeeåeeeeeeeeåeeeeeeeeåeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeåeeeeeeÍÌÌ<†Ë<kk=proportion positiveePCRåeåeeeåeeååeååeeeåÍÌÌ<†Ë<kk=proportion positiveePCRåeeeåeåeå~È=mean number per nightåeåeåeåeeeeeeeåeåeeåeåeåeåeåeCharlwood 20172013-2014Repeated cross sectionalAsia/GMSCambodia2 villages Mondolkiri ProvinceendemicAn. dirusAll ages4541180gSG6recombinant proteináWorld Malaria JournalSpatial repellents and malaria transmission in an endemic area of Cambodia with high mosquito net usageJacques D. Charlwood, Tom Hall, Somalay Nenhep, Emily Rippon, Ana Branca-Lopes, Keith Steen, Bruno Arca, Chris DrakeleyåeåeåeÀ@YYNINCLUDEDeNAb levels onlyeå“PCA̶ÕBAll agesAn. DirusÝ[”Y:K< ;An. Dirus s.l.; An. Minimus s.l.€?€?€?</data><strls></strls><value_labels><lbl>uEndemicity_5catsȪkáÚDý3¢@É$@Ȫk5$5$É$@ȪkE ,9Eliminating MalariaHypoendemicMesoendemicHyperendemicHoloendemic</lbl><lbl>YEndem_can45catsȪkáÚDý3¢@É$@Ȫk5$5$É$@Ȫk1%HypoendemicMesoendemicHyperendemicHoloendemic</lbl><lbl>Tdvs_full_n5catsȪkáÚDý3¢@É$@Ȫk5$5$É$@ȪkìGQ]jvœ·Ý	
An. AlbimanusAn. ArabiensisAn. Arabiensis; An. Funestus; An. GambiaeAn. DirusAn. FarautiAn. FunestusAn. GambiaeAn. Gambiae; An. FunestusAn. MinimusAn. Minimus; An. MaculatusAn. Minimus; An. Maculatus; An. DirusAn. Pharoensis</lbl><lbl>2endfull_n5catsȪkáÚDý3¢@É$@Ȫk5$5$É$@Ȫk
LowModerateHigh</lbl><lbl>~study_type2catsȪkáÚDý3¢@É$@Ȫk5$5$É$@Ȫk6Oi‰ªÂÏÜõ	
Cross-sectionalLongitudinalRepeated cross sectionalRepeated cross-sectionalRepeated cross-sectional Repeated cross-sectional surveyRepeated cross-sectional surveysRepeated ross-sectionallongitudina;longitudinalrepeated cross-sectionalrepeated cross-sectional surveys</lbl><lbl>‡_mergeype2catsȪkáÚDý3¢@É$@Ȫk5$5$É$@ȪkW+?master only (1)using only (2)matched (3)missing updated (4)nonmissing conflict (5)</lbl></value_labels></stata_dta>
back to top